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Purpose: To examine the variables that influence lipid deposition on conventional 
and silicone hydrogel contact lens materials and to build a physiologically relevant 
in vitro model of lipid deposition on contact lenses.  
 
Methods: Lipid deposition on contact lens materials can lead to discomfort and 
vision difficulty for lens wearers. Using a variety of radiochemical experiments and 
two model lipids (cholesterol and phosphatidylcholine), a number of clinically 
significant parameters that may influence lipid deposition were examined.  
• The optimization and characterization of a novel artificial tear solution 
(ATS) was examined (Chapter 3) 
• Optimization of an extraction system to remove deposited cholesterol and 
phosphatidylcholine from various contact lens materials  (Chapter 4) 
• The influence of different tear film components on lipid deposition was 
researched (Chapter 5) 
• The efficiency of hydrogen peroxide disinfecting solutions to remove 
deposited lipid from contact lenses was investigated (Chapter 6) 
• The effect of intermittent air exposure on lipid deposition was examined 
through the use of a custom built “model blink cell” (Chapter 7) 
 
Results: A novel complex ATS designed for in-vial incubations of contact lens 
materials was developed. This solution was stable and did not adversely affect the 
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physical parameters of the contact lenses incubated within it. An efficient 
extraction protocol for deposited cholesterol and phosphatidylcholine was 
optimized based on chloroform and methanol with the addition of water and acetic 
acid for phosphatidylcholine extraction.  Overall, cholesterol and 
phosphatidylcholine deposition is cumulative over time and found to deposit in 
greater masses on silicone-containing hydrogels.  Cholesterol and 
phosphatidylcholine deposition is influenced by the composition of the incubation 
medium and air exposure which occurs during the inter-blink period. Hydrogen 
peroxide disinfecting solutions were able to remove only marginal amounts of lipid 
from the contact lenses, with the surfactant containing solution removing more.  
 
Conclusion: This thesis has provided hitherto unavailable information on the way 
in which lipid interacts with conventional and silicone hydrogel contact lens 
materials and the in vitro model built here can be utilized in various ways in the 
future to assess other aspects and variables of lipid and protein deposition on a 
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School of Optometry and Department of Chemistry, University of Waterloo. Master 
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1 INTRODUCTION 
1.1 THE MEIBOMIAN GLANDS 
1.1.1 STRUCTURE, FUNCTION AND PHYSIOLOGY 
The meibomian glands, named after Heinrich Meibom who discovered them,1 
are sebaceous holocrine glands that produce and expel lipid through an orifice just 
anterior to the mucocutaneous junction. (Figure 1-1). The glands are found within 
the tarsal plate of the eyelid and are arranged in single parallel rows, with 20–30 
individual glands in the lower lid and 25-40 glands in the upper lid (Figure 1-2).2-9  
The glands themselves range in size from 2-5.5mm in length, depending which lid 
they reside in, with the upper lid allowing for longer glands.8 Individual glands are 
composed of 10-15 many small round acini, which are approximately 150-200 µm 
in diameter, that are attached to one central duct, which runs the entire length of 
the gland (Figure 1-3).5, 7, 10 Each individual grape-like acinus produces both polar, 
non-polar and amphiphilic lipids.2-5 It is the individual secretory cells called 
meibocytes that reside within the central part of the acini that produce the lipid 
components and then release them into the central duct.10, 11 This process is called 
2 
 
acinar cell degeneration.5 The lipids secreted give protection by providing a 
hydrophobic barrier to reduce the chance of tear overflow onto the lid margin.  The 
lipids also function to form a seal while the eye is closed during sleep and to reduce 
evaporation while the eye is open.11 The lipids function as a lubricant while the eye 
blinks, and may provide a protective layer against bacterial infection.5, 11  
 
FIGURE 1-1:  TYPICAL APPEARANCE OF HEALTHY MEIBOMIAN GLAND ORIFICES WITHIN THE 
LOWER-LID. 
 
Thank you to Sruthi Srinivasan for the use of these pictures 
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FIGURE 1-2: REPRESENTATIVE IMAGES SHOWING MEIBOMIAN GLAND TORTUOSITY (TOP LEFT), 
PARTIAL AND TORTUOUS GLANDS (BOTTOM LEFT), HEALTHY GLANDS (TOP RIGHT), GLAND 
DROP OUT (BOTTOM RIGHT) 
 




FIGURE 1-3: STRUCTURE OF THE MEIBOMIAN GLAND 
 
ep = epidermis, mcj= mucocutaneous junction 
With kind permission from Springer Science+Business Media: Knop N, Knop E. [Meibomian glands. 
Part I: anatomy, embryology and histology of the Meibomian glands] Meibom-Drusen. Teil I: 
Anatomie, Embryologie und Histologie der Meibom-Drusen Ophthalmologe. 2009 Oct; 106(10):872-
83, Figure 5. 
 
 
Our current understandings of the mechanisms that regulate meibomian 
gland secretion are not well characterized.  There have been several theories 
developed and tested over the past many years.  Currently, it is thought that 
hormonal control through progesterone, androgens, and estrogen influences the 
acinar cells and thus meibomian gland secretion.10, 12-17 Specifically, work from 
Sullivan et al. has revealed that androgens may stimulate meibomian gland 
secretion and influence the expressed lipid composition.13, 18-23 In addition to this, 
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the thick innervations of the surrounding meibomian gland tissue and the presence 
of neurotransmitters indicate neuronal control of the meibomian glands.10, 24-28 
By whatever means the glands are actually controlled and activated, the 
process to expel the lipid from the gland orifice remains the same. Two delivery 
methods exist, which are termed “active” and “passive”. The active method occurs 
when the lipid is forced out of the meibomian gland orifice during a blink by 
compression of the tarsal plate.29 The passive method is simply the continuous 
production of lipid which moves the lipid along the ducts and out the orifice. 10, 30 
This build-up raises the intraductal pressure and causes the meibomian oil to exit 
the gland.5, 10, 30-33 This accumulation is even greater during sleep when the eyelids 
are closed and there is a lack of blinking. This in turn, results in decreased secretion 
overnight and an accumulation of lipid in the duct until the eyes are opened and 
lipid can flow again, initially at an increased rate.32, 33  The proposed normal rate of 
excretion is 6.7µl/hr per gland, or approximately 333µl/hr per eye.5, 11 When the lid 
opens and closes, the meibomian oil moves along the entire ocular surface in a 
wave pattern.5, 11  
 
1.1.2 THE MEIBUM COMPOSITION 
Over the past 100 years, much work has been completed trying to categorize 
and quantify the various lipid families found within meibum.11, 29, 34-54 Many 
different families of lipids have been identified in meibum, however absolute 
amounts or even ranges of each lipid family’s presence in meibum are difficult to 
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ascertain due to variations in methodology, contamination, and inconsistencies in 
the literature.  Despite this, many groups of lipids are consistently found in meibum 
including: free fatty acids, cholesterol and other sterols, sterol and cholesteryl 
esters, wax and wax esters, triacylglycerols, diacylglycerols, polar lipids and long 
chain alpha omegas.11, 29, 34-54  
The cholesteryl esters and wax esters are thought to represent the bulk of 
lipid from meibomian gland secretions (≤60%) and are among the most non-polar 
lipids characterized.55 The types of wax esters that have been identified in meibum 
range in their chain length, saturation, branching, fatty acid or alcohol base, and 
their isomeric forms.36, 38-40, 52 The types of cholesteryl esters characterized in 
meibum have also been found to vary greatly and be of longer chain length than the 
wax esters.35, 52  
Recently, there has been much discussion over the presence or absence of 
phospholipids in meibum.5, 34, 38, 39, 49, 56-63 Phospholipids are surfactant amphiphilic 
molecules thought to be part of the polar lipid layer of the tear film, that function as 
a barrier between the surrounding layers.55 It is now thought that phospholipids, if 
they are indeed present in meibum, are at a much lower concentration38, 39, 56 and 
that previous reports of higher quantities of phospholipids may be due to the 
specific sampling, processing, contamination, instrumentation and analysis of those 
samples.34, 39, 55, 64-67  
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1.2 THE TEAR FILM 
1.2.1 THE STRUCTURE OF THE TEAR FILM 
The tear film is a complex multi-layered film that covers the anterior surface 
of the conjunctiva and cornea.  It is thought to provide several unique roles and 
therefore its composition needs to be tightly regulated. The tear film is broadly 
described as having five main functions: it allows for a smooth optical surface by 
alleviating any small imperfections in the corneal epithelium; it protects the cornea 
from debris and foreign materials by forcing them away from the central cornea 
upon blinking; it provides oxygen and nutrition to the underlying corneal 
epithelium; it keeps the bulbar and palpebral conjunctiva moist and lubricated; and 
finally, the tear film contains various antibacterial and immunological agents to 
protect against ocular infection.68   
Previously, the tear film was believed to be a relatively simply structured film, 
consisting of 3-layers: an anterior lipid layer, intermediate aqueous layer and a 
mucin layer that covers the corneal epithelium.9, 69, 70  Most of the original studies 
proposed that the mucin layer was the smallest layer, only representing 0.5% 
(0.02-0.05 µm) of the tear film, the middle aqueous layer represented the bulk of 
the tear film, possibly up to 98% (7 µm), and that the outermost lipid layer was 1-
1.5% (0.1 µm) of the entire tear film thickness.69-71 This simplistic tri-laminar 
model has been modified over the years to include a biphasic lipid layer and a more 
intricate “gel-like” mucin layer.  In 1988, Tiffany suggested an update to the tear 
film model which incorporated these “layers”. His model comprised of a non-polar 
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lipid layer at the air interface, polar lipid layer, absorbed mucoid, an aqueous layer 
rich in salts and proteins, and a mucin ‘glycocalyx’ layer covering of the corneal 
epithelial surface.72-74  
Since 1988, the arrangement of the tear film has undergone some revision,55, 
67   and much research has been completed analyzing the thickness of the tear film 
and its layers,75-81 the dynamics and organization of the layers,82, 83 as well as the 
specific components of each layer.84-88 The most current model of the tear film is 
described to include an outermost non-polar lipid layer, an inner polar lipid layer 
that contains intercalated proteins, an aqueous phase containing various proteins 
and gel-forming mucins, and finally a glycocalyx layer bordering on the corneal 
epithelium (Figure 1-4).55, 67  Current research on the tear film approximates its 
thickness to be 3 µm, with decreasing thicknesses present in those individuals with 
dry eye.75-81  
Just as the tear film as a whole has physiological and structural functions, 
each of the three broad layers of the tear film (lipid, aqueous and mucin layers), as 








FIGURE 1-4: UPDATED DIAGRAM OF THE TEAR FILM MODEL, AS PROPOSED BY THE MEIBOMIAN 
GLAND WORKSHOP55 
 
Reprinted with permission from: Green-Church KB, Butovich I, Willcox M, Borchman D, Paulsen F, 
Barabino S, et al. The international workshop on meibomian gland dysfunction: report of the 
subcommittee on tear film lipids and lipid-protein interactions in health and disease. Invest 
Ophthalmol Vis Sci. 2011 Mar; 52(4):1979-93. © Association for Research in Vision and 
Ophthalmology 2011.  
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TABLE 1-1: TEAR FILM LAYERS AND FUNCTIONS 










1. To prevent evaporation and to provide a barrier.89  
2. To provide a smooth optical surface for the refraction light.62, 90 
3. To act as a lubricant to aid the eyelid movement.62  
4. To form a barrier against tear film contamination.3  
5. To provide a surfactant layer between the non-polar lipid layer and 
the aqueous layer.91 









1. To create a favorable environment for the corneal epithelial cells, 
carry oxygen and nutrients to and from the cornea, and allow cell 
movement over the ocular surface.92  
2. To wash away toxic substances and debris during blinking.93  
3. To aid in antimicrobial activity through the tear film proteins 
(lipocalin, lactoferrin, lysozyme and IgA)92-94 
4. Growth factors present in this tear film phase play a significant role 








Glycoprotein 1. To act as a pathogen barrier using the ocular surface glycocalyx.95 
2. Mucin is a lubricant, which allows the eyelid and conjunctiva to 
move smoothly over each another during blinking and ocular 
movements.96  
3. Mucus threads protect the conjunctiva and cornea from injury by 
coating foreign bodies with a slippery mucus.95  
4. Mucus aids in glycocalyx formation and wetting the ocular surface.97 
5. Mucus helps overcome the hydrophobicity of the corneal surface.96  
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1.2.2 FORMATION OF THE LIPID LAYER OF THE TEAR FILM 
Meibomian gland secretions have unique characteristics and properties (Table 
1-3) that make it suitable to fulfill its functions as the lipid layer of the tear film, as 
previously described.  For instance, the meibomian gland lipids have a low melting 
point, which allows for smooth delivery of the lipids through the ducts and orifices 
to reach the tear film.5, 34, 56 Moreover, the integrity of the tear film, and therefore 
the overall function of the tear film, is dependent on the specific composition of 
lipids released from the meibomian glands.  
 
TABLE 1-2: PHYSICAL PROPERTIES OF MEIBUM 
Property Measurement 
Transition temperature (from a solid →liquid) 28-32oC56 
Viscosity 9.7-19.5 Pa∙S98 
Refractive Index 1.46-1.53 per the visible spectrum99 
Volume of lipids at lid margin 300 µg100 
Volume of lipids in tear film 9 µg100 
 
The role that the meibomian gland lipids play in the tear film is complicated 
and not entirely understood. Lipids are found in several locations in the tear film, 
including the base of the tear film adjacent to the outermost corneal epithelium.63 
The corneal epithelium has microvilli protruding outwards and a unique covering 
drapes over the microvilli.63 This covering is made up of a polar glycocalyx and 
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carbohydrates that separates the epithelium and the aqueous layer and anchors the 
aqueous-mucin layer.73    
When lipid is excreted from the meibomian glands, in the form of meibum, it 
mixes with the tears found on the ocular surface. Once the lipid is incorporated 
within the tears, the composition of lipid is thought to change, by undergoing 
reactions with the other components of the tear film and the environment, thus 
creating new lipid types and/or concentrations.  Comparative analysis between lipid 
profiles in tears and meibum have shown that the lipid composition in tears is more 
diverse and richer in lower molecular weight lipids and more polar phosphate 
containing esters than meibum.34, 38, 39, 41, 56, 60, 66, 101  This increase in lower 
molecular weight lipids, such as wax esters, results in high chain order and 
therefore a higher phase transition temperature.34, 41, 56, 91  All of these factors 
suggest that the lipoidal components in meibum and tears are indeed different.55, 102 
Despite these specific differences, the predominant lipid types found in the tear film 
are the same as meibum. These groups include: cholesteryl esters, wax esters, 
triglycerides, free fatty acids, monoacylglycerols, diacylglycerols, fatty sterols, and 
fatty alcohols.49-51, 103-107  It has been estimated there are thousands of specific lipids 
which are contained in the tear film and meibum.3, 108 
On the outermost surface of the tear film there is a lipid layer which contains 
two different lipid phases.  The interior layer is believed to be a polar-surfactant 
phase and the outermost phase is a non-polar phase.42, 109 Each phase of the lipid 
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layer of the tear film has unique characteristics and provides differing, yet crucial, 
functions.63  
The polar lipid layer is thought to stabilize the non-polar layer by acting as an 
intermediate medium between the non-polar hydrophobic layer and the aqueous 
layer.55 Due to the amphiphilic structure of the polar lipids, it is proposed that the 
molecules in this phase may orient themselves perpendicular to the tear film so that 
their hydrophobic tail is immersed in the nonpolar layer and their hydrophilic head 
is in contact with the aqueous layer.55  It is thought that this layer may only be 7-20 
molecules thick and be the smaller of the two lipid phases, with it only taking up 5-
15% of the lipid phase.35, 61, 67 
There are also a number of different types of polar lipids thought to be 
contained in this phase, including phospholipids, ceramides, sphingomyelin plus 
other polar lipids.41, 42, 45, 73, 101, 110 Recently it has been found that (O-acyl)-ω-
hydroxy fatty acids, a type of long chain amphiphilic lipid, has also been found to 
exist in meibum and reside in the polar lipid layer.40 
The non-polar phase is thought to be the thicker lipid phase and contain 
primarily non-polar lipids, including free cholesterol, wax esters, cholesterol esters, 
triglycerides, and hydrocarbons.73 It is thought that this layer helps to retard water 
evaporation.42 
In addition to the lipids present in the outermost layers of the tear film, it is 
probable that surfactant proteins are a prominent presence within the lipid layers.55, 
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67 These proteins, mainly lysozyme, lipocalin, lactoferrin and mucin have been 
shown in in vitro experiments to associate with lipids in artificial films and therefore 
could readily integrate themselves in with the lipid layers of the tear film.84, 86, 88, 91, 
94, 111-113 This has brought about the updated structure of the tear film shown in 
Figure 1-4.    
 
1.2.3 STABILITY OF THE TEAR FILM 
For the purposes of this thesis the stability of the tear film and its component 
layers is defined as: the ability for the tear film to be resistant to change and to 
continue to perform its functions despite influences on its composition or 
structure.114 
Research on the stability of the tear film in “healthy” individuals has been 
consistent throughout the years, showing that the tear film itself is considerably 
stable between blinks, even in the presence of particles and bubbles.70, 115 When 
there is stability of the tear film between blinks, this is confirmation that the lipid 
layers are functioning to their full potential, with compression of the layer during 
blinking. During the down stage of a blink, if stability exists in the lipid layer, then 
the lipid layer will fold and the lipid will experience little mixing between layers.116 
The stability of the entire tear film is tied directly to the composition, integrity and 
surface tension of the lipids, proteins intercalated in the tear film lipid layer, mucin 
layers and the surface tension at the air interface.84, 86, 88, 91, 117 Recent research has 
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also linked tear film instability to increased ocular surface temperature118 and 
diurnal variations119 in tear film quality. Furthermore, age, diet, medications, work 
atmosphere and the presence of contact lenses are just a few of the factors that can 
also alter the final composition of the tear film and possibly tear film stability.68, 120-
127 
In the past ten years, many studies have been completed to directly link the 
lipid layer of the tear film to the evaporation rate and tear film stability.  Specifically, 
it is known that when the lipid layer is not structurally sound, thinned or absent 
there is a dramatic increase in evaporation and the film itself becomes unstable.89, 
128-130   
It has been shown that an unstable tear film can damage the ocular surface 
and cause symptoms of ocular discomfort or dry eye. The two main causes of 
instability of the tear film are a decrease in both the quantity and quality of tears.  
The causes of dry eye are directly linked to the types of dry eye: aqueous tear 
deficiency and evaporative dry eye. 131 Tear deficient dry eye occurs when the 
lacrimal gland does not function to produce an adequate tear flow or volume.131  In 
evaporative dry eye, the lacrimal gland functions normally, but the tears are 
evaporating quickly from the ocular surface, which can be caused by numerous 
specific ocular disorders.131-133  These disorders include meibomian gland 
dysfunction, lid/globe apposition, ocular surface disorders, blink disorders, lid 
aperture disorders, blepharitis, and tear film disorders.131  
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1.3 MEIBOMIAN GLAND DYSFUNCTION 
Recently, a group of experts convened to classify and analyze our current 
knowledge of meibomian gland dysfunction (MGD) and all facets of the condition.  
All of the subcommittee reports are now available online through the journal: 
Investigative Ophthalmology and Visual Science (IOVS).  The formal definition of 
MGD, as defined by the MGD workshop in IOVS is as follows:  
“Meibomian gland dysfunction (MGD) is a chronic, diffuse abnormality of the 
meibomian glands, commonly characterized by terminal duct obstruction and/or 
qualitative/quantitative changes in the glandular secretion. It may result in alteration 
of the tear film, symptoms of eye irritation, clinically apparent inflammation, and 
ocular surface disease.”14, 134 
This definition attempts to convey the complexity of this condition, the 
possible physical changes to the glands, the resulting symptoms and ultimate 
outcomes that may occur.  It is important to realize that this condition is multi-
factorial and that MGD can manifest itself in many different ways.  It has been found 
that MGD can be broken down into two broad categories: high delivery and low 
delivery of meibum.14, 134  These two categories are further broken several more 
times to reflect possible changes to the glandular structure and the primary and 
secondary causes for each type of MGD.14, 134   
Low delivery obstructive MGD, has been linked to many different triggers 
including: contact lens wear, gland drop out, hormonal disturbances, changes in 
meibum quantity and quality, just to name a few.14, 134  A photograph of meibomian 
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gland dropout can be seen in Figure 1-2 in the bottom right corner. The 
pathophysiology of obstructive MGD can be found in Figure 1-5.  This diagram 
demonstrates how changes in various life elements (i.e. age, hormones, 
medications) can induce a chain reaction, resulting in meibum changes, 
morphological gland changes, tear film instability and even evaporative dry eye.   
 
FIGURE 1-5: OBSTRUCTIVE MEIBOMIAN GLAND DYSFUNCTION 
 
With kind permission from Springer Science+Business Media: Knop E, Knop N. [Meibomian glands : 
part IV. Functional interactions in the pathogenesis of meibomian gland dysfunction (MGD)]. 
Meibom-Drusen : Teil IV: Funktionelle Interaktionen in der Pathogenese der Dysfunktion 
(MGD).Ophthalmologe. 2009 Nov;106(11):980-7. Figure 2. 
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1.4  LIPID AND CONTACT LENSES 
 
The following section was published as follows:  
Reproduced with permission from: Lorentz H, Jones L. Lipid deposition on hydrogel 
contact lenses: how history can help us today. Optom Vis Sci 2007;84:286-95. ©The 
American Academy of Optometry 2007.  
1.4.1 TEAR FILM STABILITY AND CONTACT LENS WEAR 
Contact lens wear causes changes in the structure of the tear film, particularly 
within the lipid layer.68 Contact lenses lie within the aqueous layer of the tear film 
and therefore create a much thinner aqueous layer for the anterior lipid layer to 
cover.  The presence of a contact lens also eliminates the smooth ocular surface over 
which the eyelid moves during a blink and also acts as a physical obstacle to 
destabilize the tear film. It is therefore much more difficult to reconstruct the tear 
film over this interface.135 Due to these factors, there is only a thin lipid layer on the 
outer surface of a soft hydrogel lens and no lipid layer covering a rigid lens. 136 In 
order for a contact lens to remain “totally” biocompatible while being worn, the lens 
must form an overlying tear film that is structured similarly to that seen with no 
lens in place, which remains the ultimate goal in contact lens material research.   
With little or no lipid layer present, the tear film easily becomes 
destabilized136, 137 and the lipids come into direct contact with the lens material. 
While their interaction with rigid lenses may interfere with surface wetting, a 
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further problem exists with hydrogel lenses in that the materials are essentially 
semi-permeable membranes, which have an ability to both adsorb and absorb lipids, 
resulting in varying degrees of lipid deposition. While data on protein deposition on 
contact lens materials and its subsequent impact has been widely published,138-146 
there is a relative dearth of information on the interaction of lipid with contact 
lenses. The deposition of lipid is primarily driven by the hydrophobic lipids 
adhering to hydrophobic sites on the lens surface and the specific chemistry of the 




The following section was published as follows:  
Reproduced with permission from: Lorentz H, Jones L. Lipid deposition on hydrogel 
contact lenses: how history can help us today. Optom Vis Sci 2007;84:286-95. ©The 
American Academy of Optometry 2007.  
1.4.2 LIPID DEPOSITION ON CONVENTIONAL HYDROGEL CONTACT LENS 
MATERIALS 
Some of the earliest observations of the interaction of lipid with hydrogel 
contact lenses was that of Hart and co-workers,123, 147, 148 who examined lenses from 
both daily and overnight wearers, prior to the introduction of frequent replacement 
lenses. In one study,147 Hart reported that 15% of hydrophilic extended wear 
contact lens wearers needed to replace their lenses due to obvious deposition, with 
the rate of deposition ranging from a few weeks to a few months and was highly 
subject-dependent. The deposition pattern commonly seen was a central deposition 
of “oily bumps”, which Hart termed “jelly-bumps”, “mulberry spots” or “lens calculi”, 
as shown in Figure 1-6.147 Hart demonstrated by various forms of microscopy and 
histochemical staining analysis that lipid was present in all deposits and was the 
prime component, with the principal lipid type being cholesteryl esters.147 Scanning 
and scanning transmission electron microscopy found small amounts of calcium 
within the deposits, at much lower levels than the lipid. This was an important 
finding, as calcium was previously considered to be a major component of these 
nodular deposits,149-155 which often are white in appearance. Hart also found that 
lipid deposits formed in an in vitro model were morphologically and histochemically 




FIGURE 1-6: LENS CALCULI (JELLY-BUMP) DEPOSITED UPON A HIGH WATER CONTENT SOFT 
CONTACT LENS AFTER 18 MONTHS OF WEAR. 
 
Reproduced with permission from: Lorentz H, Jones L. Lipid deposition on hydrogel contact lenses: 
how history can help us today. Optom Vis Sci 2007;84:286-95. ©The American Academy of 
Optometry 2007.  
 
In a later study, 148 Hart determined that the jelly bump deposits had a fairly 
consistent composition of long and intermediate sized cholesteryl esters, 
triglycerides, and waxy esters. This composition is similar to the composition of 
lipids found in meibomian gland secretions. It was also found that individuals with 
higher deposition rates may have a lipid-rich tear film and a decreased tear flow, 
potentially resulting in “greasy” deposits on the front surface of their lenses (Figure 
1-7). These lipids are insoluble in aqueous mediums and therefore showed some 
resistance to cleaning products.148 Hart also examined lifestyle choices and their 
effect on lipid deposition of contact lenses.123 Individuals who consumed larger 
amounts of alcohol, protein and fat exhibited increased lipid deposition on their 
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lenses. Patients with diabetes who were medicated with diuretics, anticholinergic or 
sympathomimetic drugs were found to have lower potassium levels in the tear film 
and this correlated with increased lipid deposition.123 This was one of the first times 
that attention was drawn to the marked intersubject variability in lipid deposition 
patterns. Hart proposed that the reason such nodular deposits occurred were due to 
localised spots of drying, resulting in hydrophobic areas that attracted lipids, which 
then soaked into the lens material.147 This area then acted as a larger non-wetting 
area, which acted as a nidus for more lipid deposition. This continuous cycle of 
dewetting and lipid deposition resulted in a lipid-based nodule forming.  
 
FIGURE 1-7: HEAVY LIPID FILM DEPOSITED ON A LOW WATER CONTENT SOFT CONTACT LENS IN A 
PATIENT WITH MEIBOMIAN GLAND DYSFUNCTION. 
  
Reproduced with permission from: Lorentz H, Jones L. Lipid deposition on hydrogel contact lenses: 
how history can help us today. Optom Vis Sci 2007;84:286-95. ©The American Academy of 




The work by Hart and colleagues in the US was closely mirrored by that of 
Bowers and Tighe in the UK. They focused on analyzing the gross morphology, 
chemical composition, and arrangement of “white spot deposits” that form on 
different contact lens materials.156, 157 In their first experiment, they examined the 
occurrence, location, and gross morphology of elevated white spot deposition which 
formed on contact lenses taken from a controlled contact lens trial and randomly 
from a clinical setting.157 Deposits were analyzed using several microscopy 
techniques including phase contrast, light, dark-field, and scanning electron 
microscopy (SEM). Additionally, stereo-microscopy was used to examine deposit 
occurrence. It was determined that there are three interactive sub-layers to the 
morphology of an elevated white spot deposit and that differences in lens material 
and wearing protocol do not affect this morphology.  In contrast, the rate of 
deposition was markedly influenced by the lens materials and patient variability.157 
In their second experiment, Bowers and Tighe continued their previous white spot 
deposit analysis by examining their chemical composition and geological 
arrangement.156 The deposits were found to have a well-formed tri-layer structure 
of lipid, where the primary or basal layer was composed of unsaturated lipids, while 
the secondary and tertiary layers were predominantly cholesterol and their 
esters.156 Other tear components, like proteins, were present in the deposits, but 
were not found to play a role in the morphology of the deposits.  The wearing 
schedule, lens material chemistry and individual differences in tear film structure 
did not influence the composition or location of these deposits.156  They concluded 
from these results that it was the primary layer of unsaturated lipids that altered the 
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biological surface of hydrogel lens materials and thus cause decreased 
biocompatibility with the surrounding ocular environment.156 
Throughout the 1990’s, Franklin, Tighe, and colleagues set out to further their 
exploration into lipid deposition on contact lenses. They published a series of 
papers examining the influence that calcium, lens materials, and surfactant cleaners 
has on lipid deposition.158-161  In their first paper, Bowers, Franklin and Tighe 
examined the formation of white surface films and the importance of the role of 
calcium.161 Various contact lenses were collected, from a controlled clinical study 
and other clinical settings. During the controlled clinical study, the care solutions 
used were modified to increase the calcium concentration in the lens material in 
order to see the influence calcium has on deposit formation. They determined that 
these white surface films were morphologically different from elevated white spots, 
as these films have a heterogeneous structure where the lipid components are easily 
separated from the calcium portion.  The lipid components were mainly cholesterol 
and cholesterol esters. The lens materials that were subjected to artificially raised 
calcium levels did not exhibit increased formation of elevated white spots. These 
results suggest that calcium may only have a secondary role in stabilizing lipids that 
have already been immobilized.161 Franklin and Tighe next examined lipid and 
protein deposition on human worn lenses after 1 week and studied the effect of 
surfactant cleaning on these deposits. 160 Lipid and protein deposition was assessed 
using fluorescence spectroscopy at their respective wavelengths of emission and 
optimal excitation. This technique revealed that lipid deposition was largely 
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influenced by an individual’s life-style, tear film composition and surrounding 
environment, whereas protein deposition was driven by the composition, charge 
and water content of the contact lens material. Individual tear film chemistry also 
influenced the effectiveness of surfactant cleaners on lipid deposition, making them 
only moderately helpful, especially within the first week of lens wear.160 Other 
studies have indicated that some surfactant cleaners are more efficient at removing 
lipid and protein deposits than others, and that these cleaners are important in 
reducing reactive lipids that can accumulate further along in the deposition 
process.159 Franklin and colleagues also examined the deposition of lipids onto a 
contact lens surface and the subsequent penetration into the lens matrix.159 This 
experiment demonstrated that there is a dramatic range of lipid types that deposit 
on lenses, from polar to non-polar species and that this deposition is highly patient 
dependent. Surfactant cleaners are relatively helpful in minimizing lipid deposition 
and autooxidation of the lipids, but this is only temporary, as the lipid layer of the 
tear film is being constantly replenished.159 One further study around this time 
period by Tighe and his group examined the different types of cleaners available on 
the market and their efficiency at removing in vitro doped lipid from the surface of a 
contact lens.158 Soft contact lens surfactant cleaning solutions were compared with 
traditional chlorine-based and peroxide-based disinfectant systems. Surfactant 
cleaning solutions were found to vary widely in their ability to remove lipid from 
lens surfaces and disinfectant systems were found to remove virtually no lipid.158  
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In the early 1990’s, Mirejovsky reported on an in vitro artificial tear solution 
that contained proteins, mucin and lipids.162 This was a significant advance over 
previous doping solutions, which were almost exclusively based on proteins 
dissolved in buffer. The updated artificial tear solution better represented the range 
of components found within the tear film and therefore improved the usefulness of 
in vitro doping studies.  Her work looked at both in vitro doped lenses and also 
investigated the ability of two histochemical stains (Nile Red and Oil-Red-O) to stain 
lipids. Mirejovsky showed that the Nile Red stain was far superior at detecting lipids 
and that the in vitro model solution produced a lipid deposition pattern that was 
similar to that obtained from human worn lenses. She also demonstrated that lipids 
could deposit onto hydrogel lenses either in isolation or bound to tear film 
proteins.162  
Some of the most widely cited data on the interaction of lipids with hydrogel 
lenses was that undertaken during the early to mid 1990’s by Rapp and colleagues, 
who completed a series of experiments examining lipid deposits on a wide variety of 
contact lens types.144, 146, 163-165 In Rapp’s first experiment, patient worn soft contact 
lenses were examined for lipid deposition and analyzed for various lipid types using 
thin layer chromatography (TLC), high pressure liquid chromatography (HPLC) and 
gas liquid chromatography (GLC). Rapp showed that wax esters, fatty sterols, fatty 
alcohols, free fatty acids, and diglycerides were all detectable on hydrophilic lenses, 
whereas cholesterol, cholesteryl esters and triglycerides were not detectable.  He 
concluded that the more polar lipids will deposit preferentially on hydrophilic 
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lenses when compared to non-polar lipids and that not all available lipids present in 
the tear film appear to deposit on hydrogel lenses.165 Subsequent studies revealed 
that all lipid types interact with contact lens materials, but that the interaction is 
driven by both the lipid type and the chemical composition of the lens material.144, 
146, 163, 164 Rapp’s work with Bontempo 144, 146, 163 was crucial in indicating that, 
within conventional hydrogel materials, FDA group II lenses deposit the most lipid, 
and FDA group III deposit the least. They also reported that non-ionic materials 
deposited more lipid than ionic materials, and that high water lenses deposited 
more lipid than low water materials.163 This data led to the development of the 
“pull/push” theory of lipid deposition, in which the “pull” represents the polymer 
lens material adhering the lipid and the “push” represents the water in the lens 
material driving the lipid into the matrix.163, 166 Further research has been 
undertaken to find the differences between monomeric compositions within the 
same FDA group,167 which show that FDA classification alone is insufficient to 
accurately describe the pattern of lipid deposition that can occur. 
Rigid gas permeable (RGP) lenses were also examined by Rapp,163 and this 
work indicated that these materials generally deposit more lipid than many soft lens 
materials, probably due to the hydrophobicity of the lens. RGP lenses contain low 
amounts of water, and therefore the high lipid adherence is tied to the individual 
characteristics of the polymer. For instance, silicone-based RGP lenses deposit more 
lipid than fluorine-containing RGP lenses because the silicone addition increases the 
hydrophobicity of the lens, but the fluorine addition decreases the hydrophobicity 
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and thus decreases lipid deposition.163 Bontempo and Rapp also analyzed the 
interactions between proteins and lipid on the surface of hydrophilic and rigid gas-
permeable contact lenses in vitro.146, 164 They reported specific interactions that 
occur on a hydrophilic contact lens surface when lipids and proteins are present 
concurrently. When a group IV lens undergoes protein deposition, the surface of the 
lens becomes less hydrophilic and therefore attracts increased lipids. For group II 
lenses, the proteins compete with more polar lipid deposited on the lens surface and 
displace them.146 When rigid gas permeable lenses were examined for lipid and 
protein interactions on the lens surface, different interactions were found. The 
surface of an RGP lens is hydrophobic and thus attracts more lipids than proteins. 
The polarity of some lipid molecules allow for binding with the matrix and 
attraction toward the aqueous. When lipids bind to the contact lens, the surface 
becomes less hydrophobic and this allows for subsequent protein deposition.164 In 
their final experiment, Bontempo and Rapp continued their protein and lipid 
interaction research by studying these interactions on group I and group IV lenses in 
vivo.144 They found that lysozyme was preferentially deposited on group IV lenses 
due to the available negative charges attracting the strongly positively charged 
protein. Group IV lenses showed deposition for both protein and lipids, but the 
specific deposition composition depended on the individual.144 
Some of the more recent work on conventional hydrogel deposition with lipid 
was undertaken by Tighe and colleagues.145, 167-171 In the first of these, an in vivo 
study was conducted to evaluate the deposition of protein and lipid on FDA group II 
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lenses worn for various lengths of time.170 This was the first work to demonstrate 
that degree of deposition was influenced by frequency of replacement, with 
significantly increased deposition being noted for lenses worn for three months as 
opposed to one month.  Overall lipid deposition increased with longer replacement 
schedules and 44% less lipid was detected for the shorter replacement time, with 
individual lipid deposition being shown to vary greatly.170 In a subsequent study,167 
protein deposition was shown to be related to the degree of ionicity of the contact 
lens material, being greater in FDA group IV materials, whereas lipid deposition was 
strongly related to the monomeric composition, with increased lipid deposition 
being encountered in FDA group II materials, particularly those containing N-vinyl 
pyrrolidone (NVP). Group II lenses containing polyvinyl alcohol (PVA) exhibited 
much less lipid deposition. Lipid deposition was also found to be dependent on the 
individual.167  
Tighe and co-workers also examined both the effects of lens material and 
individual subject differences in lens spoliation. 171  This controlled clinical study 
involved clinical and analytical techniques to analyze the deposition of tear film 
components on group II and IV lenses. Lipid analysis using fluorescence 
spectrophotofluorimetry determined that contact lenses containing NVP have the 
highest lipid deposition compared to all other lens materials and that lipid 
deposition is greatly affected by patient-to-patient variations.171 In a further 
study,145 the progressive deposition of lipids was examined over a one-month 
period in both group II and group IV lenses. Lipid deposition was found to be a 
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cumulative process that does not plateau in a similar manner to that found in 
protein deposition on FDA group IV lenses. Once again, significant differences in 
individual lipid deposition were observed.145 A related study by Tighe, Maissa and 
colleagues168 found corroborating evidence that increased lipid deposition was 
detected on contact lenses that contained NVP and that lipid deposition was found 
to slowly imbed itself into the polymer matrix.168  
An overall review of the studies reported by Hart, Rapp, Tighe and colleagues 
provide us with highly relevant information concerning the deposition of lipid into 
and onto hydrogel lenses. Their work shows that lipid deposition is more prominent 
on relatively hydrophobic substrates such as FDA group II materials, particularly 
those containing NVP, that large inter-subject variations in lipid deposition 
commonly occur and that the deposition appears to be cumulative, with no plateau 
occurring. In addition, surfactant cleaning is required to adequately remove lipid 
and that cleaners vary in their ability to remove these lipid deposits.  
 
1.4.3 SILICONE HYDROGEL CONTACT LENSES: DEVELOPMENT AND PROPERTIES 
In the past 30 years, contact lens wear has increased from 10 million to over 
100 million wearers.172 The reason for this drastic increase is due to patient’s desire 
for safe, convenient, long term vision correction options to spectacles.  Some 
patients turn toward laser refractive surgery, in particular LASIK (Laser-Assisted In 
Situ Keratomileusis), but many would rather wear a safe and comfortable contact 
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lens. This has resulted in the contact lens industry developing a new range of 
contact lens materials based upon silicone, which are termed “silicone hydrogel” 
(SH) contact lenses.173 
Silicone hydrogel contact lens materials utilise silicone groups, from silicone 
rubber, combined with conventional hydrogel monomers. The silicone addition to 
the lens significantly increases the material’s oxygen transmission, whereas the 
hydrogel component allows for fluid transport and lens movement.174  
From a historical perspective, water-containing hydrogel materials intended 
for extended wear (EW) were initially developed in the late 1970’s.  Those lenses 
were commercially unsuccessful due to their inability to supply adequate oxygen to 
the cornea. Chronic deficiencies in oxygen can lead to permanent corneal damage 
due to the development of a number of hypoxic complications, including epithelial 
microcysts, epithelial thinning, loss of hemidesmosomes, changes in epithelial cell 
size and slower cell development.175 During the same time frame, silicone-based 
silicone-elastomeric materials were introduced as contact lenses, but were only 
used for special therapeutic cases or as lenses for paediatric aphakia following 
cataract surgery.176 These types of lenses had increased oxygen transmission 
compared with conventional hydrogel materials, which was highly beneficial to the 
cornea, but it was found that such lens materials rapidly deposited lipid from the 




Polymers are based on the ability of atoms to bond together to form a long 
complex stable structure. Carbon’s ability to bond with other carbon atoms, as well 
as various other atoms, including oxygen, hydrogen, nitrogen, and chlorine is the 
basis for polymer structure and function. Silicon is placed directly below carbon on 
the periodic table of elements and therefore behaves very similarly in its ability to 
bond with oxygen and hydrogen. Silicone-based polymers, siloxane polymers or 
silicones are ideal for contact lenses, as silicon-oxygen bonds are longer, flatter, and 
require less energy to rotate than carbon-oxygen or carbon-carbon bonds, thus 
allowing a contact lens based on silicone to be more flexible and less affected by 
temperature, but they are very hydrophobic. 179-181 
The contact lens industry has strived for decades to develop materials with the 
comfort and clinical performance of hydrogel lenses, and the oxygen transmission 
performance of silicone-elastomers. Through considerable financial investment, the 
release of such a group of materials – termed “silicone hydrogels” (SH) – became a 
reality in 1999.179 Currently there are eleven silicone hydrogel contact lenses 
available. All lens materials are unique in polymer structure, surface treatment, 
modulus, oxygen transmissibility, patient fit, comfort, modality and deposition. The 
unique characteristics of each lens are outlined in Table 1-5. 
The increased oxygen transport property of siloxane-based lens materials 
relates to the fact that oxygen is far more soluble in silicone rubber than it is in 
water or in polymethylmethacrylate (PMMA) contact lenses. This is because of the 
silicon-oxygen and silicon-carbon bonds that help make up the basis of silicone 
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rubber.179 The siloxane groups incorporated into these contact lenses have the 
molecular structure displayed in Figure 1-8. 174  In conventional soft contact lens 
materials, oxygen dissolves in the water phase and is transported via the water 
components. In such materials, increased oxygen transmission is obtained by 
increasing the water content. However, the oxygen transport characteristics of 
water are significantly inferior to those seen in silicone.174 
 
FIGURE 1-8: THE SILOXANE GROUP ARRANGEMENT WHEN FOUND INCORPORATED INTO A 
CONTACT LENS. 
 
Si = the silicon, O= oxygen, R = the linking groups.182 
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TABLE 1-3: MATERIAL SPECIFICS OF THE ELEVEN COMMERCIALLY AVAILABLE SILICONE HYDROGEL CONTACT LENSES 

















ADVANCE® galyfilcon A I 
Johnson & 
Johnson 0.43 70 47 86 
mPDMS, DMA, HEMA, EGDMA 
siloxane macromer, PVP 
ACUVUE® 
OASYSTM senofilcon A I 
Johnson & 
Johnson 0.72 70 38 147 
mPDMS, DMA, HEMA, TEGDMA  
siloxane macromer, PVP 
Focus® NIGHT 




AQUA lotrafilcon B I CIBA Vision 1.22 80 33 138 
DMA, TRIS, 
siloxane macromer 
PureVision® balafilcon A III Bausch & Lomb 1.06 90 36 101 NVP, TPVC, NVA, PBVC 
Biofinity® comfilcon A I Cooper Vision 0.75 80 48 160 M3U, FM0411M, HOB, IBM, 
NVP, TAIC, VMA 
AVAIRA® enfilcon A I Cooper Vision 0.50 80 46 125 M3U, BHPEA, MMA, POE, 
TREGDMA, VMA 
PremiO asmofilcon A I Menicon 0.91 80 40 161 
Silicone methacrylates, silicone 





narafilcon  A I Johnson & Johnson 0.66 85 46 118 
Hydroxy-functionalized 
mPDMS, DMA, HEMA, TEGDMA, 
PVP 
ACUVUE® 
TruEyeTM (US) narafilcon B I 
Johnson & 
Johnson  0.71 85 48 65 
Hydroxy-functionalized 
mPDMS, DMA, HEMA, TEGDMA, 
PVP 
ClaritiTM filcon II 3 II Sauflon 0.50 70 58 86 
Alkyl methacrylates, silicone 




BHPEA (2-(4-benzoyl-3-hydroxyphenoxy)ethyl acrylate); DMA (N,N-dimethylacrylamide); EGDMA 
(ethyleneglycol dimethacrylate); FM0411M (2-ethyl [2-[(2-methylprop-2-
enoyl)oxy]ethyl]carbamate); HEMA (poly-2-hydroxyethyl methacrylate); HOB ((2RS)-2-




(dimethylsilylene)])); MA (methacrylic acid); MMA (methyl methacrylate); mPDMS (monofunctional 
polydimethylsiloxane); NVA N-vinyl aminobutyric acid); NVP (N-vinyl pyrrolidone); PBVC 
(poly[dimethysiloxy] di [silylbutanol] bis[vinyl carbamate]); PC (phosphorylcholine); POE 2-(2- 
propenyloxy)ethanol); PVP (poly(vinylpyrrolidone)); TAIC (1,3,5-triprop-2-enyl-1,3,5-triazine-
2,4,6(1H,3H,5H)-trione); TEGDMA (tetraethyleneglycol dimethacrylate); TPVC (tris-
(trimethylsiloxysilyl) propylvinyl carbamate); TREGDMA (triethylene glycol dimethacrylate); TRIS 
(trimethylsiloxy silane); VMA N-Vinyl-N-methylacetamide.  
 
The first generation silicone hydrogels contact lens materials, which entered 
the market over ten years ago, were CibaVision’s Night & Day (lotrafilcon A) and 
Bausch & Lomb’s PureVision (balafilcon A) lenses.  The Night & Day (ND) lens and 
CibaVision’s newer Air Optix (lotrafilcon B) (AOp) lenses have a biphasic, inter-
penetrating network-like or two-channeled molecular structure, where the 
fluorosiloxane phase (silicone phase) facilitates the majority of oxygen transmission 
and storage and the hydrogel phase transmits water and a small amount of oxygen 
for lens movement.183, 184 These two phases work together for smooth 
transportation of oxygen and water. The exact materials used for this lens are a 
fluoroether macromer co-polymerized with the monomers trimethylsiloxy siloxane 
(TRIS) and N,N-dimethyl acrylamide (DMA).184 PureVision (PV) lenses are a 
homogenous combination of the silicone-containing monomer polydimethylsiloxane 
(a vinyl carbamate derivative of TRIS) co-polymerized with the hydrophobic 
hydrogen monomer N-vinyl pyrrolidone (NVP).180, 184-186 
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As mentioned above, initial attempts to use silicone within hydrogel lenses in 
the silicone elastomers released in the 1970’s and early 1980’s failed due to lipid 
deposition, increased lens binding to the cornea and decreased in-eye wettability of 
the lens, due to the exposure of hydrophobic silicone on the surface of the lens 
material.174 To minimize this problem, a process to convert the hydrophobic surface 
to a more hydrophilic lens surface is required.187 Other factors also need to be taken 
into account when developing a successful surface treatment.  Ideally, the treatment 
needs to maintain a stable tear film layer, provide low bacterial adherence, minimise 
deposition of substances from the tears, and be non-irritating.188 
The ND and PV lenses have different methods of creating this surface 
treatment.  The ND lenses are permanently surfaced in a gas plasma reactive 
chamber to give the lens a thin, high refractive index, homogenous hydrophilic 
surface. In contrast, the PV lenses are also treated in a gas plasma reactive chamber, 
but this chamber alters the silicone to give the surface of the lens hydrophilic glassy 
islands to mask the underlying relatively hydrophobic material.174 The process 
involved in the gas plasma reactive chamber includes many complex steps, including 
etching, ablation, oxidation, and polymerization.  The steps are controlled by several 
factors, and the success of the coating depends heavily on controlling the specific 
parameters required.182 Both the ND and PV lens surface treatments are a 
fundamental part of the lens and are not just surface modifications that can easily be 
removed during the cleaning and disinfection process.189 
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The second generation silicone hydrogels were the two lenses introduced by 
Johnson & Johnson:  Acuvue Advance (galyfilcon A) and Acuvue OASYS (senofilcon 
A).   These two lens materials are modified from the Tanaka monomer and have 
incorporated siloxy macromers, HEMA and DMA.  One important difference between 
these lenses and the others described above is that Acuvue Advance (AA) and 
Acuvue OASYS (AvO) have a proprietary internal wetting agent (HydraClear™), 
which is based upon polyvinyl pyrrolidone (PVP) and provides increased lens 
wettability.190  The other unique property of these two Johnson & Johnson contact 
lens materials is that they both have Class 1 UV blocking capabilities.190-192 
The third generation silicone hydrogels, Biofinity (comfilcon A) and Avaira 
(enfilcon A), were released by CooperVision and are not based on the TRIS molecule, 
require no surface treatments or wetting agents, and contains a unique mix of 
polymers.  These two materials, Biofinity (BIO) and Avaira (AVA), are unique 
materials as they defy some of the oxygen permeability and wettability relationships 
which were previously defined.193 
The latest silicone hydrogels to entire the world market are the Johnson & 
Johnson lenses called Acuvue TruEye (narafilcon A and B), the Menicon lens PremiO 
(asmofilcon A), and the Sauflon material Clariti (filcon II 3). Acuvue TruEye (AvT) is 
the first daily disposable silicone hydrogel contact lens material. It has incorporated 
siloxy macromers, HEMA and DMA and has an improved formulation of the 
Hydraclear internal wetting agent.194  TruEye also has the highest possible UV 
protection provided by the other two Johnson & Johnson lens materials.195 The 
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Menicon PremiO (PrO) lens polymerizes hydrophilic monomers and siloxane 
components together using a patented system called MeniSilk.196  The material then 
undergoes a surface modification using the Nanoglass technology which combines 
both the plasma oxidation and plasma coating process to provide a smooth surface 
with a low contact angle.196 Lastly, the Sauflon Clariti (Clr) lens is considered to be 
inherently wettable with no surface modifications necessary and is composed of 
acrylates, siloxane monomers and NVP.197  
 
1.4.4 LIPID DEPOSITION ON SILICONE HYDROGEL CONTACT LENS MATERIALS 
Since the release of silicone hydrogels onto the market over 10 years ago, 
there has only been a handful of papers examining their in vitro and ex vivo lipid 
deposition.  For this reason, each paper published will be discussed below.  
The first studies conducted examining lipid deposition on silicone hydrogel 
lens materials were that of Jones and Senchyna,198 who investigated the deposition 
of both protein and lipid on balafilcon A and lotrafilcon A. Their work clearly 
showed that protein deposition on silicone hydrogel materials was significantly less 
(< 15 µg/lens) than found on Group IV conventional hydrogels; however the protein 
was more denatured. In contrast, the more hydrophobic surfaces of the siloxane-
based lenses resulted in substantially greater amounts of lipid deposition being seen 
(up to 600 µg/lens).198   
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Subsequent studies from other research laboratories have also found an 
increase in lipid deposition on silicone hydrogels, but not to the same extent that 
Jones and Senchyna originally reported. In 2006, Maziarz et al. analyzed non-polar 
lipids deposited on ex vivo worn silicone hydrogel contact lens materials and 
analyzed them using two different HPLC protocols.199  Cholesterol, oleic acid, and 
oleic acid methyl ester were the three lipids examined for their deposition on 
balafilcon A, lotrafilcon A, and galyfilcon A contact lens materials worn on a daily 
wear and continuous wear basis (balafilcon A only).199  The overall order of 
deposition was as follows:  balafilcon > galyfilcon > lotrafilcon A, with cholesterol 
consistently depositing in the highest quantity out of the three lipids tested (~20 
µg/lens).  Oleic acid and its methyl ester only deposited  occasionally and often the 
deposition was lower than the level of detection.199  
The findings of greater lipid deposits on silicone hydrogels were also obtained 
during a clinical study conducted by Cheung et al. in Hong Kong in 2007.200 
Participants were fitted with galyfilcon A in one eye and etafilcon A in the 
contralateral eye and after two weeks of wear time, significant increases in grade 3 
and 4 lipid deposits (assessed via visual recognition) on galyfilcon were identified. 
The lipid deposits either had the appearance of lens calculi or hazy films. Other than 
deposits, no differences were found in lens fitting, vision, staining, subjective 
comfort, or tear film thinning. No biochemical analysis was completed on these lens 
samples and after the final follow-up appointment only half of the participants 
preferred the silicone hydrogel.200 
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The effect of in vitro lipid deposition on the wettability of silicone hydrogel and 
conventional hydrogel contact lens materials were examined by Lorentz et al. in 
2007.201 This study involved the incubation of various contact lens materials in 
saline, and two different concentrations of lipid incubation solution for both 2 and 5 
days. The lenses were then removed from their solution and advancing contact 
angles were assessed using the sessile drop technique. It was determined that initial 
lipid deposition may increase the wettability of certain contact lens materials, 
especially for surface treated silicone hydrogels and conventional hydrogels. No 
differences were found in the non-surface treated silicone hydrogels.201  
In 2008, Carney et al. conducted a large in vitro study examining the kinetic 
uptake of fluorescently-tagged cholesterol and phosphatidylethanolamine, in a 
single lipid incubation solution, with a range of both silicone hydrogel and 
conventional hydrogel lens materials.202  Their findings confirmed that there is an 
increase in lipid uptake on silicone hydrogel lenses, but they also found differences 
in deposition within silicone hydrogels, with lotrafilcon A and B depositing similar 
amounts of lipid to conventional materials.  This publication was one of the first to 
document the kinetic uptake over a 20 day period, characterize differences in a large 
number of lens materials, and see differences in polar and non-polar lipid 
deposition. Overall, Carney found that balafilcon, senofilcon, and galyfilcon silicone 
hydrogels deposited the most lipid and that deposition peaked at just over 20 
µg/lens for cholesterol and ~5.0 µg/lens of phosphatidyl-ethanolamine.202  
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In vitro lipid deposition studies on silicone hydrogels were also conducted by 
Iwata et al. in 2008.203 The research conducted by this laboratory was aimed at 
optimizing a gas chromatography mass spectrometry (GC-MS) method to analyze 
wax, squalene, cholesterol and their esters on silicone hydrogels.  Six different 
lenses were extracted with (70:30) chloroform: methanol following a 60 hour in 
vitro incubation in an artificial tear solution containing 3 or 30 µg/mL of each of the 
lipids of interest and a range of salts and proteins.  The GC-MS method examined 
was found to be sensitive, reliable and was able to recover at least 80% of the lipid 
deposited, depending on the mass of lipid originally absorbed. Overall the order of 
deposition was similar to previous studies, finding that lotrafilcon A, B and etafilcon 
A are the lowest lipid depositors (1 µg/lens) and galyfilcon A and balafilcon A are 
the highest (~8 µg/lens).  This paper was the first to examine, utilize and quantify 
squalene, a lipid secreted by the sebaceous glands, in addition to the usual 
cholesterols. 
In the past few years, Willcox and co-workers from Australia have studied and 
published several papers detailing various aspects of lipid deposition.204-206  The 
first paper, published in 2009,205 quantified cholesterol and total protein, on ex vivo 
silicone hydrogel lenses cleaned with four different care regimes.  Cholesterol was 
extracted from the various lens materials using (1:1) chloroform: methanol and 
analyzed using TLC and electron ionization MS.   Overall, cholesterol  deposition was 
highest on balafilcon A materials (4-8 µg/lens) and lowest on lotrafilcon B materials 
(0.1-0.5 µg/lens).205  When the care regimes were examined, it was found that the 
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different cleaning solutions were more efficient at cleaning different contact lens 
materials.  Opti-Free RepleniSH and AQuify were found to be the most efficient at 
removing lipid from most lens materials, and ClearCare was the least efficacious.  
This study was one of the first to outline the variation in cholesterol deposition with 
the use of different care regimes and lens materials.205 
The second paper published by the Australian group examined human-worn 
balafilcon A and senofilcon A lens materials, their phospholipid and cholesterol 
deposition, and the differences when cleaned with three different care regimes.204  
The levels of contact lens deposition were then compared to the concentration of 
cholesterol and phospholipids in tears and both tear and contact lens deposition 
samples were analyzed using various MS techniques. In total, 23 different species of 
sphingomyelin and phosphatidylcholine were identified in tears and contact lens 
depositions.204 The pattern of these polar lipids were similar, however differences 
did exist between the different lenses and care solutions used. Between the two lens 
materials tested, senofilcon A deposited significantly more lipid and cholesterol was 
deposited in the highest mass.204 
The most recent publication from Willcox et al. explored the relationship 
between bacterial adhesion and cholesterol deposition on two silicone hydrogel 
contact lens materials, senofilcon A and balafilcon A.206  It was found that balafilcon 
A lenses worn for one month deposited more cholesterol than senofilcon A worn for 
two weeks and that bacterial adhesion onto worn balafilcon A lenses was reduced 
compared to unworn lenses.206 In the end, Pseudomonas aeruginosa and 
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Staphylococcus aureus adhesion was not influenced by the presence of cholesterol. 
This was the first paper to examine the interaction of lipid and bacterial adhesion.206  
Mirroring some of the silicone hydrogel work from Australia, the Nichols 
group in the United States have also been examining both ex vivo and in vitro lipid 
deposition.207, 208 Their first study focussed on quantifying cholesteryl esters and 
cholesterol from human worn and in vitro incubated lotrafilcon B and galyfilcon A 
lens materials.208 For the in vitro portion, the two lens materials were incubated in a 
cholesteryl oleate incubation solution with a range of concentrations for three days 
and for the ex vivo portion, participants wore each lens material for about 7 days, at 
least 10 hours each day.208  Following incubation or wear time, the lenses were 
extracted with (2:1) chloroform: methanol and the cholesterol content was assessed 
using an enzymatic cholesterol esterase assay.  This study found that galyfilcon 
deposited significantly more cholesterol and its esters on both the in vitro and ex 
vivo lenses when compared with lotrafilcon B.  The benefits of a two-step extraction 
method and individual differences in cholesterol deposition between individuals 
were also revealed.208 
The second study conducted by the Nichols lab was published in 2010 and 
analysed in vitro lipid deposition on contact lens materials.207 This study involved 
the in vitro incubation of eight silicone hydrogel materials and one conventional 
hydrogel lens material, in two different single lipid incubation solutions for 1 and 14 
days.  The two lipids examined were cholesteryl oleate and phosphatidylcholine and 
each was quantified individually by using their corresponding specific assays. 
44 
 
Overall, most of the contact lens materials deposited the same or a larger mass lipid 
after 14 days of incubation, with the phosphatidylcholine deposition ranging from 
0.54 to 5.77 µg/lens throughout the entire experiment.207 Similar trends of equal or 
greater masses depositing after 14 days of incubation were also seen with 
cholesteryl oleate, however a significant decrease in deposited cholesteryl oleate 
was found with etafilcon A after 14 days.  Generally, cholesteryl oleate deposition 
ranged from 0.14 to 6.84 µg/lens.207 This study showed the marked variability in 
deposited lipids among the different lens materials. 
Also in 2010, the details of a clinical study was published where the authors 
had extracted and quantified total lipid, cholesterol and their esters, and 
phospholipid levels on three silicone hydrogel lenses: senofilcon A, galyfilcon A and 
asmofilcon A following two weeks of wear.209  Total lipid, as quantified from the 
sulfo-phospho-vanillin reaction, was on average 32.9 to 42.1 µg/lens,  cholesterol 
and cholesteryl ester deposition was 26.2 to 31.1 µg/lens, and phospholipids 
deposition ranged from 1.1 µg/lens (galyfilcon A) to 7.0 µg/lens (asmofilcon A).209 
No significant differences between lens materials for total lipid or cholesterols were 
found, however the differences in phospholipid deposition between lens materials 
were statistically significant.209 In this study, the multipurpose solutions utilized by 
the participants were not listed or examined and differences in comfort were not 
explored. 
Most recently, a paper published by Heynen et al. from the Centre for Contact 
Lens Research in Canada quantified the amount of non-polar lipids from senofilcon 
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A lenses that were either cleaned in Opti-Free RepleniSH or ClearCare following 
cross-over study.210 After each 2 weeks of wear, all lenses were extracted and 
several non-polar lipids were quantified using normal phase HPLC.  Out of the five 
lipids that were examined, two of them were below the limit of quantification 
(triolein and oleic acid), or not detected at all (oleic acid methyl ester). Cholesteryl 
oleate and cholesterol were found to be the most prevalent lipid deposited, with 
their combined mass on average being over 20 µg/lens.210 Differences in the contact 
lens cleaning solutions utilized were also found, with lenses cleaned with Opti-Free 
RepleniSH depositing significantly less cholesteryl oleate and total lipid.210  
Many of the papers discussed to this point have examined in vitro or ex vivo 
lipid deposition and the factors that may affect the deposition profile, such as lens 
material, care regime, or analysis technique.  However, an exploratory paper 
examining the possible use of phospholipids as a wetting agent to aid in contact lens 
comfort was published in April 2011.211 The authors examined the uptake and 
release of phosphatidylcholine on a CIBA Vision silicone hydrogel lens using 
radiochemical analysis and found that the uptake of phosphatidylcholine did not 
alter the lens wettability or optical clarity of the lens.  They also found that the rate 
of phospholipid release was faster when soaked in an artificial tear solution, as 
opposed to just water.211 This study introduces the concept that phospholipids, due 
to their structure, may be utilized to alter the surface of silicone hydrogel lenses to 
make them more wettable and ultimately more comfortable.  More work is required 
to test and realize the full extent of this technique. 
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The following section was published as follows:  
Reproduced with permission from: Lorentz H, Jones L. Lipid deposition on hydrogel 
contact lenses: how history can help us today. Optom Vis Sci 2007;84:286-95. ©The 
American Academy of Optometry 2007.  
1.4.5 THE FUTURE OF CONTACT LENS LIPID DEPOSITION RESEARCH 
Out of all the lipid deposition research conducted to date, what is unequivocal 
is that certain patients, when refitted from conventional HEMA-based materials into 
silicone hydrogels, exhibit clinically significant deposition on their silicone 
hydrogels that may not have been problematic with their HEMA-based materials 
(Figure 1-9).200, 212 One study reported this to occur in approximately 15% of 
silicone hydrogel wearers who use their care products using a “no-rub” regime and 
do not rub and rinse their lenses at the of the day.213 When patients were advised to 
rub their lenses prior to disinfection, this level of clinically relevant deposition 
reduced to a negligible amount. As described above, the major type of deposition on 
silicone hydrogels is lipids, with some denatured proteins, both of which require a 
physical rub to maximize their removal from the surface of lenses. Based upon the 
clinical data thus far, it would appear that silicone hydrogel wearers would benefit 
from being advised to use their care regimens with both a rub and rinse step being 
instigated prior to overnight soaking.213 Other methods to help minimize such 
deposition212 include replacing the lenses frequently, as lipids do progressively 
accumulate over time,145, 170 using a dedicated surfactant cleaner if merely rubbing 
with a multipurpose system fails, and treating any co-existing blepharitis or 
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meibomian gland dysfunction in an attempt to produce a more stable, healthy lipid 
layer to the tear film.214-218 
 
FIGURE 1-9: LIPID FILM AND LENS CALCULI ON A SILICONE HYDROGEL LENS AFTER 3 
WEEKS OF WEAR. THE PATIENT HAD PREVIOUSLY WORN AN FDA GROUP IV LENS ON A 
FOUR-WEEKLY REPLACEMENT PERIOD WITH NO SUCH DEPOSITION BEING SEEN.  
 
Reproduced with permission from: Lorentz H, Jones L. Lipid deposition on hydrogel contact lenses: 
how history can help us today. Optom Vis Sci 2007;84:286-95. ©The American Academy of 
Optometry 2007.  
 
Ultimately, the degree of deposition remains irrelevant unless it results in 
symptoms or clinically significant signs, and the effects that lipid deposition has on 
either of these is not well documented. In fact, relatively few studies have directly 
linked deposition with alterations in symptoms and signs, and most of these have 
looked at deposition overall rather than the specific impact of lipid deposition alone. 
It is known that deposition of tear film components can reduce lens comfort,170, 219-
221 probably due to reduced lens wettability.222 As deposition occurs on the lens 
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surface, the contact lens becomes progressively dewetted, resulting in poor 
wettability and subsequent sensations of dryness and discomfort. Poor vision is 
another negative affect of deposition.223, 224 These symptoms can lead to 
discontinuation of lens wear219, 221 and the more uncomfortable and irritating a 
contact lens becomes, the more likely the individual will remove the lens.221 
Whether these symptoms are due to lipid deposition, protein deposition or a 
combination of both remains to be confirmed. 
On reviewing the literature to-date, much work remains to be undertaken to 
further our understanding of the processes involved in lipid deposition, particularly 
on silicone hydrogels. Many of the studies thus far have used in vitro methodologies, 
which fail to take into account lens surface drying between blinks, which will result 
in increased hydrophobicity and enhance deposition, and the constant 
replenishment of the lipid within the surrounding fluid. Such studies need to be 
complemented and confirmed by ex vivo studies to ensure that the results are 
comparable to that found clinically. Other topics that have been inadequately 
examined are the degree to which lipid penetrates into the matrix of lens materials, 
the influence of various care regimens, the interaction between lipids and other 
constituents of the tear film, the kinetics of lipid deposition and the arrangement of 
lipid types on the surface. These are all subjects that require much greater 
understanding if our ability to further the development of lens materials, 
particularly siloxane-based materials, is to progress. What is clear from this 
literature review is that there are many factors that can affect the deposition 
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process and dictate the ultimate amount of lipid on the contact lens, with material 
composition, replacement interval, care regimen and individual patient variability 
all playing significant roles. The future for lipid research on both the tear film and its 
relationship to contact lens deposition remains bright, but novel methodologies to 
examine the lipids involved in contact lens deposition and dry eye require 
significant intellectual input to unravel these complex interactions. 
 
1.5 LIPID COLLECTION METHODS 
To study the lipid from the tear film, meibomian glands or that which is 
deposited on contact lenses requires initial collection and then analysis of the lipid. 
When analyzing lipid on contact lenses, the lenses are exposed to either an in vitro 
artificial incubation solution162, 163, 201, 203, 207, 225 or removed from the eye after a pre-
designated period of time.144, 165, 204, 205, 210 The lenses are then exposed to an 
extraction solvent, which is commonly based on methanol and chloroform in 
various ratios,163, 203, 205, 207, 210 and the extract is then analysed by a number of 
various analytical methods, as described below.  
There are different procedures that are commonly used to collect lipid from 
various areas in the eye.  The methods used to obtain meibomian gland secretions 
and samples from tears will be briefly discussed in the following section of this 
thesis.  However, despite the method of collection it has been found that proper 
storage and handling is imperative to ensure that the lipids remain free of 
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contamination and in their initial state before analysis. Lipids should be stored in an 
oxygen-free environment by drying the sample under nitrogen or argon in a plastic-
free container and placing it dry and dark location at -80oC. 55, 226  For lipid, only 
glass, stainless steel and Teflon® are recommended storage containers. 55, 226 
 
1.5.1 TEARS 
There are two commonly used methods to collect tear film samples for the 
analysis of lipid content: Schirmer strips41, 148 and microcapillary tubes. 91, 123, 227, 228 
Schirmer strips are filter paper strips which are commonly used to help diagnose 
dry eye syndrome, but can also be used to collect tear film samples. Schirmer strips 
are positioned to contact only the bulbar conjunctiva of the eye and to absorb tear 
fluid (Figure 1-10).148 This procedure is usually completed without an anaesthetic 
and is fairly uncomfortable for the participant. Following collection, the tear film 
lipids can then be extracted from the strips and analyzed.  The main disadvantages 
of this technique is that the strips can become contaminated with cellular lipids 
during collection.67 
The most popular method to collect lipid tear film samples involves using 
microcapillary tubes. These are tiny glass tubes that draw in fluid via capillary 
action when the tube is placed in contact with the tear film. The microcapillary tube 
is gently placed in the eye to collect tears from the lower tear pool that forms above 
the lower lid (Figure 1-11).91 In some cases, experimenters purposely collect 
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stimulated tears91, but usually un-stimulated tears are preferred.227 Once a tear film 
sample is collected in the microcapillary tube, the fluid is then removed, extracted 
and analyzed. The popularity of this method can be seen in the number of studies 
that have used this technique for the collection and analysis of lipids in the tear 
film.91, 123, 227, 228  
 
FIGURE 1-10: TEAR FILM COLLECTION USING A SCHIRMER STRIP 
 




FIGURE 1-11: TEAR FILM COLLECTION USING A GLASS MICROCAPILLARY TUBE. 
 
Thank you to Sruthi Srinivasan for the use of this picture 
 
1.5.2 MEIBOMIAN GLAND FLUID 
The principal method used to collect lipid from the meibomian glands 
involves wiping the lid clean with a sterile swap, compressing the eyelid to gently 
squeeze out the lipids, and collecting the lipid.34, 39, 229 The lid can be compressed 
between a lid conformer and a swab (Figure 1-12) 34, 39, 42, 44, 229, 230 or between the 
clinician’s fingers,11, 51, 128, 231 with or without the use of an anaesthetic. The 
meibomian gland secretions can then be collected using a spatula34, 39, 42, 44, 229, 230  or 
a curette.51, 231  
Meibomian gland lipid collection at the orifices using microcapillary tubes has 
also been utilized.34 This method is not as invasive for the participant, however the 
disadvantages of this procedure include: smaller volumes being collected, the 
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samples quickly solidify at room temperature, and small volumes of tears may also 
be collected with the meibum thus contaminating the meibum sample.29, 36, 54, 67  
  
FIGURE 1-12: “SQUEEZING” THE MEIBOMIAN GLANDS OF THE LOWER LID TO EXPRESS 
MEIBOMIAN GLAND FLUID, IN A PATIENT WITH FRANK MEIBOMIAN GLAND DYSFUNCTION 
 
Thank you to Sruthi Srinivasan for the use of this picture 
 
1.6 LIPID ANALYSIS METHODS 
In the early days of research investigating lipid deposition on lens materials, 
qualitative techniques based on histochemical staining were used, primarily to 
determine the presence or absence of lipids only.162 Light microscopy and electron 
microscopy were typically used in conjunction with these staining techniques, to 
determine differences in deposition patterns.147, 148  
More recently, quantitative or semi-quantitative methods have been 
employed, typically based around the use of chromatographic methods. The three 
common chromatographic techniques used to analyze lipids are thin layer 
54 
 
chromatography (TLC), high performance liquid chromatography (HPLC), and gas 
chromatography (GC).  HPLC and GC are now commonly linked with mass 
spectroscopy (MS) analysis to become a very sensitive and powerful method of 
qualitative and quantitative analysis. The methods described below are standard 
methods for the examination of lipid from the tear film, meibomian gland fluid or 
from contact lens depositions.  
 
1.6.1 THIN LAYER CHROMATOGRAPHY (TLC) 
In every TLC procedure, a plate made of glass, metal or plastic is coated with 
a thin layer of solid adsorbent material, usually alumina or silica.232 The sample is 
applied to the bottom of the plate, which is then placed in an enclosed chamber with 
a shallow pool of solvent.  The liquid in the chamber is known as the mobile phase 
and is drawn up the plate via capillary action.232  The components in the sample 
solution separate on the plate according to their differing solubilities, polarity and 
their strength of adsorption.232 If the sample solution contains many different types 
of substances to be separated, then more than one solvent can be used.  The types of 
substances separated dictate the method that will be used to view the plate.232  For 
ink separation, the bands can be seen by the naked eye.  If the components 
separated are colourless, then the compounds can be viewed under UV light. In the 
case of lipids, the plate can be charred by a fine mist spray of sulphuric acid and is 
then baked.  This blackens the resolved bands so they can be viewed without special 
equipment.232 A TLC plate used to separate and identify lipids found on contact 
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lenses can be seen in Figure 1-13. If individual lipid species identification is required 
then the TLC lipid band is removed, further processing of the sample is required and 
then the sample can be analyzed using other techniques including HPLC, GC, HPLC-
MS and GC-MS .73  
TLC is a fundamental qualitative method to determine the classes of lipids 
which are present in a sample.  It can be used for quantitative means with limited 
accuracy, however it often requires a fairly large volume of sample, which is not 
usually available in tears and meibum.55  Another limitation of TLC lies in the 
techniques propensity to encourage sample degradation due to lengthy exposure to 
air during processing and band charring, which prevents further analysis.67 Due to 
these restrictions, some of the earlier research was conducted with TLC51, 148, 233 but 




FIGURE 1-13: A SAMPLE TLC PLATE CHARRED WITH SULPHURIC ACID TO VISUALIZE LIPID 
BANDING PATTERNS 
 
A sample TLC plate charred with sulphuric acid to visualize lipid banding patterns following lipid 
removed from an experiment in which 5 model lipids were deposited onto silicone hydrogel contact 
lenses using an in vitro model and were then extracted and separated using TLC. Each lane 
represents one extract from one contact lens. The various bands that are visible are due to the 
presence of one or more of the lipids extracted. 
 
1.6.2 HIGH PRESSURE LIQUID CHROMATOGRAPHY (HPLC) 
HPLC is a significantly more technically advanced chromatography method of 
separation, which is relatively easy to use and is not limited by the volatility or 
stability of the sample compound.232  The separation techniques involve mass 
transfer between the stationary and mobile phases.  Like its name, HPLC uses a 
liquid mobile phase to separate the components of a substance.  The first step to 
separate a mixture is to dissolve it in a solvent and then to force it through a 
chromatographic column under high pressure, where the mixture is separated into 
its individual components.232  
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The type of compounds being separated dictates the types of solvents, 
columns, and detectors used to analyze the sample.  Frequently, different HPLC 
procedures are used to analyze polar and non-polar lipids.166 Once separated, the 
lipids of interest are studied by using specific detectors such as UV absorption, 
fluorescence, infrared, flame ionization, radioactive or mass spectrometry.  Due to 
the variety of solvents, columns, and detectors available, HPLC has proven to be a 
very powerful tool in lipid analysis which is seen in the number of studies that have 
used this technique.11, 120, 165, 210, 234  An HPLC lipid chromatogram, used to identify 
and quantify lipid on contact lenses can be seen in Figure 1-14. 
 
FIGURE 1-14: A TYPICAL REVERSE-PHASE LIPID CHROMATOGRAM ANALYZED USING UV-LC 
 
 
A typical reverse-phase lipid chromatogram analyzed using UV-LC for an experiment in which 5 
model lipids were deposited onto silicone hydrogel contact lenses using an in vitro model and were 
then extracted and separated using HPLC. Each annotated peak represents one specific lipid 
identified at a wavelength of 205 nm. 
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1.6.3 GAS CHROMATOGRAPHY (GC) 
Gas chromatography (GC) induces separation of a compound using a gaseous 
mobile phase.235 The main component of the GC system is the separation column. 
Since the sample is carried through the column within the gaseous phase, the 
sample must be volatile.  Samples of low volatility can be separated at high 
temperatures that allow for a high vapour pressure.235 However, samples separated 
at temperatures that are too high can cause unwanted decomposition of the sample 
and its components. Another limitation of GC relies on its lengthy preparations steps 
and the difficulty in analysis. The specific compound classes that can be analyzed via 
GC are dictated by their thermal stability.235 Therefore, large polar molecules are not 
usually separated using GC. The separated compounds can be identified by their 
various retention times235 and there have been many studies that have utilized GC 
techniques to analyze lipid. 27,44,38 
Just like HPLC, GC techniques can be linked to various types of detectors 
including mass spectrometers, infrared, UV absorption, and flame ionization. These 
detectors produce a chromatogram that is analyzed to identify each component. The 
type of detector used depends on the class of compound.235 
 
1.6.4 CHROMATOGRAPHIC TECHNIQUE NOTES 
Many studies have used TLC, HPLC, or GC or a combination of these to quantify 
lipid deposits from contact lenses, meibomian gland, and tear film samples. Often 
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one chromatographic technique is not sufficient to analyze all lipid types found in 
the eye due to the wide range of polar and non-polar lipids. Each method has its own 
strengths with certain lipid types. TLC is usually used as a general separation 
technique where many different lipid types are separated from a complex unknown 
sample.232 Following TLC separation, the broad lipid bands, that represent different 
groups of lipids, are removed and analyzed using other techniques like HPLC and 
GC.  HPLC is often used for the separation of polar lipids, like cholesterols, and GC 
for the separation of non-polar lipids, like fatty acid methyl esters.232 TLC has been 
used to quantify lipid content from extracted contact lens deposition,144, 146, 148, 163-
165, 233 from tear samples,91, 148 and from meibomian gland secretions.11, 42, 44, 46, 51, 121, 
229, 236 The quantification of lipids within these samples allow for a comprehensive 
understanding of the lipoidal role in the eye and what and how external factors 
affect lipid content. HPLC has also been commonly used to analyze lipid content.  
Jones et al.189, 198, 210 utilized HPLC to quantify in vitro and in vivo lipid content 
deposited on silicone hydrogel lenses. In contrast, HPLC has been used to analyze 
lipid content from contact lens materials,120, 161, 165, 166, 210 tears120, 234 and meibomian 
gland secretions.2, 42, 57, 66, 73, 230, 231, 237 GC is most often used for meibomian gland 
secretions2, 11, 42, 44, 46, 51, 230, 236, 237 and occasionally tears.91 The majority of these 




1.6.5 MASS SPECTROMETRY (MS) 
Mass spectrometry is very commonly used as a detector due to its ability to 
reveal structural detail about the sample under investigation, its sensitivity, its 
efficiency, and its ability to quantify its components.55, 67, 232 However, it is a costly 
technique.232 The process of mass spectrometry involves bombarding the sample 
with high-energy electrons that creates ions that are separated in a magnetic or 
electric field according to their mass-to-charge ratio. The resulting output is a 
spectrum of peaks corresponding to the molecular fragments and ionized 
molecules.232  
Specifically, mass spectrometry detection methods have been used to 
determine lipid content in meibomian gland secretions 40, 51, 57, 73, 238, 239 and contact 
lenses.165, 203, 204 The common MS techniques utilized for lipids are atmospheric 
pressure chemical ionization (APCI) or electrospray ionization (ESI).  The choice 
between these two methods usually resides with the type of lipid that will be 
analyzed: polar or nonpolar.  APCI is usually utilized for nonpolar compounds and 
ESI has been found to function best for more polar species.67 An example of a mass 
spectrometer chromatogram used to identify the lipids in tears can be seen in Figure 
1-15. Mass spectrometry detection methods are often used in eye-related lipid 
research, but it is not the only detection method, as UV absorption and fluorescence 




FIGURE 1-15: A SAMPLE MASS SPECTROMETRY LIPID STANDARD CHROMATOGRAM. 
 
A sample mass spectrometry lipid standard chromatogram. Four lipid standards at a concentration of 
2 ppm were analyzed using LC MS in ESI SIM mode with a mobile phase of chloroform, methanol and 
10mM NH4OAc. Each annotated peak represents one specific lipid. Figure courtesy of Yu Gu. 
 
1.6.6 NUCLEAR MAGNETIC RESONANCE (NMR) SPECTROSCOPY 
Nuclear magnetic resonance is a technique that measures an atomic nucleus’s 
quantum magnetic properties.  This technique can be utilized for any nucleus that 
has a spin, with common examples being 13C, 31P, and 1H, just to name a few.240, 241 
NMR is a non-destructive method of analyzing organic molecules like lipids and 
their molecular structure; however the technique struggles due to low sensitivity 
and therefore requires long processing time.45, 110, 242, 243 
 
1.6.7 FLUORESCENT LIPIDS 
Other techniques are available for the quantification of lipids taken from 
tissues and contact lens surfaces. One technique involves a fluorescence assay for 
contact lens deposits.145, 167, 170  Fluorescence techniques can be used to analyze lipid 
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deposition due to the fluorescence signal emitted from lipids themselves. In this 
technique, lenses are placed in distilled water in a quartz cell. The sample is excited 
with an incident beam measured at a wavelength of 360 nm and the emission peak 
is monitored at a wavelength of 440 nm.145, 167, 170 The height of the emission peak is 
correlated with the amount of lipid deposition on the lens. Lipid deposition on 
conventional hydrogel lenses were analyzed using this technique to discover the 
deposition patterns on group II and group IV lenses that were previously discussed. 
This method is accurate for determining relative total lipid content, but not 
applicable for individual lipid concentrations.145, 167, 170  
A second fluorescence technique has been used in the past. This technique 
involves staining the lenses with Nile Red, a fluorescence probe. 244 The lenses are 
then mounted on silica plates and loaded into a fluorescence cell and imaged using 
customized equipment.  From this technique, differences in lipid deposition 
between different contact lens materials could be seen. This method of 
quantification is an imaging technique, which is not applicable for individual lipoidal 
species quantification.244 
A third fluorescence technique is available for in vitro examination of lipid or 
protein deposits on the surface and for examination of the deposition that occurs 
within the contact lens matrix. This technique utilizes proteins or lipids that have a 
fluorescent probe chemically attached to it and examination of the material either 
by a fluorescent plate reader or by confocal microscopy.202, 245-248  This technique of 
utilizing lipids tagged with a fluorescent probe is more conducive for the 
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examination of lipid deposition on silicone hydrogel lens materials, as silicone 
hydrogels will interfere with the natural lipoidal signals. Therefore, the addition of a 
probe molecule increases the fluorescent signal so that it is seen over the lens 
background. This technique has been used to examine kinetic uptake of lipids onto 
lens materials and the depth of lipid penetration into the matrix.202, 248  However, 
one limitation of this technique lies in the incorporation of a fluorescent probe that 
is a substantial size relative to the lipid or protein, possibly its own charge, and 
chemical characteristics, all which may interfere with the natural interactions of the 
lipid with its surroundings and the lens surface. 245 
 
1.6.8 RADIOCHEMICAL EXPERIMENTS 
One of the techniques that can be used to analyze deposition in an in vitro 
model is radiolabeled lipids225 or proteins.139, 249-253 By inserting radiolabeled lipids 
such as 3H-cholesteryl oleate and 14C-dioleoyl phosphatidylcholine into complex 
artificial incubation solutions and incubating the lenses, Prager and colleagues225 
were able to quantitatively analyze the radiolabeled lipid using scintillation beta 
counting.  Radiochemical experiments have the benefit that the radioactive “label” is 
thought not to change the lipid or protein in size, structure or function, which is 
different than other analysis techniques that use proteins or lipids that are labelled 




1.6.9 LIPID ANALYSIS NOTES 
It is clear from reviewing the literature on lipid analysis that this is a very 
technically challenging area, whether the lipid under investigation is from the tear 
film, meibomian glands, or contact lens materials. Since the eye contains such a 
large range of lipid types, there is no one direct or correct method to analyze all the 
lipids present. Therefore, more research on methods of lipid analysis must be 
undertaken, particularly given the interest in these areas relating to the role of lipids 
in dry eye and the deposition of lipids on hydrophobic silicone hydrogel materials.   
 
1.7 CONTACT LENS SURFACE CHARACTERIZATION 
There are a whole new range of techniques that have been or could be used 
for surface characterization of contact lens materials.  Many of these techniques 
have been extensively used in biomaterials research and have the ability to 
contribute vast amounts of information for the contact lens world.  
 
1.7.1 CONTACT ANGLE AND WETTABILITY 
The wettability of a contact lens is described as the ability of the tear film to 
cover the surface of a contact lens.254  Conventional hydrogel contact lenses have 
relatively high water contents with a hydrophilic surface. Therefore, these lenses 
(when fresh out of the original packaging) have no issues with wettability. However, 
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once these lenses have been inserted into the eye, changes to the lens occur which 
can decrease their wettability. 255 
There are two factors that can lead to a lens becoming decreasingly wettable. 
When the lens is placed on the cornea, water from the lens will be lost to the tear 
film and into the environment. The amount of water lost will depend on the 
environmental conditions the lens is exposed to. This process is progressive and 
therefore occurs over an extended period of time. The second factor is a dynamic 
process that occurs during blinking. Every time a contact lens wearer blinks the 
surface of the contact lens and the tear film changes. When the contact lens is 
exposed to the tear film and other aqueous substances the lenses hydrophilic groups 
“flip” or re-orientate so that they are exposed at the surface. In contrast, when the 
lens is exposed to hydrophobic environments, such as air, the hydrophilic groups 
“flip” to expose the hydrophobic groups of the lens. This process is called chain 
rotation. This progressive evaporation of water contributes to the discomfort felt by 
lens wearers at the end of the day.255 
Historically, wettability is measured by the contact angle that forms between 
the hydrogel lens material and a water interface. The three most common methods 
of measuring the contact angle of a contact lens material: sessile drop, captive 
bubble, and Wilhelmy plate.  
In the sessile drop method, a contact lens has any excessive surface fluid 
removed using lens paper and is placed posterior side down on a convex shaped 
mantle. A 5 µl drop of water or saline is dispensed from a syringe on to the apex of 
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the contact lens. The drop is allowed to settle for 2-3 seconds and the contact angle 
can be measured between the drop of water and the contact lens surface, as seen in 
Figure 1-16. The sessile drop method measures the advancing contact angle. 
 
FIGURE 1-16: THE SESSILE DROP METHOD USED TO MEASURE THE CONTACT ANGLE AND 




In the captive bubble method, the contact lens is immersed in a chamber that 
contains saline solution or water with the contact lens oriented anterior side down. 
An air bubble is placed on the apex of the contact lens surface using a syringe. The 
contact angle between the contact lens surface and the air bubble is then measured.  
This technique can be seen in Figure 1-17. 256,257 This technique is analogous to a 




FIGURE 1-17: THE CAPTIVE BUBBLE TECHNIQUE TO MEASURE THE CONTACT ANGLE AND 
ULTIMATELY THE WETTABILITY OF A CONTACT LENS. 
 
 
The Wilhelmy plate method can be used to measure both the advancing and 
receding contact angles of the same contact lens.  In this method, a contact lens is 
mechanically lowered into a beaker containing water or a saline solution. Advancing 
contact angles are measured as the contact lens is being lowered into the solution. 
Then, receding contact angles are measured as the contact lens is slowly being 
removed from the solution. The specific angles that are being measured in each case 




FIGURE 1-18:  THE WILHELMY PLATE TECHNIQUE TO MEASURE THE CONTACT ANGLE AND 
ULTIMATELY THE WETTABILITY OF A CONTACT LENS. 
 
 
Each method of measuring contact angles has its advantages and 
disadvantages and each method delivers different final measurement values.256, 258, 
259 However the contact angle is measured, better contact lens material wettability 
corresponds with smaller contact angles. Therefore, the ideal contact angle is zero, 
which would denote a completely wettable contact lens. Unfortunately, the newer 
silicone hydrogel contact lens materials are more hydrophobic and thus have the 
distinct characteristic of being unwettable in nature. This is the main reason for 
surface treatments and internal wetting agents. 259  
Contact angle methods are based on the contact angle or Young-Dupree 
equation as seen below:260 
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EQUATION 1-1: YOUNG-DUPREE EQUATION 
γSV = γSL + γLV cos θe 
Where:  
γSV  = solid/vapour interfacial tension, γSL  = solid/liquid interfacial tension, γLV  = 
liquid/vapour interfacial tension, cos θe  = equilibrium contact angle 
 
Overall, novel silicone hydrogel materials are, as described previously, less 
wettable than conventional hydrogels and thus the issue of contact lens wettability 
has become a topic of great interest again.201, 258, 261-268    
 
1.7.2  MICROSCOPY 
Microscopy is a powerful technique to help characterize the surface 
morphology and the environmental interactions of biomaterials.269-271 There are 
many different types of microscopy which have aided in our understanding of the 
materials surfaces, such as:  scanning election microscopy (SEM), transmission 
electron microscopy (TEM), atomic force microscopy (AFM), and confocal scanning 
microscopy. 269, 272 Microscopy techniques such as TEM and SEM have the advantage 
of creating very high resolution images, however sample preparation is extensive 
and destructive, and these processes can alter the surface characteristics of the 
material. 269  
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Atomic force microscopy has become increasingly utilized for biomaterials and 
contact lens surface characterization (Figure 1-19).273-281 In AFM, the surface is “felt” 
by a probe which measures the interactions, either repulsive or attractive, and 
converts it into a high resolution image.282  AFM has the advantage over other 
microscopic techniques in that the sample does not have to be processed prior to 
analysis and it can be imaged in an aqueous environment.282 To obtain high quality 
images, the researcher must carefully choose the AFM tip, AFM settings and the 
optimal mode to image in.282 One of the main disadvantages of AFM is the length of 
time it takes to image the sample.269  
 
FIGURE 1-19: ATOMIC FORCE MICROSCOPY IMAGES TAKEN FROM BALAFILCON A SHOWING THE 
SILICATE GLASSY ISLANDS AND POROUS NATURE OF THE MATERIAL. A) IMAGE TAKEN IN 
CONTACT MODE B) IMAGE TAKEN IN PHASE CONTRAST MODE. 20X 20µM 
 




Confocal microscopy is a powerful technique that is able to visually section a 
sample so that different portions of the sample are imaged individually through the 
z-plane.269  This technology requires no special sample preparation and therefore 
biomaterials can be imaged and analyzed without the need for freezing, embedding 
or physical sectioning. Fluorescent confocal microscopy has been used in hydrogel 
and biomaterial research, very successfully.202, 245-248, 283-285 
 
1.7.3 SPECTROSCOPY 
Spectroscopy techniques have become valuable tools for the analysis and 
characterization of biomaterials.  Not only can spectroscopy give information 
regarding the chemical structure and morphology of a biomaterial surface, but also 
the constituent elements.269, 286  In addition to that, some of the methods can be 
performed in real time with very little sample preparation and processing.  The 
main types of spectroscopy being used for biomaterial analysis are X-ray 
photoelectron spectroscopy (XPS),270, 287-292 secondary ion mass spectrometry 
(SIMS),289, 293, 294 attenuated total reflectance Fourier transform infrared 
spectroscopy (ATR-FTIR),291, 292, 295 and surface matrix-assisted laser desorption 
ionization mass spectrometry (Surface MALDI).288, 296-299  Each of these methods has 
their own limitations, advantages and unique abilities for biomaterial and contact 





2 OBJECTIVES AND IMPORTANCE 
To date, there has been very little research analyzing the factors that affect 
lipid deposition on silicone hydrogel contact lens materials and comparing them to 
conventional hydrogel deposition. Much of the recent research has been spent 
simply assessing the quantity of lipid depositing during in vitro and ex vivo 
experiments, however very little work has been done trying to characterize the 
types of interactions that affect deposition in both laboratory-based and human 
contact lens studies. Lipid deposition is a multifactorial phenomenon and to simply 
assess ex vivo lenses, without being able to control all of the variables could lead to 
incorrect assumptions. However, by using an in vitro model and building it up one 
step at a time, the individual variables can be assessed and catalogued for future 
more complex model analysis.  
The main research questions examined throughout this thesis are: What are 
the variables that influence lipid deposition during human contact lens wear and 
how can those variables be incorporated into a physiologically relevant laboratory-
based in vitro model of lipid deposition? 
With that research question in mind, the overall objectives of this thesis were 
to develop an in vitro model of lipid deposition by systematically analysing some of 
the factors that may influence carbon-14 cholesterol and phosphatidylcholine 
deposition such as: the artificial tear solution composition used for incubation, the 
extraction solvent system, the cleaning regimes used to clean the contact lenses, the 
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effect of incubation time, and the effect of intermittent air exposure has on lipid 
deposition.  By conducting these individual experiments it is the hope that a better 
model for lipid deposition can be obtained and that more knowledge will be gained 






















In the following chapter of this thesis, the development of a complex and 
stable artificial tear solution optimized specifically for in-vial incubations of contact 
lenses is described. The development of this artificial tear solution is the first step in 
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Purpose: To characterize solution properties of a physiologically relevant artificial 
tear solution (ATS) that contains a range of tear film components within a complex 
salt solution, measure contact lens parameters and lipid deposition after incubation 
in ATS. 
Methods: A complex ATS was developed that contains a range of salts, proteins, 
lipids, mucin and other tear film constituents in tear film relevant concentrations. 
This ATS was tested to confirm that its pH, osmolality, surface tension and 
homogeneity are similar to human tears and remain so throughout the material 
incubation process, for up to 4 weeks. To confirm that silicone hydrogel and 
conventional hydrogel contact lens materials do not alter in physical characteristics 
beyond what is allowed by the ISO 18369-2; the diameter, centre thickness, and 
calculated base curve were measured for five different lens materials directly out of 
the blister pack, after a rinse in saline and then following a two week incubation in 
the modified ATS.  To test the ATS and the effect of its composition on lipid 
deposition, two lens materials were incubated in the ATS and a modified version for 
several time points.  Both ATS solutions contained trace amounts of carbon-14 
cholesterol and phosphatidylcholine, such that deposition of these specific lipids 
could be quantified using standard methods.   
Results: This ATS is a complex mixture that remains stable at physiologically 
relevant pH (7.3-7.6), osmolality (304-306 mmol/kg), surface tension (40-46 
dynes/cm) and homogeneity over an incubation period of three weeks or more.  The 
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centre thickness, diameter and calculated base curve measurements showed no 
changes beyond what is allowed by the ISO guidelines. Incubations with the ATS 
found that balafilcon A lenses deposit significantly more cholesterol and 
phosphatidylcholine than omafilcon A lenses, p<0.05 and that removing the 
lactoferrin and immunoglobulin G from the ATS can significantly decrease the mass 
of lipid deposited. 
Conclusions: This paper describes a novel complex artificial tear solution specially 
designed for in-vial incubation of contact lens materials. This solution was stable 
and did not adversely affect the physical parameters of the soft contact lenses 
incubated within it and showed that lipid deposition was responsive to changes in 
ATS composition.  
 
3.2 INTRODUCTION 
In vitro biomaterial models have been used extensively to analyze surface 
interactions that occur with an implanted medical device and their surroundings.1-5 
Contact lenses are similar to an implant in that they are a temporary biomaterial 
that is exposed to a very complex environment, in some cases more complex than 
permanently implanted biomaterials, such as a hip or knee replacement.  Unlike 
these biomaterials, contact lenses are exposed to a continuously changing tear film 
composition and structure induced by continuous blinking and drying of the lens 
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surface, changes in environmental surroundings, humidity, occupation, systemic 
diseases, medications, alcohol consumption and diet.6-9   
The composition of the human tear film is complex, and is believed to contain 
several layers, including a glycocalyx mucin layer covering the corneal epithelium, 
an aqueous layer rich in proteins, salts and electrolytes, and a lipid layer divided 
into both a polar and non-polar lipid component.10-12  Although this layered tear film 
model is still favoured, it is now believed that this structure is not as 
compartmentalized as previously thought and that the components from each layer 
can be found throughout the entire tear film.13-17  Soft contact lens materials, once 
inserted into the eye, lie  in the middle of this tear film structure and are known to 
readily adsorb many different tear film components, including lipids, proteins, and 
mucins.18-27 
Building an in vitro model to examine deposition of tear film components onto 
contact lens materials would allow for systematic and structured analysis of tear 
film interactions. These models could then be used to analyze various lens materials 
and their affinity for different tear film components, the conformation of proteins on 
contact lens materials, the exploration of tear film component interactions and 
competition, and the effectiveness of contact lens cleaning solutions to remove such 
deposits. These types of experiments would be difficult, if not impossible, to conduct 
in a controlled manner using in vivo or ex vivo studies. Therefore, in vitro models 
examining these interactions and processes can provide pertinent information to 
further our understanding of the ever growing field of contact lens material science. 
79 
 
In vitro models have many benefits over in-eye clinical studies. They allow for 
analysis of specific variables without the use of human or animal testing, the 
variables are easily and tightly controlled in laboratory settings, many different 
analysis techniques can be used that otherwise would not be available using in vivo 
or ex vivo based studies, allow for the examination of both simple and complex 
models, and lastly in vitro studies tend to require less financial support and time to 
conduct, since participant remuneration and ethics approval are not required.  
Although in vitro models can never fully mimic the complex nature of human 
contact lens wear, they can be designed to be physiologically relevant and help 
understand the basic tear film interactions that occur.  Many early in vitro contact 
lens deposition models involved incubating contact lens material in a simple saline 
solution with one tear film component, such as a single protein or lipid.18, 24, 28-31  
This model is very simplistic and is not indicative of what is found in the human tear 
film.  It is clear that there is a relative dearth of information on contact lens in vitro 
models, especially for lipid deposition. In addition to this, many of the in vitro 
deposition models that have been used to-date do not address several important 
factors affecting deposition on human-worn contact lenses, including the complexity 
of the tear film, the inter-blink period where the contact lens is directly exposed to 
air, and the sheer force that occurs during blinking. All of these factors can greatly 
contribute to the deposition and wettability of a contact lens material.32-34 
More recently, researchers have started to increase the complexity of the 
artificial tear solutions used to mimic the tear film. Mirejovsky et al., was the first to 
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report on the use of a complex artificial tear film that contained a range of salts, 
proteins, and lipids.35  Artificial tear solutions used in in vitro studies must contain 
physiologically relevant components, maintain physiologically relevant solution 
properties and must not change the contact lens parameters during incubation, as 
alterations in these parameters can cause changes in the contact lens dimensions 
themselves.  The contact lenses may swell/shrink, thicken/thin, or experience a 
change in their base curve if an inappropriate solution is used.  These lens 
parameter changes could alter the deposition pattern and lens interactions with tear 
film components. If in vitro contact lens deposition models are to mimic human 
contact lens wear, then the artificial tear solutions used must be more complex than 
a single component system.  Recent work from our laboratory has shown that an in 
vitro incubation solution consisting of a mixture of lipids, proteins, mucins and 
buffers is significantly different to that obtained in an in vitro model which uses 
single lipids alone.32   In this paper, we wanted to explore how sensitive the lipid 
deposition was to smaller changes in solution, such as adding or removing 
individual components. 
Our laboratory has characterized a complex physiologically relevant artificial 
tear solution (ATS) designed for in vitro vial-enclosed incubation experiments. This 
solution has been tested to maintain its properties and lens parameters throughout 
contact lens incubation. Although this solution does not contain all of the individual 
human tear film components, it does contain a broad representation of the most 




3.3.1 THE ATS COMPOSITION 
ATS preparation required four main steps. These included preparation of the 
complex salt solution, lipid stock solution, adding lipids to the salt solution and 
addition of the proteins and mucin to complete the solution. 
3.3.2 THE COMPLEX SALT SOLUTION 
The first step in making an ATS was the preparation of a complex salt solution 
(CSS). The composition of the CSS, which is used as the base of the ATS, is shown in 
Table 3-1. These specific salts and their relative concentrations are based on 
literature values.35-38 All CSS components were ACS grade and purchased from 
Sigma (Oakville, ON). The individual components were measured on an analytical 
balance and sequentially added to the desired volume of MilliQ water in the order 
that they are listed in table. Once all of the components had been added, ProClin 
300, a preservative and antimicrobial agent, was added to the system.  The use of 
ProClin 300 allows for incubation at 37oC for prolonged periods of time with no fear 
of microbial contamination. After all the ingredients were added, the pH was 
approximately 7.15 and the osmolality was 305 mmol/kg. When the CSS was left at 
room temperature for three or more days it equilibrated naturally to the desired pH 
of 7.4, which is the typical pH of the human tear film.39 However, if the solution was 
to be used immediately then purging with nitrogen gas equilibrated the solution to 









Sodium chloride NaCl 90.0 
Potassium chloride KCl 16.0 
Sodium citrate Na3C6H5O7 1.5 
Glucose C6H12O6 0.2 
Urea (NH2)2CO 1.2 
Calcium chloride CaCl2 0.5 
Sodium carbonate Na2CO3 12.0 
Potassium hydrogen carbonate KHCO3 3.0 
Sodium phosphate dibasic Na2HPO4 24.0 
Hydrochloric acid (10 molar) HCl 26.0 
   
ProClin 300 (Supelco 48912-U)  0.2 µL/ 1L 
MilliQ Water   
 
3.3.3 CONCENTRATED LIPID STOCK SOLUTION 
The next step in the ATS preparation was to make a concentrated lipid stock. 
Here, a 2000X concentrated lipid stock solution (LSS) was made to help facilitate 
dissolving the pure lipids into the CSS. Lipids, especially non-polar lipids, do not 
naturally dissolve into aqueous solutions, so dissolving them first into a solution of 1 
hexane: 1ether and then adding an aliquot of the hexane/ether LSS to the CSS helps 
facilitate the incorporation of lipids.  To make a LSS, pure lipids were warmed up to 
room temperature and weighed out using an analytical balance (solid lipids) or 
pipetted using a positive displacement pipette (liquid lipids). The concentrated LSS 
was placed in an amber vial, sealed with Parafilm®, wrapped in foil and stored at -
20oC until required.  Table 3-2 shows the lipids used in the ATS, their 
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characteristics, the lipid stock concentration and final ATS concentration used for 
each lipid.  All pure lipids were purchased through Sigma (Oakville, ON).  The lipids 
used in this ATS were chosen specifically so that a broad range of human tear film 
lipids were represented and their concentrations were chosen based on human tear 
film concentrations, artificial tear solution literature values, and lipid solubility in 
aqueous solutions.28, 35, 40-42 
 
TABLE 3-2: MOLECULAR AND EXPERIMENTAL DETAILS OF THE SPECIFIC LIPIDS USED FOR ALL 
LIPID DOPING SOLUTIONS28, 35, 40-42 






Lipid type Triglyceride Sterol Fatty acid Fatty ester Cholesteryl ester Phospholipid 












0.016 0.0018 0.0018 0.012 0.024 0.0005 
 
 
3.3.4 LIPID ARTIFICIAL TEAR SOLUTION 
The next step in making an ATS was to make the lipid artificial tear solution 
(LTS). This was accomplished by removing the LSS from the freezer and allowing it 
to warm up to room temperature in a dry dark place.  The desired volume of room 
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temperature CSS was placed into a glass septum jar and the required volume of LSS 
was added to the CSS.  The cap was screwed onto the septum jar and the whole jar 
was placed into an ultra-sonic bath that was warmed to 37°C.  Two syringes were 
pierced through the septum, one large blunt syringe was placed into the solution 
and one smaller syringe was left sitting in the air space of the septum jar. The large 
syringe was connected to a nitrogen tank and the small syringe remained open to air 
to act as a vent. The LTS was sonicated at 90 watts and purged with nitrogen gas at a 
pressure of 3 psi until the LSS was fully incorporated into the CSS and the odour of 
hexane: ether had dissipated.  The LTS was now complete. 
 
3.3.5 INCORPORATION OF PROTEINS AND MUCIN TO COMPLETE PREPARATION 
OF THE ATS 
The last step in preparing the ATS was the addition of proteins and mucin.  The 
specific proteins and mucin used and their concentrations in the final ATS are 
outlined in Table 3-3 and are based on literature values of the human tear film, 
literature ATS concentrations, and based on the cost of the component, as in the 
case of lactoferrin and IgG.35, 43-50 All proteins and mucin were purchased from 
Sigma (Oakville, ON).  Bovine and hen-egg proteins were chosen for use in this ATS 
due to their cost and their similarities to human proteins in molecular weight, pI, 
amino acid chain length, and number of charged residues.  The proteins and mucin 
were weighed out on an analytical balance and added to the LTS while stirring. 
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When all components were incorporated fully, the complete ATS was sonicated at 
37°C for a maximum of 5 minutes, to prevent destruction of the proteins.51  
 








Bovine Albumin 66.4 0.20 A7888 
Hen Egg Lysozyme 14.3 1.90 L6876 
Bovine Mucin 3 × 105 to 4 × 107  0.15 M3895 
Bovine Colostrum 
Lactoferrin 
83.1 1.80 L4765 
Bovine Immunoglobulin G 161 0.02 I5506 
 
3.3.6 SOLUTION PROPERTIES 
3.3.6.1 PH AND OSMOLALITY 
In order to test the consistency of the ATS’s pH and osmolality during in vitro 
incubations, a 28 day study was performed.  Clear borosilicate glass 6 mL vials were 
half filled with freshly made ATS with a starting pH of 7.35 and an osmolality of 305 
mmol/kg. Vials were closed with PTFE-sealed screw caps, further sealed with 
Parafilm® and incubated at 37°C for six different time points including: 1, 3, 7, 14, 
21, and 28 days in triplicate. On the specific days, the vials were opened and the pH 
was measured using the SympHony SB20 pH meter (VWR, Mississauga, ON) and the 
osmolality was measured using the Wescor “Vapro” Vapor Pressure Osmometer 
5520 (Discovery Diagnostics, Claremont, ON).  
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3.3.6.2 SURFACE TENSION AND HOMOGENEITY OF ATS 
In order to test the surface tension and liposome homogeneity of the solution a 
3.5 week study was conducted.  Fresh ATS was made and tested for its surface 
tension and homogeneity and then the ATS was incubated for 3.5 weeks at 37°C and 
tested again for the two parameters. The surface tension was measured using the 
Wilhelmy Balance using a platinum ring and the homogeneity of the solution was 
tested by staining liposomes in the ATS with Nile Red.  In order to stain with Nile 
Red, the Nile red was dissolved in acetone at 1 mg/mL, then 1 µL of the Nile red 
solution was added to 100 µL of the test solution in a micro-centrifuge tube and 
shaken so the two components were well mixed.35 Then 20 µL of the Nile red test 
solution was then pipetted onto a slide (prewashed with Methanol), and a cover slip 
was placed on top. The sample was then examined and photographed on the 
microscope at 10x and 40x magnifications using a green light filter.  Samples of the 
complex salt solution and artificial tear solution were analyzed at several points in 
the preparation process and compared with the solution after 3.5 weeks of 
incubation.  The distribution and diameter of the liposomes was analyzed for each 
sample. 
 
3.3.7 LENS PARAMETERS 
Five contact lens materials were tested in triplicate including: Acuvue® 2 
[etafilcon A; Vistakon], Proclear® [omafilcon A; CooperVision], Acuvue® OASYS™ 
[senofilcon A; Vistakon], Biofinity® [comfilcon A; CooperVision], PureVision™ 
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[balafilcon A; Bausch & Lomb].  The material characteristics of all contact lens 
materials can be found in Tables 3-4 and 3-5. All lens materials tested had a 
spherical power of -3.00D and had an approximate base curve of 8.6 ± 0.2 mm. The 
individual lenses were measured at three times:  out of the blister pack, after 40 
hours of soaking in CSS, and after 2 weeks’ incubation at 37°C in the ATS previously 
described.  The centre thickness was measured using a Rehder Development Co.  
E.T.-1 (Castro Valley, CA) and the diameter and sagittal height (Sag) of each lens was 
measured using the Optimec Soft Contact Lens Analyzer (Malvern, UK). The base 
curve was then calculated from the diameter and sagittal height. The contact lens 
parameter measurements were taken so that comparisons could be made between 
the three parameters tested and was not meant to assess the contact lens parameter 
variability from their specified package dimensions. 
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TABLE 3-4: CONVENTIONAL HYDROGEL CONTACT LENS MATERIAL CHARACTERISTICS UTILIZED 
Material Type Conventional Hydrogel 
USAN Etafilcon A Omafilcon A 
Proprietary name Acuvue®2 Proclear® 
Manufacturer Johnson & Johnson CooperVision 
Power (D)  -3.00 -3.00 
Base Curve (mm) 8.7 8.6 
Diameter (mm)  14.0 14.2 
Monomers HEMA, MA HEMA, PhC 
Surface Modification None None 
Dk/t (x10-9) 31.0 52.3 
Water Content 58% 62% 
FDA Class Group IV Group II 
Dk/t: oxygen transmissibility; USAN: United States adopted name;  




TABLE 3-5: SILICONE HYDROGEL CONTACT LENS MATERIAL CHARACTERISTICS UTILIZED 
Material Type Silicone Hydrogel 
USAN Senofilcon A Comfilcon A Balafilcon A 
Proprietary name Acuvue® OASYSTM Biofinity® PureVisionTM 
Manufacturer Johnson & Johnson CooperVision Bausch & Lomb 
Power (D)  -3.00 -3.00 -3.00 
Base Curve (mm)  8.4 8.6 8.6 
Diameter (mm)  14.0 14.0 14.0 
Centre Thickness 
(mm) -3.00D 
0.07 0.08 0.09 
Monomers 




HOB, IBM, NVP, 
TAIC, VMA 




PVP as an internal wetting 
agent 
None Plasma oxidation 
Dk/t (x10-9) 147 160 110 
Modulus (MPa) 0.7 0.75 1.1 
Water Content 38% 48% 36% 
FDA Class Group I Group I Group III 
Dk/t: oxygen transmissibility; USAN: United States adopted name; DMA (N,N-dimethylacrylamide); EGDMA 
(ethyleneglycol dimethacrylate); FM0411M (2-ethyl [2-[(2-methylprop-2-enoyl)oxy]ethyl]carbamate); HEMA 
(poly-2-hydroxyethyl methacrylate); HOB ((2RS)-2-hydroxybutyl 2-methylprop-2-enoate); IBM (Isobornyl 
methacrylate); M3U (α-[[3-(2-[[2-(methacryloyloxy)ethyl] carbamoyloxy]ethoxy)propyl]dimethylsilyl]-ω-[3-(2-
[[2-(methacryloyloxy)ethyl] carbamoyloxy]ethoxy)propyl]poly([oxy[(methyl) [3-[ω-
methylpoly(oxyethylene)oxy]propyl]silylene] /[oxy[(methyl)(3,3,3-trifluoropropyl)]silylene]/oxy 
(dimethylsilylene)])); mPDMS (monofunctional polydimethylsiloxane); NVA (N-vinyl aminobutyric acid); NVP 
(N-vinyl pyrrolidone); PBVC (poly[dimethysiloxy] di [silylbutanol] bis[vinyl carbamate]); PVP 
(poly(vinylpyrrolidone)); TAIC (1,3,5-triprop-2-enyl-1,3,5-triazine-2,4,6(1H,3H,5H)-trione); TPVC (tris-
(trimethylsiloxysilyl) propylvinyl carbamate); VMA (N-Vinyl-N-methylacetamide) 
 
3.3.8 LIPID DEPOSITION 
As the last step of the ATS characterization process, the ATS was examined for its 
lipid deposition using a simple radioactive experiment previously developed by our 
laboratory.  In this experiment, omafilcon A and balafilcon A lens materials were 
incubated in two different ATS solutions for three different time periods, as outlined 
in the flowchart, Figure 3-1.  The first ATS solution composition was identical to the 
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ATS described above (+LF/IgG) and the second ATS solution was a slightly simpler 
version with lactoferrin (LF) and immunoglobulin G (IgG) removed (- LF/IgG).  In 
order to facilitate sensitive quantification of lipid deposition, both ATS solutions 
were prepared by adding a small aliquot of one of two radiolabelled lipids (Table 3-
6); 14C-cholesterol or 14C-phosphatidylcholine.  The radiolabeled cholesterol and 
phosphatidylcholine was added to the ATS at a concentration of 3% and 8.5% of the 
total individual lipid concentration respectively. Lenses (n=3) were then incubated 
in each solution for 3, 7 and 20 days.  
At the end of the incubation period, each lens was rinsed twice in saline and 
blotted on lens paper.  The lenses were then placed in 20 mL glass scintillation vials 
with 2 mL of 2:1 chloroform: methanol extraction solution and were incubated for 
three hours each at 37°C while shaking on an orbital shaker.  Each lens was 
extracted in this way on two separate occasions and both extracts were pooled 
together in the same vial.  
The extract vials were dried completely using nitrogen evaporation at 37°C.  
All samples were re-suspended in 1 mL of chloroform, sonicated for one minute, and 
10 mL of Ultima Gold F scintillation cocktail (Perkin-Elmer) was added.  The vials 
were submitted for liquid scintillation beta counting to determine the mass of 
radioactive lipid deposited.  In the experiment, the radioactive lipid was used as a 
probe and the ratio of radioactive lipid to non-radioactive lipid in the incubating 
ATS was kept constant.  Therefore, quantification of the total amount of cholesterol 
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and phosphatidylcholine deposited was extrapolated and calculated using standard 
radioactive lipid calibration curves.  
 
 






















3.3.9 STATISTICAL ANALYSIS 
Statistical analysis was completed using Statistica 9 software. Lens parameter 
statistical analysis was completed using a paired t-test and lipid deposition data was 






3.4.1 PH AND OSMOLALITY 
When examining the stability of pH and osmolality of the ATS it was found that pH 
ranged from 7.35 to 7.49 and osmolality ranged from 305.0 to 303.7 mmol/kg, over the 
28 days of incubation.   
 
3.4.2 SURFACE TENSION AND HOMOGENEITY OF ATS 
After the complex salt solution and ATS preparation was complete, several 
aliquots of each solution were stained with Nile Red examined microscopically at 
200x –400x and photographed.   Following a three week in-vial incubation, ATS 
aliquots were once again stained and photographed. Following staining with Nile 
Red, the CSS samples had no visible liposomes present in its solution, as expected.  
However, both ATS samples, freshly made and post incubation solutions, showed 
similar distribution and sizes of liposomes stained by the Nile Red. The liposomes 
present in both ATS solutions ranged in size from 6-20 µm, with average sizes 
around 12 µm. Therefore, no discernible differences were found in fresh versus 
incubated ATS solutions in terms of its homogeneity.   
The surface tension of the freshly prepared ATS was 51.5 ± 0.38 dynes/cm and 
following the 25 days of incubation the surface tension fell to 45.05 ± 1.25 




3.4.3 LENS PARAMETERS 
The centre thickness of each lens material measured out of blister pack, 
following a saline soak, and after ATS incubation at 37°C for two weeks can be 
graphically in Figure 3-2. One statistically significant difference was seen when 
analyzing the difference between the blister pack and post-incubation conditions.  
Omafilcon A lenses experienced a 1.0% average increase in centre thickness 
following two week incubation in ATS. These changes in centre thickness would not 




FIGURE 3-2: AVERAGE CENTRE THICKNESS AS MEASURED DIRECTLY FROM THE BLISTER PACK, 
AFTER A SALINE SOAK, AND FOLLOWING 14 DAY INCUBATION 
 
* denotes statistically significantly different from blister, p<0.05 
 
The average contact lens diameter results measured out of blister pack, 
following a CSS soak, and following a two week incubation in ATS can been seen in 
Figure 3-3. Only etafilcon A had a statistically significant change in diameter 
following incubation in ATS, where the average diameter decreased by 0.81%.  
These changes in diameter are not considered to correlate to any significant 




FIGURE 3-3: AVERAGE LENS DIAMETER AS MEASURED DIRECTLY FROM THE BLISTER PACK, AFTER 
A SALINE SOAK, AND FOLLOWING 14 DAY INCUBATION 
 
* denotes statistically significantly different from blister, p<0.05 
 
Average base curve results for each contact lens material after each lens 
treatment are displayed in Figure 3-4.  No statistically significant differences were 
seen when comparing the blister pack measurements to the post-incubation in ATS 




FIGURE 3-4: AVERAGE BASE CURVE AS MEASURED DIRECTLY FROM THE BLISTER PACK, AFTER A 
SALINE SOAK, AND FOLLOWING 14 DAY INCUBATION 
 
 
3.4.4 CONTACT LENS LIPID DEPOSITION 
The results of the radioactive cholesterol (C) and phosphatidylcholine (PC) 
kinetic uptake with and without the presence of lactoferrin and IgG can be seen in 
Figure 3-5 and Figure 3-6. As seen in the figures below, the silicone hydrogel lens 
material deposited more than the conventional hydrogel lens and that more 
cholesterol was deposited than phosphatidylcholine. The lipid uptake for all lens 
materials, especially the silicone hydrogels, was continuous throughout the 20 day 
period, with no plateau. The presence of lactoferrin and IgG in the ATS correlated 
with a statistically significant increase in cholesterol and PC deposition for 
balafilcon A at every time point p≤0.001.  Cholesterol deposition on omafilcon A in 
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the presence of LF/IgG was greater than without, however the trend was not 
statistically significant for any time point, p>0.05. However, PC deposition on 
omafilcon A did show statistically significant increases in the presence of LF/IgG for 
every time point, p≤ 0.008.  Overall, there were statistically significant differences in 
the entire repeated measures ANOVA model including all the variables and variable 
interactions for each lipid tested, as seen in Table 3-7 and Table 3-8. 
 





TABLE 3-7: CHOLESTEROL REPEATED MEASURES ANOVA RESULTS 
Variables SS DF MSq F p 
Time 5255742 2 2627871 2774 <0.0001 
± LF/IgG 851579 1 851579 1739 0.0006 
Lens 21480765 1 21480765 24367 <0.0001 
Time * ± LF/IgG 266177 2 133089 196 0.0001 
Time * Lens 4865540 2 2432770 1506 <0.0001 
± LF/IgG * Lens 634230 1 634230 794 0.0013 
Time * ± LF/IgG * Lens 254090 2 127045 334 <0.0001 
Error 1523 4 381   
SS = sum of squares, DF = degrees of freedom, MSq = mean square, F = F statistic, p = probability 
 





TABLE 3-8: PHOSPHATIDYLCHOLINE REPEATED MEASURES ANOVA RESULTS 
Variables SS DF MSq F p 
Time 476975 2 238488 737.92 <0.0001 
± LF/IgG 889902 1 889902 1468.12 0.0007 
Lens 3127668 1 3127668 2588.36 0.0004 
Time * ± LF/IgG 30717 2 15358 21.80 0.0071 
Time * Lens 221962 2 110981 424.64 <0.0001 
± LF/IgG * Lens 212945 1 212945 440.59 0.0023 
Time * ± LF/IgG * Lens 5516 2 2758 12.91 0.0180 
Error 855 4 214   
SS = sum of squares, DF = degrees of freedom, MSq = mean square, F = F statistic, p = probability 
 
3.5 DISCUSSION 
In the creation of an in vitro model designed to analyze the dynamics of tear 
film interactions on a contact lens surface, the development of an appropriate 
artificial tear solution that is both physiologically relevant and stable is imperative. 
A handful of papers have been published using in vitro experimental models to 
examine contact lenses, their deposition and their tear film interactions. Many of 
these papers have used very simple in vitro solution models with single components 
for investigation, such as a single lipid or protein.  These individual component 
model systems have been regularly used for the last 25 years and are continually 
being utilized. In the mid-80’s, Castillo et al. utilized lysozyme incubation solutions 
dissolved in a phosphate buffered saline (PBS) to examine conformational changes 
that occur on PHEMA materials fabricated using different methods via ATR-FTIR.52 
Garrett et al.24 and several studies from Jones et al.18, 29, 30 utilized lysozyme or 
lactoferrin only solutions in PBS for radiochemical studies examining lysozyme or 
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lactoferrin adsorption and conformation onto various contact lens materials.  
Similar to proteins, there are several papers using single lipid in vitro systems, 
including Carney and colleagues work in 2008, where they examined kinetic uptake 
of lipid onto various contact lens materials using fluorescently labeled cholesterol 
and phosphatidylethanolamine solutions independently.28  Most recently, Pucker et 
al. published a similar paper examining the uptake of cholesterol oleate and 
phosphatidylcholine separately in an undisclosed buffer solution.31  In most of these 
publications, a phosphate buffered solution with a single lipid or protein is used; 
however in many of the papers there is no information about the specific 
composition or concentrations of the PBS itself.  Since there is no standardized 
composition of PBS, many of these papers are lacking important information 
regarding the ATS used.   
There are several experimental papers where moderately complex in vitro 
artificial tear solutions were used. These solutions are mixtures of proteins or lipids 
dissolved into a saline base.  Castillo et al.53 and Bohnert et al.54 both used an ATS 
which contained a mixture of several proteins dissolved into a saline solution to 
examine protein adsorption and conformation onto contact lens materials. Ho and 
Hlady examined lipid deposition using a mixture of several lipids dissolved into a 
more complex mixture of salts.55  In each of these three examples, lipids and protein 
components were not mixed together within the ATS and there was no 
incorporation of mucin. 
Recent work from our laboratory32 and past work from Bontempo and Rapp23, 
56 have found a dramatic difference in the amount of lipids and proteins deposited 
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onto conventional and silicone hydrogel contact lens materials from an ATS of 
different complexities. Single component systems, moderately complex systems (no 
mixing of lipids and proteins together) and complex multiple lipid and protein 
systems have different deposition behaviours. Although simpler systems can be 
useful for particular experimental models, they are unsuitable to mimic human 
contact lens wear deposition and tear film interactions, due to their lack of 
complexity. 
Papers have been published introducing more complex in vitro artificial tear 
solutions. The first of these papers was by Mirejovsky et al. in 1991, where lipids, 
proteins, mucin, and a variety of salts were all incorporated to form a complex tear 
solution.35  Mirejovsky’s ATS contains a range of different proteins, lipids from 
different classification groups, and a non-physiological biochemical buffer.  It was 
more complex than many of the past solutions and the first to more accurately 
mimic human tear fluid with individualized concentrations for each component.  
Since the introduction of Mirejovsky’s ATS, several other research groups have 
begun using a more complex ATS including: Prager and Quintana,25, 46 Bontempo 
and Rapp,56, 57 and Iwata et al.58  Prager and Quintana’s solution has the same 
protein portion as the Mirejovsky ATS and the lipid portion is similar, but instead of 
using a specialized blend of salts, Prager and Quintana use a Hank’s Balanced Salt 
solution as their saline base.25, 46 The Bontempo and Rapp ATS incorporated five 
tear film lipids, all incorporated in the same concentration, three tear film proteins, 
all incorporated in the same concentration, and a 0.9% saline base.56, 57  The most 
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recent solution of note is the one utilized by Iwata et al.58 This solution uses a 
mixture of four lipids, three proteins and a simplistic saline base.58 
It is common in in vitro ATS deposition models that the ATS is a homogenous 
composition with the proteins, lipids, and mucin mixed together throughout the 
solution.  In other words, the solution is not in the layered biophysical structure as it 
is in the natural tear film. This is for several reasons; first, in-vial static aqueous 
incubations are not conducive to a lamellar structure, as the contact lens would not 
be exposed to all of the tear film components as they are in human contact lens 
wear.  The blinking action, tear film mixing, tear film thinning and the eventual tear 
film breaking that occurs in human contact lens wear exposes the lens to all layers 
and components of the tear film. The second reason for using a homogenous non-
layered incubation solution is because this model is simpler to execute and has 
similar deposited masses of tear film components as ex vivo examined lenses.59, 60 
Therefore, the biophysical arrangement of the ATS doesn’t impact deposition to the 
same extent as the interactions that occur between the contact lens and tear film 
components. Therefore, even though the ATS structure is not necessarily identical to 
human tear film structure, it is still known to be a good model for deposition and 
tear film interaction research.  Future models will incorporate a layered tear film 
analogue and incorporate air exposure mimicking the inter-blink period. 
With the modified ATS solution introduced in this paper, we have tried to 
combine all of the necessary complexity by incorporating a variety of lipids, 
proteins, mucin, salts and also other prevalent tear film components such as 
physiological buffers, glucose and urea, all within a stable system specially designed 
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for in-vial incubations.  All of these previously published solutions are indeed a 
great improvement over the more simplistic solutions; however none of the papers 
have shown the stability of their solutions especially in terms of their pH and 
osmolality during contact lens incubations.   
It is known that the pH and osmolality of a stable human tear film is 6.6-7.839 
and 305 mmol/kg61 respectively and that the surface tension of tears is 40-46 
dynes/cm.62 Therefore, we contend that the model ATS with the specific complex 
salt solution introduced in this paper is a suitable physical and chemical 
representation of the human tear film.  The complex salt solution introduced in this 
paper was specially designed and extensively tested to confirm its stability. Many 
different combinations and concentrations of salts and physiological buffers were 
tested, however many of the test solutions did not remain stable in pH or osmolality 
over time, this was especially true for solutions with higher concentrations of 
carbonates, as carbonates tend to react with carbon dioxide in the air and therefore 
change in pH easily, especially if vials are not tightly sealed. This process was 
exacerbated when the ATS was incubated in plastic vials, instead of glass.  All plastic 
vials tested, including low-density polyethylene, high-density polyethylene, super 
polyethylene, and Teflon coated plastic vials all have intrinsic gas permeability and 
therefore the pH and osmolality of the ATS was constantly changing.  Therefore the 
final stable physiologically relevant complex salt solution modified by our 
laboratory contained only biological buffers and a slightly reduced concentration of 
carbonates. This solution was specifically designed for closed in-vial incubations 
within borosilicate glass vials with screw caps with PTFE liners that are sealed with 
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Parafilm® so that ATS pH and osmolality remain stable throughout the incubation 
periods.  
In all of these papers on in vitro model systems, only one of them has 
mentioned the lens parameter changes that occur upon incubation. Pucker et al., 
admit that due to the incorporation of chloroform in their incubation solution, the 
lens materials do indeed swell.31 Most of the other systems do not have this 
chloroform addition and the extra solvents such as hexane that may be present from 
the use of a lipid stock are evaporated prior to lens incubation. None of the other 
papers have reported measuring the diameter, centre thickness or base curve prior 
to incubation and following incubation in their ATS to know if the composition of 
the ATS is causing lens parameter changes beyond that which is considered 
allowable by the FDA.   Contact lenses and their cleaning solutions are tightly 
regulated so that contact lens parameter changes do not occur.  According to the ISO 
tolerance guidelines,63 contact lens materials are only allowed to change by ±0.20 
mm in diameter and base curve and by approximately ±18 µm in centre thickness, 
depending on the specific lens material,  during cleaning or contact lens wear. 
Swelling, stretching, shrinking and curvature changes could all induce power 
changes, fitting changes, and comfort issues for the contact lens wearer. In an in 
vitro experiment, these changes can affect contact lens deposition and interactions 
with tear film components so that the contact lenses no longer react naturally to 
their surroundings.  
In this experiment, the diameter, centre thickness, and base curve of all contact 
lens materials were measured directly after removing them from the blister pack, 
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following a soak in CSS, and after two weeks of incubation in the artificial tear 
solution described.  The diameter, base curve and centre thickness measurements 
all showed no clinically significant changes following incubation in the ATS and no 
parameter changes were found beyond what is allowed by 2006 ISO 18369-2 
tolerance guidelines.63 In a few instances, statistically significant changes in lens 
parameters were found between the blister pack measurements and following 
incubation in the ATS, however these changes were still well within ISO tolerances.  
As the final step in the development of this ATS, the ATS was tested for its 
ability to deposit lipid onto both a conventional and silicone hydrogel contact lens 
material.  Omafilcon A and balafilcon A lenses were chosen for the experiment, as 
previous research has shown that conventional hydrogels tend to deposit low 
amounts of lipid, whereas silicone hydrogel lenses, especially balafilcon A, are 
known to be more lipophilic and more likely to deposit lipid.28, 58, 64  Cholesterol and 
phosphatidylcholine were chosen for examination using a radiochemical 
experiment.  Radiochemical experiments have been widely used in biomaterials 
research65-70 including contact lens research, especially protein deposition 
research.18, 24, 25, 29, 30, 71  It has been shown to be a very sensitive, repeatable and 
reliable method of analysis and thus was chosen for this experiment. Cholesterol 
was selected as a representative non-polar lipid as it has been widely cited to be one 
of the most prevalent deposited lipids59, 64, 72-74 and phosphatidylcholine was chosen 
as a polar lipid species, due to its presence in the tear film.11, 75, 76  
The results of the deposition experiment clearly showed that lipid deposition, 
especially on balafilcon A lenses tend to continually deposit without plateau 
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throughout the 20 day incubation period, that the specific composition of the ATS 
will have a large impact on the deposition pattern for lipids, and that cholesterol 
tends to deposit more than phosphatidylcholine.  Bontempo and Rapp had 
previously examined the impact that ATS composition has on lipid and protein 
deposition for conventional hydrogel lenses,56 but to date nothing has been 
published on silicone hydrogel lens materials.   
This research supports the notion that the specific composition of an artificial 
tear solution will greatly impact the mass of tear film components that deposit.  By 
simply removing two proteins from the ATS, lactoferrin and immunoglobulin G, lipid 
deposition significantly decreased.  Data has established that the incubation volume 
(not shown) and lipid component concentrations77 also affect the amount of lipid 
deposited.  It is known that meibum, tear film, and deposited lipid concentrations 
and compositions can vary widely between individuals and that diet, medications, 
systematic diseases, and work environment can influence this deposition.6-9, 78, 79  
Therefore, it is very difficult to build an in vitro model to fully mimic all of the 
relationships and interactions that occur in human contact lens wear, so the first 
step is to begin unraveling the factors that may influence deposition.   
When the deposited mass of lipids quantified in this experiment is compared 
with other in vitro and ex vivo data, it can be seen that differences do exist.  In this 
experiment, after 7 and 20 days of incubation in the ATS solution (+ LF/IgG), 
balafilcon A lenses deposited 1.80 ± 0.06 and 3.22 ± 0.04 µg of cholesterol and 0.93 
± 0.02  and 1.22 ± 0.07µg of phosphatidylcholine per lens, respectively.  Omafilcon A 
lenses deposited 0.17 ± 0.005 and 0.21 ± 0.02 µg/lens of cholesterol after 7 and 20 
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days of incubation and similar masses of phosphatidylcholine at the same time 
points.  Much of the other in vitro lipid work completed recently have quantified 
higher masses of cholesterol and phospholipids (either phosphatidylcholine or 
phosphatidylethanolamine) depositing on balafilcon A and on conventional 
hydrogel lens materials such as etafilcon A. In vitro work from Carney et al.,28 Iwata 
et al.,58 and Pucker et al.,31 all cited higher deposition values than the work 
presented here.  However, these other in vitro studies had one more of these main 
differences in their experimental design which may account for increased 
deposition of lipids: the use of single lipid incubation solutions, higher 
concentrations of lipids in the ATS, altered incubation volumes, and replenishment 
of the ATS with fresh solution during incubation.28, 31, 58 All of these factors may 
explain the higher deposition of cholesterol and phosphatidylcholine.  
When the cholesterol deposition results found in this in vitro experiment are 
compared with recent ex vivo data it is found that results from the balafilcon A 
material are quite similar.  Zhao et al.59 quantified 4.1-8.2 µg/lens after 30 days of 
wear (depending on the cleaning solution used) and Saville et al.80 found 3.9 µg/lens 
after 30 nights of wear.  Saville also examined phosphatidylcholine deposition and 
quantified 0.019 µg/lens following 30 nights of wear which is lower than our 
quantified mass of 1.2 µg/lens on balafilcon A.80 Many of the recent in vitro and ex 
vivo studies were not completed with the same silicone hydrogel lens materials, did 
not include conventional hydrogel lens materials such as omafilcon A, and some of 
them examined different lipids than those quantified in this experiment. 
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It is clear that in vitro models do not always directly mimic what happens in 
vivo. Many times the masses deposited are lower or higher than what is reported in 
human worn contact lenses. This may be due to the simplicity of the models being 
used, different ATS compositions and concentrations or an incomplete 
understanding of all of the interactions and influences that are present.  The only 
way that in vitro models can be improved in their usefulness is to take a more in-
depth look at the relationships that are occurring during human contact lens wear 
and then test and incorporate them into the in vitro models.  It may transpire that 
the success of an in vitro model should not be measured according to the absolute 
mass deposited during human contact wear, as these values have large variations 
based on the populations tested, but should be examined to see if the hierarchy of 
deposition is consistent when comparing different lens materials and if the trends of 
wear are conducive to human wear. In the end, in vitro models must become more 
physiologically relevant so that their use can be validated and provide a basis for 
research and development of new and existing products.  
As a first step in developing an in vitro model, the ATS developed in our 
laboratory has been shown to remain stable throughout incubation periods up to 
four weeks, the lens parameters show no significant changes following a two week 
incubation, and deposited lipids are in line with recent ex vivo data. The ATS 
solution introduced in this paper has the flexibility to be tailored to the individual 
needs of the specific in vitro experiment and can be used to mimic human worn lens 





This paper has introduced a novel complex artificial tear solution specially 
designed for in-vial incubations. This solution maintains its own solution 
parameters and the parameters of the incubating contact lenses constant.  This 
solution characterization is the first step in developing a new in vitro model for 
contact lens deposition and tear film interactions.  
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In this chapter, the efficiency of removal of deposited cholesterol and 
phosphatidylcholine from both conventional and silicone hydrogel contact lens 
materials is examined using radiochemical experiments and various extraction 
solvent protocols, when necessary. Optimized extraction efficiencies of 85% or 
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Purpose: To examine and optimize the ability of several extraction systems to 
remove deposited cholesterol and phosphatidylcholine from various contact lens 
materials using 14C-labeled model lipids.  
Methods: A previously optimized complex artificial tear solution (ATS) that 
contained a mixture of proteins, lipids and one of  either 14C-cholesterol  or 14C-
phosphatidylcholine was used to incubate six different contact lens materials 
(etafilcon A, lotrafilcon B, omafilcon A, senofilcon A, comfilcon A, and balafilcon A) 
for seven days. Following incubation, all lenses were rinsed in saline and then three 
extractions of 3 hrs at 37°C in 2 mL of (2:1) chloroform: methanol were completed.  
All samples including rinses, contact lens incubated ATS, lens extracts, and 
standards were processed and quantified using standard calibration curves to 
calculate masses deposited and extraction efficiencies.  If the extraction efficiency 
was calculated to be less than 85% then alternate extraction solvent systems were 
tested.  
Results:  Extraction efficiencies for deposited cholesterol were calculated to be 
>90% with the extraction protocol of 3 hrs at 37°C in 2 mL of (2:1) chloroform: 
methanol.  The extraction efficiency of phosphatidylcholine with (2:1) chloroform: 
methanol was >98% for four of the six contact lens materials tested.  Balafilcon A 
and lotrafilcon B lens materials were re-tested with three different extraction 
procedures in an attempt to increase extraction efficiency beyond 85%.  The 
(60:50:1:4) chloroform: methanol: acetic acid: water extraction procedure removed 
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over 20% more phosphatidylcholine when compared with the original procedure. 
Balafilcon A was the highest depositor of cholesterol, lotrafilcon B was the highest 
depositor of phosphatidylcholine, and etafilcon A was the lowest depositor for both 
model lipids tested.   
Conclusions: An efficient extraction protocol for deposited cholesterol and 
phosphatidylcholine on two conventional hydrogel and four silicone hydrogel 
contact lens materials has been optimized based on chloroform and methanol.  
Confirming previous studies, conventional hydrogel contact lens materials 
deposited significantly less lipid than silicone hydrogel lenses; following one week 
of incubation in an artificial tear solution.  
 
4.2 INTRODUCTION 
To-date, most contact lens deposition studies have investigated protein 
deposition,1-11 with very little published data on lipid deposition, particularly 
silicone hydrogel lipid deposition.12-16 However, lipid deposition on silicone 
hydrogel lens materials is currently a “hot” topic at contact lens conferences around 
the world, with reports suggesting that these relatively hydrophobic materials tend 
to deposit more lipid than conventional hydrogels.15, 17, 18 Lipid deposits may result 
in decreased comfort, visual acuity, and wettability over time19 for the lens wearer 
and induce chemical changes in the contact lens itself.20 
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As described above, data characterizing lipid deposition on silicone hydrogel 
contact lens materials in vitro or ex vivo is sparse.   In vitro models exploring contact 
lens deposits from tear film components can be utilized to assess tear film 
interactions, kinetics of deposition, confirmation of the deposited species, 
penetration of deposits into the lens matrix, and the general factors that affect 
deposition.  One of the techniques that can be used to analyze deposition in an in 
vitro model is one in which radiolabeled lipids21 or proteins 2, 9, 22-25 are used as 
reporter molecules to quantify the degree of deposition. Radiochemical experiments 
have the benefit that the radioactive “label” is thought not to change the lipid or 
protein in size, structure or function, which is different to other analysis techniques 
that use proteins or lipids which have a conjugated probe molecule attached. 
Specifically, fluorescently labelled molecules are known to exhibit altered 
structures, masses, functions and interactions with their surroundings, as the 
fluorescent probe itself has its own structure, mass and active sites to react with 
surrounding materials.26 
When building an in vitro model of lipid deposition on contact lenses based on 
radiochemical carbon-14 experiments, our laboratory has found (unpublished data) 
that extraction of the lipid from the contact lens is required for accurate 
quantification of the deposited species. This is mainly due to the inability of the 
scintillation cocktail to penetrate the lens matrix and quantify the radioactivity, in 
addition to the lens polymer masking the scintillation signal.  Since an extraction 
step is required, it is also imperative to ensure that all (or at least the majority) of 
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the deposited lipid is extracted from the lens material. Therefore, the extraction 
system used must be evaluated and optimized.  Each individual lipid and contact 
lens material is unique; therefore to ensure optimal extraction efficiency it is 
imperative that every combination is tested independently.  In many in vitro models 
and ex vivo experiments, the most desirable lipid extraction procedure is one that 
removes all the different lipid species present in the sample. However, in some cases 
a broad-spectrum extraction protocol is not required and therefore the optimal 
procedure may selectively extract one or more specific lipids.  Whichever extraction 
profile is used, it should be tested for its reproducibility and efficiency. 
An examination of the literature reveals that a wide range of extraction 
solvents and procedures have been used to remove deposited lipid from contact 
lenses.  Common extraction solvents include chloroform,14, 27 methanol,28-30 
toluene31 and tetrahydrofuran,13 just to name a few. Furthermore, each experiment 
describes variations in length of extraction time, presence or absence of agitation, 
and differences in temperature during the removal process.  However, very few 
publications have examined the efficiency of the reported extraction protocol and 
there is clearly no widely accepted standard for lipid extraction.  
Our laboratory is developing an in vitro model of lipid deposition for 
conventional hydrogel and silicone hydrogel contact lens materials using an 
optimized artificial tear solution that is based on a stable and complex salt 
solution.32 Using this model and with the addition of lipids radiolabeled with 14C, the 
extraction efficiency of one or many different extraction solvent systems can be 
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evaluated using several different lipids and contact lens materials. In the experiment 
described below, six different contact lens materials were incubated in an artificial 
tear solution (ATS) complete with lipids, proteins, mucin and one of two different 
14C radiolabeled lipids. Following incubation, all lens materials were extracted and 
all other experimental sources of lipid were processed alongside standard samples, 
such that extraction efficiency could be calculated.  
 
4.3 METHODS 
4.3.1 ARTIFICIAL TEAR SOLUTION (ATS) 
The details of preparing a non-radioactive ATS have been previously 
reported32 and expanded on in Chapter 3, and thus only a summarized version will 
be given here, along with the adjustments required for the preparation of a 
radioactive ATS. The individual components of the ATS and their concentrations can 
be found in Table 4-1. Preparation of a radioactive ATS required four main steps. To 
begin, the complex salt solution was made by dissolving all of the salt components, 
in the order that they appear in Table 4-1, together into MilliQ water. Next, a 
concentrated lipid stock solution was made by dissolving the pure lipids together, in 
their required ratios, into (1:1) hexane and ether. This solution was stored at -20°C 
until required for future use.  Once the concentrated lipid stock was made, it was 
then used to make the lipid solution, by adding the required aliquot of lipid stock 
solution into the complex salt solution. The lipid solution was then placed into an 
ultrasonic bath set at 37°C and purged with nitrogen to evaporate the stock solvent. 
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This helps to fully incorporate the lipid. The desired radioactive lipid was then 
added to the lipid solution and it was sonicated for 15 minutes.  The radiolabeled 
cholesterol and phosphatidylcholine was added to the ATS at a concentration of 3% 
and 8.5% of the total individual lipid concentration respectively. The required 
proteins and mucin were then dissolved into the radioactive lipid tear solution and 
sonicated for an additional five minutes. The details of the radioactive lipids tested 
can be found in Table 4-2. 
 
TABLE 4-1: ARTIFICIAL TEAR SOLUTION COMPONENTS 
Salt component mM Lipid Component 
Concentration 
(mg/mL) 
Sodium chloride 90.0 Cholesterol 0.0018 
Potassium chloride 16.0 Cholesteryl oleate 0.024 
Sodium citrate 1.5 Oleic acid 0.0018 
Glucose 0.2 Oleic acid methyl ester 0.012 
Urea 1.2 Phosphatidylcholine 0.0005 
Calcium chloride 0.5 Triolein 0.016 
Sodium carbonate 12.0   
Potassium hydrogen carbonate 3.0 Protein Component Concentration 
(mg/mL) 
Sodium phosphate dibasic 24.0 Bovine Albumin 0.20 
Hydrochloric acid (10 molar) 26.0 Hen Egg Lysozyme 1.90 




TABLE 4-2: RADIOACTIVE LIPID CHARACTERISTICS 












Supplier Perkin-Elmer Perkin-Elmer 
 
4.3.2 INCUBATION VIAL PREPARATION 
Borosilicate glass vials were used for all contact lens incubations and were 
pre-treated with non-radioactive ATS for four to seven days at 37°C with constant 
shaking, to saturate the inside surface with lipid and protein prior to the radioactive 
ATS incubation. Previous studies in our laboratory (unpublished) have found that all 
vial materials readily bind some of the ATS components, therefore changing the 
concentration available to deposit onto the contact lens materials. Following 
pretreatment, the vials were then emptied, rinsed with saline, and radioactive ATS 
(with either 14C-cholesterol or 14C- phosphatidylcholine) was added.  
 
4.3.3 CONTACT LENS MATERIALS 
Six contact lens materials were tested in triplicate, including: Acuvue® 2 
[etafilcon A; Vistakon], Proclear® [omafilcon A; CooperVision], Acuvue® OASYS™ 
[senofilcon A; Vistakon], Air Optix™ [lotrafilcon B; Ciba Vision], Biofinity® [comfilcon 
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A; CooperVision], PureVision™ [balafilcon A; Bausch & Lomb]. The material 
characteristics of all contact lens materials can be found in Tables 4-3 and 4-4. 
 
TABLE 4-3: CONVENTIONAL HYDROGEL CONTACT LENS MATERIAL CHARACTERISTICS 
Material Type Conventional Hydrogel 
USAN Etafilcon A Omafilcon A 
Proprietary name Acuvue®2 Proclear® 
Manufacturer Johnson & Johnson CooperVision 
Monomers HEMA, MA HEMA, PhC 
Surface Modification None None 
Oxygen Transmissibility (x10-9) 31.0 52.3 
Water Content 58% 62% 
FDA Class Group IV Group II 
USAN: United States adopted name; DMA (N,N-dimethylacrylamide);  






TABLE 4-4: SILICONE HYDROGEL CONTACT LENS MATERIAL CHARACTERISTICS 
Material Type Silicone Hydrogel 
USAN Senofilcon A Lotrafilcon B Comfilcon A Balafilcon A 
Proprietary name Acuvue® OASYSTM Air OptixTM Biofinity® PureVisionTM 
Manufacturer Johnson & Johnson CIBA Vision CooperVision Bausch & Lomb 
Monomers 
mPDMS, DMA, HEMA, 
siloxane macromer, 
EGDMA, PVP 
DMA, TRIS, Siloxane 
macromer 
M3U, FM0411M, 
HOB, IBM, NVP, 
TAIC, VMA 









None Plasma oxidation 
Dk/t (x10-9) 147 138 160 110 
Water Content 38% 33% 48% 36% 
FDA Class Group I Group I Group I Group III 
Dk/t: oxygen transmissibility; USAN: United States adopted name; DMA (N,N-dimethylacrylamide); EGDMA (ethyleneglycol dimethacrylate);                                        
FM0411M (2-ethyl [2-[(2-methylprop-2-enoyl)oxy]ethyl]carbamate); HEMA (poly-2-hydroxyethyl methacrylate);                                                                                                     





/[oxy[(methyl)(3,3,3-trifluoropropyl)]silylene]/oxy (dimethylsilylene)])); mPDMS (monofunctional 
polydimethylsiloxane); NVA (N-vinyl aminobutyric acid); NVP (N-vinyl pyrrolidone); PBVC (poly[dimethysiloxy] 
di [silylbutanol] bis[vinyl carbamate]);   PVP (poly(vinylpyrrolidone)); TAIC (1,3,5-triprop-2-enyl-1,3,5-triazine-
2,4,6(1H,3H,5H)-trione); TPVC (tris-(trimethylsiloxysilyl) propylvinyl carbamate);   TRIS (trimethylsiloxy 
silane); VMA (N-Vinyl-N-methylacetamide) 
 
4.3.4 EXPERIMENTAL DESIGN 
Each of the six different contact lens materials were removed from their blister 
pack solutions and placed in 12-well plates, with 5 mL of the complex salt solution. 
They were soaked for 24 hours, while being gently rotated at 60 rpm, to remove any 
residual blister pack solution.  After soaking, each contact lens was rinsed twice in 
complex salt solution, blotted on lens paper and placed in individual borosilicate 
glass incubation vials containing radioactive ATS that had one of the carbon-14 
lipids described in Table 4-2. The vials were capped, sealed with Parafilm®, and 
incubated at 37°C and 60 rpm for seven days. Four replicates of each lens material 
with each of the radioactive lipids were tested. 
At the end of the seven days, each lens was rinsed in two successive vials, each 
containing 2 mL of complex salt solution, to remove loosely bound incubation 
solution.  The lenses were then placed in 20 mL glass scintillation vials with 2 mL of 
(2:1) chloroform: methanol (v/v) extraction solution and were incubated for three 
hours each at 37°C while shaking.  Each lens was extracted in this way three times 
and each individual extract was processed separately.  
All vials, including unused ATS control solutions with no lenses, contact lens 
lipid extracts, used ATS, and the rinses were all dried down completely using 
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nitrogen evaporation and heat up to 40°C.  All samples were resuspended in 
chloroform, sonicated for one minute, and Ultima Gold F scintillation fluor was 
added.  The samples were counted for their radioactive signal using the LS6500 
Beckman Coulter liquid scintillation beta counter (Beckman Coulter, Mississauga, 
ON).  In the experiment, the radioactive lipid was used as a probe and the ratio of 
radioactive lipid to non-radioactive lipid in the incubating ATS was kept constant.  
Therefore, quantification of the total amount of cholesterol and phosphatidylcholine 
deposited was extrapolated and calculated using standard radioactive lipid 
calibration curves.  
By processing all used ATS solutions, lens rinses, and contact lens extracts in 
this experiment, the radioactivity and mass of lipid in each sample could be 
calculated. The extraction efficiency could then be calculated by comparing to 
controls the solutions, as shown in Equation 4-1 below. The % recovery of lipid was 
calculated using Equation 4-2. 
 
EQUATION 4-1: EXTRACTION EFFICIENCY FORMULA 
 





ATS and radioactive standards were prepared and processed alongside the 
experimental samples and the lipid that was unaccounted in the entire system was 
then assumed to be left un-extracted in the lens materials. If the extraction efficiency 
calculated for any lens material was less than 85%, then the (2:1) chloroform: 
methanol extraction procedure utilized was deemed unacceptable, and another 
extraction procedure was tested. The alternate extraction procedures that were 
tested were based on toluene, hexane, and other combinations of chloroform and 
methanol. 
 
4.3.5 STATISTICAL ANALYSIS 





The results of the extraction efficiency experiment for cholesterol (C) are 
found in Table 4-5. From these results it can be seen that the largest amount of 
cholesterol is extracted from the contact lens materials during the first extraction 
using 2 mL of (2:1) chloroform: methanol, while shaking for 3 hours at 37°C. On 
average, more than 90% of the total C extracted occurred with the first extraction, 
less than 10% was extracted in the second, and less than 1% was extracted in the 
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third and final extraction procedure.  Cholesterol deposition after one week of 
incubation in a complex ATS was approximately 1650-2350 ng/lens on the silicone 
hydrogel materials and <150 ng/lens was deposited on the conventional HEMA 
materials. Balafilcon A contact lens materials deposited the most cholesterol, with 
2335 ng/lens and etafilcon A was the lowest depositor, with 73 ng/lens.  
After the lenses were removed from their radioactive incubation ATS, they 
were rinsed twice in 2 mL of saline. These two rinses together contained a total of 
400–700 ng/lens of cholesterol and over 80% of this cholesterol was “washed off” 
during the first rinse. The mass of cholesterol removed in the rinses is the 
equivalent of 200–400 µL of the lens liquid envelope that was rinsed away. 
Omafilcon A lenses had the most cholesterol rinsed away per lens and etafilcon A 
had the least. 
The extraction efficiency for each lens material was calculated independently 
and the overall percent recovery of the cholesterol was also calculated. The percent 
recovery of cholesterol from the entire experiment was 98.8% ± 1.62 and the 
extraction efficiency calculated was over 90% for all lens materials. Since the 
extraction efficiency for all of the contact lens materials was over 85%, no further 
optimization was required for cholesterol.  
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TABLE 4-5: CHOLESTEROL EXTRACTION EFFICIENCY RESULTS 
 
Conventional Hydrogels Silicone Hydrogels 
 
Etafilcon A Omafilcon A Senofilcon A Lotrafilcon B Comfilcon A Balafilcon A 
Total C extracted 
(ng/lens) ± STD 
73.04 ± 8.89 130.79 ± 7.24 2190.12 ± 59.99 1678.79 ± 63.64 2122.22 ± 50.76 2335.10 ± 55.18 
Average C in 1st extract 
(ng/lens) ± STD 
72.56 ± 7.99 130.34 ± 7.50 2054.21 ± 55.83 1575.55 ± 63.12 2014.65 ± 71.52 2180.14 ± 51.57 
% of total C extracted in 
1st extract ± SD 
99.44% ± 1.12 99.65% ± 0.71 93.8% ± 0.53 93.85% ± 0.41 95.37% ± 1.59 93.37% ± 0.59 
% of total C extracted in 
2nd extract ± SD 
0.56 % ± 1.12 0.35 % ± 0.71 6.36 % ± 0.59 4.55 % ± 1.52 6.11 % ± 0.45 6.08 % ± 0.44 
% of total C extracted in 
3nd extract ± SD 
0.00 % ± 0.00 0.00% ± 0.00 0.27 % ± 0.09 0.08 % ± 0.09 0.05 % ± 0.06 0.13 % ± 0.12 
Extraction Efficiency ± 
STD 
100 % ± 0.00 94.51% ± 3.91 100 % ± 0.00 91.75 % ± 3.45 90.38 % ± 2.15 96.48 % ± 2.27 




The results of the initial extraction efficiency experiment for 
phosphatidylcholine (PC) are found in Table 4-6. This table shows that the first of 
three extractions using 2 mL of (2:1) chloroform: methanol while shaking for 3 
hours at 37°C extracted the largest amount of PC of the three extractions. On 
average, more than 89% of the total PC extracted occurred with the first extraction, 
less than 7% was extracted in the second, and less than 1% was extracted in the 
third extraction.  Silicone hydrogel contact lens materials deposited 600-800 
ng/lens of PC after one week of incubation in the complex ATS and the conventional 
HEMA contact lenses deposited approximately 80 ng/lens. Lotrafilcon B contact lens 
materials deposited the most PC, with 774 ng/lens and etafilcon A deposited the 
least PC, with 57 ng/lens.  
All contact lenses were rinsed twice in 2 mL of complex salt solution following 
removal from their incubation in radioactive ATS. The rinses held a total of 100–250 
ng/lens of PC which represents a liquid envelop of 200–500 µL/lens.  Over 80% of 
the PC was “washed off” in the first rinse alone. Omafilcon A lenses had the most PC 
rinsed away per lens and etafilcon A had the least. 
The extraction efficiency for each lens material was calculated independently 
and the overall percent recovery of the PC was also calculated, using Equation 1. The 
percent recovery of PC from the entire experiment was 94.2% ± 9.8 and the 
extraction efficiency calculated was over, if not close to 100% for four of the 
materials tested (etafilcon A, omafilcon A, comfilcon A and senofilcon A). Due to the 
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low extraction efficiency for balafilcon A and lotrafilcon B, a secondary experiment was conducted on the extraction 
efficiency of phosphatidylcholine for these two lens materials.  
TABLE 4-6: EXTRACTION EFFICIENCY RESULTS FOR PHOSPHATIDYLCHOLINE 
 
Conventional Hydrogel Silicone Hydrogel 
 
Etafilcon A Omafilcon A Balafilcon A Comfilcon A Lotrafilcon B Senofilcon A 
Total PC extracted 
(ng/lens) ± STD 
56.61 ± 7.50 64.33 ± 15.10 699.81 ± 34.42 644.64 ± 21.50 774.15 ± 20.12 608.11 ± 24.04 
Average PC in 1st 
extract (ng/lens) 
± STD 
42.75 ± 6.63 49.57 ± 13.61 580.33 ± 29.34 528.17 ± 18.14 664.39 ± 17.58 470.12 ± 19.52 
% of total C 
extracted in 1st 
extract ± SD 
89.70% ± 4.43 91.79 % ± 4.95 93.93 % ± 0.65 92.52% ± 2.44 93.74 % ± 0.32 93.30% ± 1.01 
% of total PC 
extracted in 2nd 
extract ± SD 
9.46 % ± 4.68 7.23 % ± 4.42 5.70 % ±  0.64 6.87 % ± 2.46 6.05 % ± 0.29 6.16 % ± 0.89 
% of total PC 
extracted in 3nd 
extract ± SD 
0.84 % ± 1.00 0.98 % ± 0.87 0.38 % ± 0.25 0.61 % ± 0.16 0.48% ±  0.16 0.54 % ± 0.17 
Extraction Efficiency 
± STD 
100 % ± 0.00 100 % ± 0.00 75.00% ± 15.11 100% ± 0.00 85.42 % ± 6.08 100%  ±  0.00 
* Extraction efficiency was calculated according to Equation 1.  n=4 
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The results of the secondary PC extraction efficiency experiment for balafilcon 
A and lotrafilcon B are seen in Table 4-7. The different extraction procedures tested 
were: the original (2:1) chloroform: methanol “2CM” and three new extraction 
methods including: (1:1) chloroform: methanol33 “CM”, (5:1) toluene: isopropanol31 
“TI”, and (60:50:1:4) chloroform: methanol: acetic acid: water34 “CMAW”. The 
CMAW extraction method extracted the most PC for balafilcon A lenses however, no 
statistically significant difference was found when compared with the 2CM method 
(p >0.05). A statistically significant increase in PC was extracted using CMAW over 
2CM for lotrafilcon B (p < 0.001).  Generally, the CM extraction method was found to 
extract the least amount of PC for both lens materials tested. The calculated 
extraction efficiency for lotrafilcon B and balafilcon A with the CMAW extraction 
method tested close to 100% for both lens materials, therefore no further 




TABLE 4-7: COMPARISON OF THREE DIFFERENT PHOSPHATIDYLCHOLINE EXTRACTION METHODS 




Lotrafilcon B p value Balafilcon A p value 
2 CM                                                         ng/lens 562.37 ± 8.93 - 765.92 ± 48.76 - 
CM  
ng/lens 534.97 ± 33.72       
0.245 
668.70 ± 4.08 
0.026 
% change from 2CM -4.87% -12.69% 
TI 
ng/lens 599.14 ± 46.01 
0.246 
729.49 ± 16.34 
0.287 
% change from 2CM +6.54% -4.76% 
CMAW 
ng/lens 686.90 ± 12.60 
<0.001 
806.48 ± 19.03 
0.251 
% change from 2CM +28.40% +20.60% 
n=3, p values of < 0.05 are considered to be statistically significant 
2CM = (2:1) chloroform: methanol, CM = (1:1) chloroform: methanol, TI = (5:1) toluene: isopropanol,                           
CMAW = (60:50:1:4) chloroform: methanol: acetic acid: water 
2CM, CM, CMAW extraction methods = 2 extractions for 3 hrs at 37°C with shaking 
TI extraction method = 2 extraction for 30 minutes at 37°C with sonication 
 
4.5 DISCUSSION 
There are many different extraction protocols that are currently used to 
extract lipids from conventional hydrogel contact lenses and/or silicone hydrogel 
contact lens materials. Some of the common extraction solvent systems include 
chloroform: methanol,14, 27, 33, 35 methanol,28-30 toluene: isopropanol,31 hexane36 and 
tetrahydrofuran.13 However, upon exploration of the literature, more than just the 
extraction solvents varied between experiments. The volume of solvent, the length 
of time the contact lens remains within the solvent, the number of extractions 
conducted, the temperature at which the extraction takes place, the level of agitation 
during extraction and the specific lipids being extracted are some of the other 
parameters that vary widely depending on the research group. With such a wide 
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variety of published protocols, it is impossible to know which is the most efficient 
procedure to maximally extract lipid from the contact lens materials.  
Most publications do not mention the efficiency of their utilized extraction 
procedure and the few that do, either do not give a detailed description of how the 
results were obtained or the deposition methods used for the extraction efficiency 
portion were not the same methods of deposition as the experimental portion.  
Determining the efficiency of the extraction method is critical, especially when the 
method is eventually to be used for human worn contact lens extractions.  Much of 
the ex vivo contact lens lipid deposition literature specifies the mass of lipids 
quantified from the lens. However, without a proper extraction efficiency 
experiment these quoted values may not be representative of the deposited lipid 
masses.  
In the mid to late 1990’s, Bontempo and Rapp completed a series of 
experiments examining lipid and protein deposition on conventional hydrogel 
contact lens materials.28-30, 37  Their original experiment in 1994,37 utilized a three 
step method for lipid extraction that involved various concentrations of methanol 
and rinses with chloroform: methanol (1:1). The experiment enabled a calculated 
extraction efficiency by processing unused and used samples of ATS and the lens 
extract samples via thin layer chromatography (TLC).37 This in vitro study incubated 
lenses for 24 hours in an ATS containing four non-polar lipids. From this 
experiment, they determined that over 90% of the lipid was extracted. In future 
papers, the extraction procedure used was condensed to one extract with 50% 
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methanol,29, 30 however the extraction efficiency that is quoted is the same as the 
multi-step extraction process. 
More recently, two publications examining lipid deposition have tested and 
recorded extraction efficiency from silicone hydrogel contact lens materials.18, 27 In 
both studies,  the extraction efficiency experiment was completed by adsorbing 
known masses of lipid onto the lens, letting the samples dry and then extracting 
them back out with their specific extraction procedures.  Iwata et al, adsorbed 
several known masses of several lipid types to one lens material, however later in 
the experiment several different lens materials are quantified.27  
The radioactive in vitro lipid deposition model introduced in this paper is an 
ideal way to examine in vitro extraction efficiency. Since this model is currently 
being utilized in our laboratory for numerous in vitro deposition experiments, it was 
imperative to determine extraction efficiencies for each lens type in order to make 
meaningful comparisons.   There are many variables in an in vitro model that can 
have an influence on the results, including manner of lipid deposition, materials 
examined and solution composition.  Therefore, we sought to tightly control the 
system to accurately and consistently quantify lipid deposition.  
It is widely known that there are large differences between conventional 
HEMA hydrogel and silicone hydrogel contact lens materials; however there are 
many differences within each of those classes of contact lenses as well.  
Conventional hydrogels are known to deposit protein and lysozyme in a fairly 
consistent manner and this level of deposition is broadly related to their FDA 
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classification, which is based on water content and ionicity. However, currently 
there is no recognized classification system for silicone hydrogel lenses. These 
materials vary widely in their characteristics due to the specific mix of polymers 
used and the presence or absence of a particular surface treatment. Therefore each 
silicone hydrogel lens is remarkably unique and for this reason each lens material 
being utilized needs to be tested individually.   
In addition to the variation in lens materials, there are also variations in the 
types of lipids that are present in the tear film38-41 and therefore variations in 
deposits onto contact lens surfaces.13, 17, 30, 42 The characteristics of each lipid group 
also vary widely.  Fatty acids, cholesterols and phospholipids, for example, all have 
different characteristics, bonds, and components and differences within each lipid 
family are prevalent as well. The function and behaviour of phospholipids 
themselves can vary greatly depending on the size and charge of the head group and 
the length, bonding and composition of the tails for that specific phospholipid. 
Therefore, completing an extraction efficiency experiment on one lipid species does 
not necessarily predict the extraction efficiency of other lipids, especially for lipids 
from other families. 
This paper has introduced a systematic in vitro experimental process to 
examine the extraction efficiency for two lipid types and multiple lens materials.  
This experiment could easily be expanded to examine different incubation 
concentrations, lengths of incubations, in vitro models and could be transferred to 
the ex vivo situation.   
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 As seen from this experiment, one individual extraction protocol does not 
always extract each lipid and lens material combination equally. Therefore, the 
specific extraction procedure utilized may depend on the experiment being 
conducted and whether a broad-spectrum extraction solution is desired or 
optimized extraction for a particular lipid and lens combination.  
The value of rinsing lenses following removal from an incubation solution of 
an in vitro experiment was also demonstrated in this experiment. A relatively large 
mass of lipid was found to reside in a liquid envelope surrounding the lens and was 
not tightly bound or deposited to the lens. If this rinsing step had been eliminated 
then the quantified lipid would have been artificially high. This experiment is the 
first to report on the possible volume and mass of lipid that is removed in a simple 
rinse. Therefore, rinsing human-worn lenses prior to extraction and/or analysis as 
part of a clinical study should also be considered. Although, the tear envelope may 
not be as large in ex vivo lenses, there still may be a portion of tear film components 
that are present in this liquid phase surrounding the lens or loosely associated but 
not bound to the lens.  
This optimized extraction protocol for deposited cholesterol was two 
extractions of 3 hrs at 37°C with shaking in 2 mL of chloroform: methanol (2:1). This 
procedure recovered over 90% of the cholesterol deposited during the incubation 
with the radioactive in vitro model.  The same extraction procedure was optimized 
for the extraction of phosphatidylcholine from etafilcon A, omafilcon A, comfilcon A, 
and senofilcon A with extraction efficiencies calculated to be 100%. The optimized 
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extraction of phosphatidylcholine from balafilcon A and lotrafilcon B included two 
extractions of 3 hrs at 37°C with shaking in 2 mL of chloroform: methanol: acetic 
acid: water (60:50:1:4), which recovered 100% of the phosphatidylcholine.  
When the deposited mass of lipids quantified in this experiment is compared 
to other in vitro and ex vivo data, it can be seen that differences do exist.  In this 
experiment, after 7 days of incubation in the ATS solution, the silicone hydrogel 
lenses deposited between 1.65-2.35 µg/lens of cholesterol and the conventional 
hydrogels deposited less than 0.15 µg/lens of cholesterol.  Phosphatidylcholine 
deposition on silicone hydrogels was 0.60-0.80 µg/lens and the conventional HEMA 
contact lenses deposited approximately 0.08 µg/lens of phosphatidylcholine per 
lens.  Much of the other in vitro lipid work completed recently have quantified 
higher masses of cholesterol and phospholipids (either phosphatidylcholine or 
phosphatidylethanolamine) depositing on balafilcon A and on conventional 
hydrogel lens materials such as etafilcon A. In vitro work from Carney et al.,15 and 
Pucker et al.,14 all cited higher deposition values than the work presented here.  
However, these other in vitro studies had one or more of these main differences in 
their experimental design which may account for increased deposition of lipids: the 
use of single lipid incubation solutions, higher concentrations of lipids in the ATS, 
different incubation volumes, different incubation times and replenishment of the 
ATS with fresh solution during incubation.14, 15, 27 All of these factors may explain the 
higher deposition of cholesterol and phosphatidylcholine reported by others. 
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When the cholesterol and phosphatidylcholine deposition results found in this 
in vitro experiment are compared with recent ex vivo data, it is seen that the results 
tend to fall within the same range of deposition.  However it is impossible to make 
direct comparisons as the wear time of the ex vivo lenses are much longer than the 
incubation time of this experiment, ex vivo lenses are cleaned nightly, and it would 
be incorrect to extrapolate the data.18, 43 Many of the recent in vitro and ex vivo 
studies were not completed with the same silicone hydrogel lens materials, did not 
include conventional hydrogel lens materials such as omafilcon A, and some of them 
quantified other lipids than those investigated in this experiment. 
It is known that in vitro contact lens deposition models do not always mimic 
directly what occurs during human contact lens wear. Many times the masses 
deposited in an in vitro model are lower or higher than what is quantified ex vivo. 
There are many reasons for this, including: differences in ATS compositions and 
concentrations utilized, the simplicity of the model, the wear time or incubation 
time of the lens, differences in lens materials utilized, and an incomplete 
understanding of all the interactions present.  The only way that in vitro models can 
become more physiologically relevant is to analyze all of the interactions that occur 
during human contact lens wear and then integrate them into newer in vitro models.  
Ultimately, in vitro models must be improved so that their results are more reliable, 
repeatable, and representative and only then will they provide a basis for research 
and development of new and existing products.   
Finally, once again this experiment has supported other research that shows 
that conventional hydrogel contact lens materials deposit significantly less lipid 
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when compared to the silicone hydrogel lens materials.  The presence or absence of 
a specific surface treatment did not alter this result.  
 
4.6 CONCLUSION 
In conclusion, an extraction protocol for deposited cholesterol and 
phosphatidylcholine on two conventional hydrogel and four silicone hydrogel 
contact lens materials has been optimized based on chloroform and methanol.  An 
extraction efficiency of over 90% was achieved for both lipids and all contact lenses 
tested. Confirming previous studies, conventional hydrogel contact lens materials 
deposit significantly less lipid than silicone hydrogel lenses, following one week of 
incubation in an artificial tear solution.  
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In the next chapter, the effects of the composition of the in vitro incubation 
solution utilized are examined. Three different lens materials and two specific 
radiolabelled lipids over two different incubation lengths are examined, to assess 
how the lipid deposition profiles are influenced by the surrounding tear film 
constituents.  This experiment is designed to examine the competitive binding that 
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Purpose: To analyze the influence of various tear film components on in vitro 
deposition of two lipids (cholesterol and phosphatidylcholine) on silicone hydrogel 
(SH) and conventional hydrogel (CH) contact lens materials.  
Methods: Etafilcon A, balafilcon A, and senofilcon A were incubated in four different 
incubation solutions for 3 or 14 days: an artificial tear solution (ATS) containing six 
common lipids and 5 proteins, a protein tear solution (PrTS) containing 5 proteins 
and the lipid of interest, a lipid tear solution (LTS), containing 6 lipids and no 
proteins, and a single lipid tear solution (SLTS), containing the lipid of interest only.  
Proteins and lipids were at physiological concentrations. Each incubation solution 
contained one of the two radiolabelled lipids: 14C-cholesterol (C) or 14C-
phosphatidylcholine (PC). After soaking, lenses were removed from the incubation 
solution, the lipids were extracted then quantified using a LS6500 Beckman Coulter 
beta counter.  Deposition of lipids on lenses was calculated using standard 
calibration curves.  
 Results:  This experiment examined several different parameters influencing lipid 
deposition on contact lenses, including: lens material, length of incubation, and the 
composition of the incubation solution. Overall, lipid deposited differently on 
different lens materials (p<0.0005), with the order of deposition most commonly 
being balafilcon > senofilcon > etafilcon.  Incubation solution had a large impact on 
how much lipid was deposited (p<0.00001), though cholesterol and 
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phosphatidylcholine demonstrated different deposition patterns. Lipid deposition 
after 14 days of incubation was consistently greater than after 3 days (p<0.02). 
Conclusion: This in vitro study demonstrates that C and PC deposition are 
cumulative over time and that SH materials deposit more lipid than a CH FDA group 
IV material. It also clearly demonstrates that deposition of C and PC is influenced by 
the composition of the incubation solution and that in vitro models must use more 
physiologically relevant incubation solutions that mimic the natural tear film if in 
vitro data is to be extrapolated to the in vivo situation.   
 
5.2 INTRODUCTION 
In vitro models for examining deposition of tear film components onto 
contact lens materials have been used for many years.1-10   These models have been 
used to examine the protein-lipid-mucin interactions that occur on the surface and 
in the tear film,1-14 to examine the conformation of protein on the surface of a 
contact lens,5, 15 to examine the wettability,16 contact angle and hydrophobicity of a 
lens material,16, 17 and to analyze the interaction between corneal cells and their 
interaction with contact lens materials and solutions,18-20 to name just a few.  
Although in vitro models can never incorporate every element of human contact lens 
wear, they are indispensable for quickly characterizing and assessing new and 
commercially available materials and cleaning solutions.   
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The first in vitro models utilized were simple.1-6, 21  These models included 
contact lens materials being incubated in a single lipid or protein saline solution for 
as little as 24 hours for an extended wear lens.  Earlier analysis techniques11, 22 have 
been updated or replaced with increasingly sensitive technology, including high 
performance liquid chromatography (HPLC), mass spectroscopy (MS), 
radiochemical assessments and matrix assisted laser desorption ionization mass 
spectroscopy (MALDI-MS). These techniques are just a few of the methods which 
are able to assess the interaction of various biological fluids with biomaterials, 
sometimes without extraction, and can often quantify components in the picogram 
range.   
In the last 20 years, in vitro models of contact lens wear have started to 
become more complex.  In the early 1990’s, Mirejovsky spear-headed this by using a 
complex artificial tear solution which incorporated lipids, proteins, and mucin 
dissolved within a multi-component saline solution.10 Since then, many researchers 
have begun adding more physiological chemicals to their in vitro contact lens 
interaction models.  However, still more research needs to be completed to analyze 
the influence that different variables have on contact lens deposition, comfort, 
wettability, and vision.  
Of interest is the composition of the tear film or the artificial tear solution 
used for in vitro studies. It is known that even though the general composition of 
lipids found in the human tear film and meibum are similar,22-28 there are still quite 
a few individual differences between the specific lipids and their concentrations. 29-37 
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Variations in tear film composition have been recorded between people, and an 
individual’s lifestyle can contribute to the tear film’s unique composition.  A person’s 
diet, work environment, medication, alcohol consumption, and any systemic disease 
can all greatly affect their tear film composition.29-37 This poses unique challenges 
when trying to develop an in vitro model and an artificial tear solution (ATS) for that 
model.   In addition, the cost of the components of the ATS may not justify their 
inclusion, if the results are not impeded by their absence.  Therefore, some of the 
main questions that need to be answered before an in vitro contact lens deposition 
model incorporating an ATS is finalized are: How do the components of the ATS 
contribute to the deposition profile? How does altering the complexity of the 
solution change deposition?  
In the mid to late 1990’s, Bontempo and Rapp conducted a set of experiments 
analyzing lipid deposition and the effect of lipid and protein interactions on 
conventional hydrogel and rigid gas permeable (RGP) contact lens deposition.11-14 
Their research found that FDA group III contact lens materials deposit the least lipid 
and group II lenses, the high water non-ionic lenses, deposit the most lipid.11  This 
finding led them to develop the “pull/push” theory to explain lipid deposition. 11, 38   
In their theory, the “pull” represents the contact lens polymer material attracting 
the lipids into the matrix and away from the aqueous ATS and the “push” represents 
the water content of the lens encouraging the lipid to move into the matrix.11, 38   
Bontempo and Rapp also found that when both lipids and proteins are present in 
the ATS the deposition pattern was different than when the contact lenses were 
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exposed to proteins alone or lipids alone.  For example, they found that protein 
deposition onto group IV contact lens material rendered the surface of the lens less 
hydrophilic, resulting in a subsequent increase in the deposition of lipids.  In 
contrast, when non-polar lipids bound to the contact lens, the surface became more 
hydrophobic, resulting in decreased protein deposition.12, 13  Differences in the 
deposition of specific lipids were also found, as more polar lipids deposited 
differently than non-polar lipids, depending on the complexity of the ATS.13  
The competitive binding research completed by Bontempo and Rapp was a 
major contribution to the industry’s knowledge of deposition and the relationship 
between lipids and protein in the tear film and on the surface of a contact lens.  
However, many years have passed and we now have new contact lens materials 
based on silicone. These materials behave very differently than conventional 
hydrogel contact lens materials and therefore more work needs to be completed to 
examine the competitive binding of tear film components on these materials. Even 
within the group of silicone hydrogel lenses, many differences exist.  Some lenses 
are surface coated, some have internal wetting agents, some have no coatings or 
wetting agents, some are based on trimethylsiloxy siloxane TRIS derivatives, and 
some are a combination of new siloxane macromers.  Due to the uniqueness of each 
of these new materials it cannot be assumed that they will behave as the 
conventional hydrogel lenses or the same as each other.  
The purpose of this study was to examine the competitive binding of tear film 
components onto various contact lens materials by altering the composition of the 
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ATS being used.  A radiochemical in vitro model and an ATS, previously optimized by 
our laboratory, will be used to examine cholesterol and phosphatidylcholine 
deposition specifically.  In order to examine the role of different tear film 
components on deposition, four different tear solution compositions will be 
examined including: a protein + lipid ATS, protein only, lipid only and single lipid.  
One conventional and two silicone hydrogel lens materials will be examined.  
 
5.3 METHODS 
5.3.1 ARTIFICIAL TEAR SOLUTION (ATS) 
Chapter 3 of this thesis has comprehensively outlined the protocol to prepare 
the ATS that will be utilized in this experiment and therefore only a brief overview 
will be given here.  Table 5-1 displays each of the components of the ATS and the 
final concentrations that were utilized. Preparing an ATS solution involves several 
steps. First, all of the salt components were dissolved into the desired volume of 
MilliQ water to prepare the complex saline solution (CSS). To avoid precipitation of 
some of the components, all of the ingredients were dissolved in the order that they 
are listed in Table 5-1. Before a lipid tear solution could be made, all of the pure 
lipids required for the specific experiment were first dissolved into a (1:1) hexane: 
ether solution at high concentrations.  This lipid stock solution was prepared 
previously and stored at -20oC until needed.  Once the lipid stock was prepared and 
was equilibrated to room temperature, it was utilized to make a lipid tear solution 
by dispensing an aliquot of the stock into the required volume of saline.  In order to 
evaporate the hexane: ether and to ensure that the lipids were fully incorporated, 
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the lipid solution was sonicated at 37oC while being purged with nitrogen gas.  Once 
the odour of solvent had dissipated, the radioactive lipid was then dispensed into 
the solution and further sonicated for 15 minutes. The radiolabeled cholesterol and 
phosphatidylcholine was added to the ATS at a concentration of 3% and 8.5% of the 
total individual lipid concentration respectively. The lipid portion of the ATS was 
now complete and the proteins and mucin were then dissolved into the solution to 
create the full ATS.  In this experiment, a number of different tear incubation 
solutions were utilized and therefore not all of these steps were required, therefore 
the individual steps utilized were adjusted according to the desired incubation 
solution.  The radioactive lipids details can be found in Table 5-2. 
 
TABLE 5-1: ARTIFICIAL TEAR SOLUTION COMPONENTS 
Salt component mM Lipid Component Concentration (mg/mL) 
Sodium chloride 90.0 Cholesterol 0.0018 
Potassium chloride 16.0 Cholesteryl oleate 0.024 
Sodium citrate 1.5 Oleic acid 0.0018 
Glucose 0.2 Oleic acid methyl ester 0.012 
Urea 1.2 Phosphatidylcholine 0.0005 
Calcium chloride 0.5 Triolein 0.016 
Sodium carbonate 12.0 Protein Component Concentration (mg/mL) 
Potassium hydrogen carbonate 3.0 Bovine Albumin 0.20 
Sodium phosphate dibasic 24.0 Hen Egg Lysozyme 1.90 
Hydrochloric acid (10 molar) 26.0 Bovine Mucin 0.15 
  
Lactoferrin 1.90 
ProClin 300 0.2 µL/ 1L Immunoglobulin G 0.02 
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Lipid type Sterol Phospholipid 
Molecular Formula C27H46O C40H80NO8P 
Molecular Weight (g/mol) 386.7 734.0 
Position of Radiolabel 4-14C DiPalmitoyl-1-14C 
Specific Activity (mCi/mmol) 49.78 114 
Polarity of Molecule Non-polar Polar 
Charge of Lipid Neutral Zwitterionic head group 
Manufacturer Perkin-Elmer Perkin-Elmer 
 
5.3.2 CONTACT LENS MATERIALS 
Three contact lens materials were tested (n=4) including: Acuvue® 2 [etafilcon 
A; Vistakon], Acuvue® OASYS™ [senofilcon A; Vistakon], and PureVision™ [balafilcon 
A; Bausch & Lomb]. The material characteristics of all contact lens materials can be 









USAN Etafilcon A Balafilcon A Senofilcon A 
Proprietary name Acuvue®2 PureVisionTM Acuvue® OASYSTM 
Manufacturer Johnson & Johnson Bausch & Lomb Johnson & Johnson 
Monomers HEMA, MA 
NVP, TPVC, 
NVA, PBVC 
mPDMS, DMA, HEMA, 
siloxane macromer, EGDMA, 
PVP 
Surface Modification None Plasma 
oxidation 




31 110 147 
Water Content 58% 36% 38% 
FDA Class Group IV Group III Group I 
USAN: United States adopted name; DMA (N,N-dimethylacrylamide); EGDMA (ethyleneglycol dimethacrylate); 
HEMA (poly-2-hydroxyethyl methacrylate); MA (methacrylic acid); mPDMS (monofunctional 
polydimethylsiloxane); NVA (N-vinyl aminobutyric acid); NVP (N-vinyl pyrrolidone); PBVC (poly[dimethysiloxy] 
di [silylbutanol] bis[vinyl carbamate]); PVP (poly(vinylpyrrolidone)); TPVC (tris-(trimethylsiloxysilyl) 
propylvinyl carbamate) 
 
5.3.3 EXPERIMENTAL DESIGN 
A flow chart outlining the experimental setup is shown in Figure 5-1.  6 mL 
glass incubation vials (Wheaton, VWR, Mississauga) were all incubated in non-
radioactive ATS for at least 4 days at 37°C before lens incubation. This process 
allows lipid and protein to coat the interior vial surface of the vial. Previous work in 
our laboratory has found that pre-treatment of the vials is a necessary step to 
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ensure that the contact lens incubation solution components do not preferentially 
adsorb to the vial and are therefore available to deposit onto the lens.  This 
experiment utilizes several different solution formulations for the incubation of 
lenses.  The vial pre-treatment solution that was used was matched with the specific 
incubation solution that was to be used. Following pretreatment, the vial’s solution 
was removed, saline was used to rinse the vial, and 6.0 mL of the prepared 
radioactive solution was inserted.  
All contact lens materials were removed from their packaging solutions and 
then soaked in 12-well plates filled with CSS for at least 24 hours, to remove 
components of the individual blister pack solutions.  After each lens was soaked, 
they were rinsed twice in CSS, blotted on lens paper and placed into their incubation 
vials that had been filled with one of four different incubation solution 
compositions: an ATS containing the full complement of lipids and proteins (ATS), a 
lipid only solution (LTS), a protein only solution (PrTS), and a single lipid solution 
(SLTS). Each of these solutions was tested with both radioactive lipids 
independently. The details of each of these solutions are outlined in Figure 5-1. The 
vials were capped, sealed with Parafilm®, and incubated at 37°C with shaking for 3 
or 14 days. Four replicates of each lens material with each of the radioactive 
solutions were tested. 
At the end of incubation times (3 or 14 days), each lens was rinsed twice in 
CSS, to remove loosely bound lipid.  For extractions with the 14C-cholesterol, the 
lenses were placed in 20 mL glass scintillation vials with 2 mL of 2:1 chloroform: 
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methanol extraction solution and incubated for three hours each at 37°C while 
shaking.  Each lens was extracted twice and the extracts were pooled together for 
processing. For extractions with the 14C-phosphatidylcholine, the lenses were placed 
in 20 mL glass scintillation vials with 2 mL of 60:50:1:4 chloroform: methanol: 
acetic acid: water extraction solution and were incubated for three hours each at 
37°C while shaking.  Once again, two extractions were completed and pooled 
together.  
The contact lens extracts were then dried down using nitrogen evaporation, 
re-suspended in 1 mL of chloroform, sonicated for one minute, and 10 mL of Ultima 
Gold F scintillation fluor was added.  The lens extract samples and prepared 
standard radioactive counts were counted for their radioactive signals using a 
Beckman-Coulter L6500 liquid scintillation counter.  In the experiment, the 
radioactive lipid was used as a probe and the ratio of radioactive lipid to non-
radioactive lipid in the incubating ATS was kept constant.  Therefore, quantification 
of the total amount of cholesterol and phosphatidylcholine deposited was 




FIGURE 5-1: EXPERIMENTAL DETAILS AND DESIGN 
 
 
5.3.4 STATISTICAL ANALYSIS 
Statistical analysis was performed with Statistica 9, using repeated measures 







The results for cholesterol deposition on each of the three contact lens 
materials and for each of the four incubation solutions tested are found in Figure 5-2 
and Table 5-4.  Overall, after 14 days, balafilcon A and senofilcon A lenses deposited 
the most cholesterol when incubated in the PrTS (5754.73 ± 245.23 ng/lens and 
6353.08 ± 255.19 ng/lens respectively), and the least in the lipid only LTS solution 
(770.19 ± 68.98 ng/lens and 423.73 ± 84.57 ng/lens respectively).  Etafilcon A 
deposited the least amount of cholesterol for all incubation solutions.  
 




Solution Time Balafilcon A Senofilcon A Etafilcon A 
SLTS 
3 Days 716.71 ± 25.06 567.55 ± 86.32 354.28 ± 27.68 
14 Days 1027.30 ± 79.21 813.72 ± 128.82 439.06 ± 38.10 
LTS 
3 Days 378.21 ± 12.79 272.45 ± 8.77 155.98 ± 8.94 
14 Days 770.19 ± 68.98 423.73 ± 84.57 235.58 ± 11.53 
PrTS 
3 Days 2290.74 ± 124.61 2392.46 ± 88.59 477.17 ± 31.61 
14 Days 5754.73 ± 245.23 6353.08 ± 255.19 401.85 ± 24.59 
ATS 
3 Days 585.97 ± 51.33 491.05 ± 20.24 73.37 ± 4.70 
14 Days 1440.59 ± 97.21 1229.32 ± 21.84 56.02 ± 2.56 
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PrTS = protein tear solution, SLTS = single lipid tear solution, LTS = lipid tear solution, ATS = artificial tear 
solution 
 
FIGURE 5-2: EFFECT OF SOLUTION COMPOSITION ON CHOLESTEROL DEPOSITION 
 
PrTS = protein tear solution, SLTS = single lipid tear solution, LTS = lipid tear solution, ATS = artificial tear 
solution 
 
The results of the repeated measures ANOVA are seen in Table 5-5.  The 
repeated measures ANOVA results found statisticaly significant differences between 
all of the variables tested (lens materials, incubation time, and incubation solution) 





TABLE 5-5: REPEATED MEASURES ANOVA RESULTS FOR CHOLESTEROL DEPOSITION 
  SS DF MSq F p 
Lens Material 37219611 2 18609805 1834.10 <0.00001 
Incubation Time 17303371 1 17303371 1726.34 0.000031 
Incubation Solution 103849125 3 34616375 3001.30 <0.00001 
Lens*Time  8291614 2 4145807 545.20 <0.00001 
Lens*Solution 44250798 6 7375133 911.62 <0.00001 
Time*Solution 20892548 3 6964183 640.64 <0.00001 
Lens*Time*Solution 12140883 6 2023480 316.25 <0.00001 
Error 115171 18 6398     
SS = sum of squares, DF = degrees of freedom, MSq = mean square, F = F statistic 
 
When examining the specific solutions in which the lenses were incubated, it 
was found that cholesterol deposition on balafilcon A and senofilcon A followed the 
order of PrTS > SLTS > ATS > LTS after 3 days and PrTS > ATS > SLTS > LTS after 14 
days of incubation.  However, etafilcon A deposited the most cholesterol when 
incubated in the PrTS > SLTS > LTS > ATS after 3 days and SLTS > PrTS > LTS > ATS 
14 days. Etafilcon A cholesterol deposition was lower and more variable between 
the time points and solutions. The orders listed above represent the ranking for the 
overall deposition amounts. However when the statistical differences between the 
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individual solutions are examined using a Tukey Post-hoc analysis (Table 5-6), it is 
found that not all solution comparisons were statistically different.  
 
TABLE 5-6: SOLUTION COMPARISONS FROM TUKEY POST-HOC ANALYSIS FOR CHOLESTEROL 
DEPOSITION 
 














SLTS vs LTS 0.0018 0.0075 0.1787 0.0274 0.0005 0.1535 
SLTS vs PrTS 0.0002 0.0002 0.8403 0.0002 0.0002 1.0000 
SLTS vs ATS 0.7719 0.9981 0.0122 0.0003 0.0003 0.0005 
LTS vs PrTS 0.0002 0.0002 0.0031 0.0002 0.0002 0.4120 
LTS vs ATS 0.1351 0.0967 0.9953 0.0002 0.0002 0.2985 
PrTS vs ATS 0.0002 0.0002 0.0004 0.0002 0.0002 0.0014 




The results for phosphatidylcholine (PC) deposition on each of the three 
contact lens materials and for each of the four incubation solutions tested are found 
in Figure 5-3 and Table 5-7.  Overall, after 14 days, balafilcon A and senofilcon A 
lenses deposited the most PC when incubated in the SLTS (581.39 ± 85.32 ng/lens 
and 366.95 ± 62.17 ng/lens respectively), and the least in the lipid only LTS solution 
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(107.89 ± 34.75 ng/lens and 114.25 ± 15.03 ng/lens respectively).  Etafilcon A 
deposited the least amount of PC for all incubation solutions.  
 
TABLE 5-7: PHOSPHATIDYLCHOLINE DEPOSITION WITH VARIOUS LEVELS OF COMPLEX 
ARTIFICIAL TEAR SOLUTIONS  
  
Lens Material 
Solution Time Balafilcon A Senofilcon A Etafilcon A 
SLTS 
3 Days 531.12 ± 42.98 309.68 ± 81.44 254.90 ± 44.75 
14 Days 581.39 ± 85.32 366.95 ± 62.17 186.13 ± 8.86 
LTS 
3 Days 89.87 ± 3.89 54.62 ± 9.94 33.54 ± 2.32 
14 Days 107.89 ± 34.75 114.25 ± 15.03 36.24 ± 3.74 
PrTS 
3 Days 103.75 ± 2.91 101.84 ± 3.89 25.84 ± 2.18 
14 Days 258.82 ± 9.56 222.80 ± 8.06 26.75 ± 1.81 
ATS 
3 Days 172.33 ± 8.44 127.91 ± 11.50 24.44 ± 1.04 
14 Days 350.12 ± 11.48 300.31 ± 27.53 37.49 ± 4.09 






FIGURE 5-3: EFFECT OF SOLUTION COMPOSITION ON PHOSPHATIDYLCHOLINE DEPOSITION  
 
PrTS = protein tear solution, SLTS = single lipid tear solution, LTS = lipid tear solution, ATS = artificial tear 
solution 
 
The results of the repeated measures ANOVA are seen in Table 5-8.  The 
repeated measures ANOVA results found statisticaly significant differences between 
all of the variables tested (lens materials, incubation time, and incubation solution) 




TABLE 5-8: REPEATED MEASURES ANOVA RESULTS FOR PHOSPHATIDYLCHOLINE DEPOSITION 
  SS DF MSq F p 
Lens Material 460563 2 230282 107.732 0.00032 
Incubation Time 68119 1 68119 64.840 0.01508 
Incubation Solution 980088 3 326696 3752.869 <0.00001 
Lens*Time  52333 2 26166 147.983 0.00018 
Lens*Solution 146434 6 24406 9.952 0.00045 
Time*Solution 41209 3 13736 10.554 0.00830 
Lens*Time*Solution 15374 6 2562 15.449 0.00005 
Error 1990 12 166     
SS = sum of squares, DF = degrees of freedom, MSq = mean square, F = F statistic 
 
When examining the specific solutions in which the lenses were incubated, it 
was found that PC deposition on balafilcon A and senofilcon A followed the order of 
SLTS > ATS > PrTS > LTS after 3 days and 14 days of incubation.  However, etafilcon 
A deposited the most PC when incubated in the after 3 days SLTS > LTS > PrTS > 
ATS and SLTS > ATS > LTS > PrTS 14 days.  Etafilcon A PC deposition was lower and 
more variable between the time points and solutions. The orders listed above 
represent the ranking for the overall deposition amounts. However when the 
statistical differences between the individual solutions are examined using a Tukey 
Post-hoc analysis (Table 5-9), it is found that not all solution comparisons are 




TABLE 5-9: SOLUTION COMPARISONS FROM TUKEY POST-HOC ANALYSIS FOR 
PHOSPHATIDYLCHOLINE DEPOSITION 
 














SLTS vs LTS 0.0002 0.0002 0.0002 0.0002 0.0002 0.0002 
SLTS vs PrTS 0.0002 0.0002 0.0002 0.0002 0.0002 0.0002 
SLTS vs ATS 0.0002 0.0002 0.0002 0.0002 0.0034 0.0002 
LTS vs PrTS 0.9974 0.0836 1.0000 0.0002 0.0002 1.0000 
LTS vs ATS 0.0007 0.0017 1.0000 0.0002 0.0002 1.0000 
PrTS vs ATS 0.0033 0.5227 1.0000 0.0005 0.0003 1.0000 




 This study was designed to examine lipid binding to contact lenses in 
the presence or absence of other macromolecules.  Specifically, the contact lens 
competitive binding profiles for cholesterol and phosphatidylcholine were 
examined by varying the components and complexity of the incubation solutions 
used, through use of a radiochemical carbon-14 in vitro model.  Many other 
researchers are now beginning to incorporate a more complex artificial tear fluid 
into their in vitro models for material, deposition and solution testing. However, the 
question remains whether this complex and expensive artificial human tear analog 
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is really necessary and if it adds any pertinent information to the research 
conducted.  
The results from this study show quite clearly that experiments performed 
with simple, moderately complex or complex incubation solutions will exhibit 
different deposition results. Cholesterol and phosphatidylcholine behaved 
differently in their deposition profiles between the four different incubation 
solutions and between silicone hydrogel and conventional hydrogel contact lens 
materials. For the two silicone hydrogel contact lens materials, cholesterol 
deposition was highest when the lenses were incubated in the PrTS, followed by the 
ATS then SLTS. The lowest deposition was found with the LTS incubation.  This 
implies that the cholesterol is out-competed for binding sites when it is in the 
presence of other lipids, but when protein is present in the solution and most likely 
depositing on the material, protein deposition increases cholesterol deposition, as is 
seen with the deposition profile in the PrTS and ATS.  This is likely occurring 
because protein deposition and denaturation is making the lens surface more 
hydrophobic during binding, thus providing additional binding sites for cholesterol.   
Protein denaturation is thought to be more prevalent on silicone hydrogels than on 
conventional hydrogel materials, where a much higher percentage of the protein 
remains in its native state.5, 39, 40 This trend of increasing non-polar lipid deposition 
was also seen by Bontempo and Rapp in their solution composition studies with 
conventional hydrogel lenses.12-14  
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When examining the cholesterol deposition on etafilcon A, a different trend 
was seen.  In this case, when incubating in the SLTS solution for 14 days, the 
greatest amount of lipid was deposited, followed closely by the PrTS.  Incubation in 
the LTS deposited significantly less cholesterol and the ATS incubation deposited 
only minute amounts of cholesterol.  However, the only statistical differences in 
cholesterol deposition on etafilcon A were found between the SLTS solution and the 
other three.  Therefore, these results imply that cholesterol is easily out competed 
for the hydrophobic binding sites by other non-polar lipids on this material and that 
protein deposition does more to encourage deposition than other lipids. 
When examining the phosphatidylcholine deposition a different trend of 
deposition was seen. The highest amount of PC was deposited on all materials using 
the SLTS solution, followed by ATS, PrTS and the LTS deposited the least amount of 
PC. This order of deposition was statistically significant for both silicone hydrogel 
materials, but this was not the case for etafilcon A.  For the two silicone hydrogel 
lens materials, phosphatidylcholine was deposited in the highest masses when it did 
not have to compete with any other tear film constituents, proteins or lipids alike.  
PC is in fairly low concentration in the tear film and does not have a strong 
attraction toward these hydrophobic materials, and thus is easily out competed by 
more prevalent, hydrophobic and attractive lipids and proteins.  This is evident 
when incubating in the LTS, as the other lipids available in the solution restrict the 
deposition of PC.  When PC is surrounded with proteins, as is the case when 
incubating in the PrTS and ATS, PC deposition decreases when compared to SLTS 
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deposition levels, but increase significantly when compared to the LTS.  This shows 
that protein deposition alters the lens surface chemistry so that it is less hydrophilic 
and thus creates more sites for PC to bind. 
Etafilcon A results show a similar trend, with higher deposition of PC 
occurring when it is the only lipid present, however no significant differences were 
seen in deposition masses for the other three solutions, p>0.05.  Therefore, this 
results shows that phosphatidylcholine has little affinity for etafilcon A, especially 
with other tear film components present. 
When the overall deposition relating to lens material is analyzed, it is seen that 
balafilcon A usually accumulates the most lipid for both cholesterol and PC; however 
senofilcon A deposited the most cholesterol when incubating in the PrTS.  Balafilcon 
A’s propensity to deposit higher masses of lipid has also been found by other 
researchers, and has been attributed to both its polymer composition, polymeric 
structure and its plasma oxidation process.40-42    As seen in Table 5-3, one of the 
monomeric constituents of balafilcon A is N-vinyl pyrrolidone (NVP),43-46 a 
monomer known to be lipophilic and a cause of increased lipid deposition for FDA 
Group II conventional hydrogel lens materials12, 13, 47, 48 which incorporate it.  In 
addition to NVP, the incorporation of silicone, a very hydrophobic molecule also 
increases the lens’ lipophilic nature.  In order to mask the hydrophobic matrix of 
balafilcon A, the lens is subjected to a plasma oxidation process which converts the 
surface into silicate.49 However, this does not create a continuous silicate surface 
but creates silicate “glassy” islands across the entire surface of the lens, Figure 5-
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4a.49  Therefore, there are portions of the polymer surface that have not been 
converted into silicate and are therefore still relatively hydrophobic.  Finally, the 
balafilcon A material also contains a vast amount of pores, Figure 5-4b.44, 50-53 These 
pores are classified as macropores and are much larger in size than what is common 
in other silicone hydrogels as network pores.44, 51, 52  These macropores are thought 
to be continuous from the anterior to the posterior surface of the lens material and 
therefore are another area for lipid to deposit.44, 51, 52  For a lipid such as cholesterol, 
which is non-polar, balafilcon A still provides many available hydrophobic sites and 
thus results in higher levels of cholesterol deposition.  When analyzing 
phosphatidylcholine deposition, balafilcon A is also an ideal deposition matrix.  
Phosphatidylcholine is an amphiphilic molecule that contains both a hydrophilic 
“water loving” head group (in this case choline), and a hydrophobic “water hating” 
tail group which contains two fatty acid chains, one saturated and one unsaturated. 
This dual nature of PC allows it to then deposit not only on the hydrophobic 




FIGURE 5-4: ATOMIC FORCE MICROSCOPY IMAGES TAKEN FROM BALAFILCON A. A) IMAGE TAKEN 
IN CONTACT MODE B) IMAGE TAKEN IN PHASE CONTRAST MODE. 20X 20µM 
 
 
Senofilcon A, is a second generation silicone hydrogel lens and unlike 
balafilcon A, it does not have a silicate surface coating. However, it does have an 
internal wetting agent incorporated into its polymeric structure which is designed 
to act as an umbrella and potentially “hide” the hydrophobic silicone properties of 
the lens. This wetting agent is a high molecular weight molecule of poly vinyl 
pyrrolidone (PVP). 54   PVP is a polymer of the monomer NVP, which is known to be 
lipophilic in nature (as discussed with balafilcon A), and thus senofilcon A also 
deposits increased amounts of cholesterol and phosphatidylcholine, when 
compared with a conventional hydrogel such as etafilcon A. 
Etafilcon A, is a FDA Group IV conventional hydrogel material composed of 
poly-2-hydroxyethyl methacrylate (HEMA) and methacrylic acid (MA). Conventional 
hydrogel materials based on HEMA have a long history of proving to be relatively 
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low lipid depositors, especially when compared with silicone hydrogels. However, 
ionic materials such etafilcon A tend to deposit large amounts of proteins, 
specifically lysozyme. This is because the MA in etafilcon A gives the lens material a 
net negative charge and therefore attracts positively-charged lysozyme through 
electrostatic interactions.3, 55, 56  These electrostatic interactions cause heavy 
deposits of lysozyme onto these materials, thus allowing little lipid to deposit in 
comparison. 
Much of the other in vitro lipid work completed recently has quantified higher 
masses of cholesterol and phospholipids (either phosphatidylcholine or 
phosphatidylethanolamine) depositing on these materials.  In vitro work from 
Carney et al.,1 and Pucker et al.,6 all cited higher deposition values than the work 
presented here.  However, these other in vitro studies had one or more of these 
main differences in their experimental design which may account for increased 
deposition of lipids: the use of different incubation solutions, higher concentrations 
of lipids in the ATS, different incubation volumes, different incubation times and 
replenishment of the ATS with fresh solution during incubation.1, 6, 9 All of these 
factors may explain the higher deposition of cholesterol and phosphatidylcholine 
When the cholesterol and phosphatidylcholine deposition results found in this 
in vitro experiment are compared with recent ex vivo data, it is seen that the results 
tend to fall within the same range of deposition.  However direct comparisons 
should not be made as the wear time of the ex vivo lenses are much longer than the 
incubation time of this experiment, ex vivo lenses are cleaned nightly, and it would 
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be incorrect to extrapolate the data.42, 57 Many of the recent in vitro and ex vivo 
studies were not completed with the same silicone hydrogel lens materials, did not 
include conventional hydrogel lens materials, and some of them examined different 
lipids than those quantified in this experiment. 
The results from this experiment show that the composition of the incubation 
solution, the lipids under examination, length of incubation and the lenses utilized 
will all have an influence on the overall deposition profile.  The interactions between 
the components of the tear film and the contact lens surface will dictate the 
deposition that occurs.  If in vitro models are really meant to mimic in vivo 
conditions than it is imperative that more complex models are utilized and that 
every attempt is made to make the in vitro conditions as similar as possible to 
human contact lens wear.  It is only by completing these types of experiments that 
we can improve an in vitro model’s usefulness and systematically explore the 
relationships that are occurring during human contact lens wear and then test and 
incorporate them into the in vitro models. In the end, in vitro models need to become 
more physiologically relevant so that their use can be validated and provide a solid 
foundation for further research and development of new and existing products.  
 
5.6 CONCLUSION 
This in vitro study demonstrates that cholesterol and phosphatidylcholine 
deposition is cumulative over time and that SH materials deposit more lipid than a 
CH FDA group IV material. It also clearly demonstrates that deposition of cholesterol 
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and phosphatidylcholine is influenced by the composition of the incubation medium. 
Specifically, cholesterol exhibited significant increases in deposition with protein 
rich incubation solutions, however significant competition with other lipids 
decreased deposition in the lipid rich LTS and ATS solutions.  Phosphatidylcholine 
deposited extremely well when it was the only component in the incubation 
solution, only moderately well with a protein rich ATS and ATS solutions and very 
poorly when it competes with other lipids in the LTS.   
These results prove that in vitro models must use more physiologically 
relevant incubation solutions that mimic the natural tear film if in vitro data is to be 


















In the next chapter, the efficiency of hydrogen peroxide cleaning systems to 
remove bound cholesterol and phosphatidylcholine from three different contact 
lens materials was examined. Lenses were incubated in an artificial tear solution for 
eight hours and were then cleaned in one of two commercially available hydrogen 
peroxide cleaning systems. This cycling was completed for seven days and following 
the last cycle the lenses were extracted, analyzed and compared to control lenses.  
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6 USING AN IN VITRO  MODEL OF LIPID DEPOSITION TO 
ASSESS THE EFFICIENCY OF HYDROGEN PEROXIDE 
SOLUTIONS TO REMOVE LIPID FROM VARIOUS CONTACT 
LENS MATERIALS 
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Purpose: To test the ability of two commercially available hydrogen peroxide 
disinfection solutions to remove lipid from conventional and silicone hydrogel 
contact lens materials incubated in an artificial tear solution (ATS) using 
radiochemical experiments. 
Methods: Etafilcon A, senofilcon A and balafilcon A contact lens materials were 
incubated in an ATS solution containing a mixture of lipids, proteins, mucin and 
either 14C-cholesterol or 14C-phosphatidylcholine for 8 hours. Following incubation, 
the lenses were removed, rinsed, and placed for 16 hours in either ClearCare®, 
AOSept® or stored without solution (control). This process was repeated every day 
for one week until completion.  The lenses were extracted with a previously 
optimized extraction protocol, evaporated, re-suspended, fluor added and counted 
for their radioactive signals.  Masses of lipids deposited were calculated based on 
standard calibration curves, the disinfection solutions were compared and repeated 
measures ANOVA and post-hoc statistical analysis was completed using Statistica 9. 
Results: The results of this experiment found that daily disinfection with hydrogen 
peroxide solutions reduced the amount of cholesterol and phosphatidylcholine 
deposited on the three contact lens materials examined, however in many cases the 
reduction in deposition was less than 15% when compared to the control.  
Disinfection with ClearCare resulted in the least deposited cholesterol and 
phosphatidylcholine for all materials, however not all of the comparisons were 
statistically significant.  
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Conclusions: Overall, the ClearCare hydrogen peroxide disinfection solution 
removed the most lipid from lenses when compared to AOSept or the control, for 
both lipids and all lens materials.  However, the differences found were quite small 




In the mid-1990’s, hydrogen peroxide and chlorine-based contact lens cleaning 
systems had a predominant stance in the market, comprising almost half of all 
cleaning regimes prescribed.1, 2  Since then, the two-step hydrogen peroxide, 
requiring a second neutralization step, and chlorine-based systems have become 
basically obsolete and the one-step hydrogen peroxide systems have experienced a 
drastic drop in use due to the growing popularity of multipurpose solutions.1, 2  
Multipurpose solutions now account for over 85%1, 2 of the market for contact lens 
cleaning and disinfection solutions and for  many years have been the preference of 
patients due to their simplicity, ease of use, and speed of use.  However, in recent 
years there have been two worldwide recalls of multipurpose solutions due to 
microbial keratitis outbreaks3-5 and practitioners have seen an increased prevalence 
of corneal staining with the use of polyhexamethyl biguanide (PHMB)6-8 containing 
multipurpose solutions in combination of certain lenses.  Due to these factors, there 
has been a resurgence of interest in hydrogen peroxide systems, which had been a 
“gold standard” for years due to their disinfection power.9, 10  
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Historically, hydrogen peroxide-based systems have been very simplistic in 
their composition, with mainly buffers plus 3% hydrogen peroxide. However, over 
the past decade manufacturers have begun adding surfactants and various wetting 
agents to their hydrogen peroxide solutions. Of particular note are the surfactants, 
which are designed to aid in removal of debris, deposits and microorganisms11-13 as 
well as enhance the wettability of the contact lens, specifically silicone hydrogel 
contact lenses.14, 15 However, surfactants are known to vary in their ability to 
remove particular deposits, especially lipids.16, 17  
Yearly, more and more practitioners are fitting their patients with silicone 
hydrogel lens materials. 18 These materials are superior to the conventional 
hydrogel materials in their marked increase in oxygen transmissibility; 19-22 
however the incorporation of silicone into these materials results in a more 
hydrophobic or lipid-loving surface. 23-28 With lipid deposition-prone lenses 
becoming more prevalent in the market and contact lens cleaning solutions not 
necessarily designed to remove lipid, there is concern about the amount of lipid 
accumulating on the surface and in the matrix of lens materials, and its effects on 
comfort, vision, and wettability for the contact lens wearers.  Specifically, the 
efficiency of hydrogen peroxide-based solutions to remove lipid from silicone 
hydrogel contact lenses has been questioned and of particular note is whether the 




In vitro models of tear film deposition on contact lenses can be utilized to 
evaluate the cleaning efficiency of new experimental formulations and commercially 
available contact lens cleaning and disinfection solutions.  The value of assessing 
contact lenses and contact lens cleaning and disinfection solutions via an in vitro 
model lay in its ability to control many experimental variables, eliminate the need 
for participant recruitment and remuneration, and the ability to test many 
conditions simultaneously, for example many different incubation periods.  The 
other main advantage of using in vitro models for contact lens deposition and the 
effectiveness of contact lens disinfection solutions is that control “uncleaned” 
contact lenses deposited with tear film components can be prepared and then 
directly compared to the cleaned and disinfected lenses, allowing a true assessment 
of the efficiency of the disinfection solution.  
The purpose of this experiment was to use the radioactive in vitro model of 
lipid deposition previously developed by our laboratory to compare cleaning 
efficacies of two hydrogen peroxide disinfection solutions on various lens materials, 
relative to uncleaned lenses.  
 
6.3 METHODS 
6.3.1 ARTIFICIAL TEAR SOLUTION  
An abridged version of the artificial tear solution (ATS) preparation protocol 
will be described in this section, as the in-depth protocol has been previously 
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discussed29 in Chapter 3. Table 6-1 and 6-2 lists all of the non-radioactive and 
radioactive ATS components and their concentrations. In general, the ATS 
preparation involves several steps beginning with the making of the salt solution, 
which acts as the base of the ATS.  All components of the salt solution were 
dissolved into MilliQ water in the order listed in Table 6-1.  Next, a hexane: ethyl 
ether (1:1) solution was used to dissolve pure lipids together in order to prepare a 
concentrated lipid stock solution. Larger volumes of this solution were made and 
frozen for future experiments. An aliquot of the lipid stock solution was then 
pipetted into the desired volume of salt solution. In order to evaporate off the 
hexane: ether and to create a solution of lipid homogeneity, the lipid salt solution, 
was purged with nitrogen while sonicating at 37°C, until the odour of the solvent 
had dissipated.  Then the radioactive lipid was added into the solution and further 
sonicated for 15 minutes. The radiolabeled cholesterol and phosphatidylcholine was 
added to the ATS at a concentration of 3% and 8.5% of the total individual lipid 
concentration respectively. Once the lipid solution was complete, the ATS was 
finished by dissolving the proteins and mucin into the solution and sonicating the 




TABLE 6-1: ARTIFICIAL TEAR SOLUTION COMPONENTS 
Salt component mM Lipid Component Concentration 
(mg/mL) 
Sodium chloride 90.0 Cholesterol 0.0036 
Potassium chloride 16.0 Cholesteryl oleate 0.048 
Sodium citrate 1.5 Oleic acid 0.0036 
Glucose 0.2 Oleic acid methyl 
ester 
0.024 
Urea 1.2 Phosphatidylcholine 0.001 
Calcium chloride 0.5 Triolein 0.032 
Sodium carbonate 12.0 Protein Component Concentration 
(mg/mL) 
Potassium hydrogen carbonate 3.0 Bovine Albumin 0.20 
Sodium phosphate dibasic 24.0 Hen Egg Lysozyme 1.90 





ProClin 300 0.2 µL/ 1L  Bovine Lactoferrin 0.90 
 
 
TABLE 6-2: RADIOACTIVE LIPID CHARACTERISTICS 
















6.3.2 CONTACT LENS MATERIALS AND DISINFECTION SOLUTIONS 
Three contact lens materials were tested: Acuvue® 2 [etafilcon A; Vistakon 
(ETA)], Acuvue® OASYS™ [senofilcon A; Vistakon (SEN)], and PureVision™ 
[balafilcon A; Bausch & Lomb (BAL)](Table 6-3). The disinfection solutions tested 
were: ClearCare® and AOSept®, both manufactured by CIBA Vision (Table 6-4). 
 
TABLE 6-3: CONTACT LENS MATERIAL CHARACTERISTICS 
Material Type Conventional Hydrogel Silicone Hydrogel 
USAN Etafilcon A Balafilcon A Senofilcon A 
Proprietary name Acuvue®2 PureVisionTM Acuvue® OASYSTM 
Manufacturer Johnson & Johnson Bausch & Lomb Johnson & Johnson 
Monomers HEMA, MA 
NVP, TPVC, 
NVA, PBVC 
mPDMS, DMA, HEMA, 
siloxane macromer, 
EGDMA, PVP 
Surface Modification None 
Plasma 
oxidation 
PVP as an internal 
wetting agent 
Dk/t (x10-9) 31 110 147 
Water Content 58% 36% 38% 
FDA Class Group IV Group III Group I 
Dk/t: oxygen transmissibilityUSAN: United States adopted name; DMA (N,N-dimethylacrylamide); EGDMA 
(ethyleneglycol dimethacrylate); HEMA (poly-2-hydroxyethyl methacrylate); MA (methacrylic acid); mPDMS 
(monofunctional polydimethylsiloxane); NVA (N-vinyl aminobutyric acid); NVP (N-vinyl pyrrolidone); PBVC 
(poly[dimethysiloxy] di [silylbutanol] bis[vinyl carbamate]); PVP (poly(vinylpyrrolidone)); TPVC (tris-





TABLE 6-4: HYDROGEN PEROXIDE SOLUTION PROPERTIES 
Solution ClearCare® AOSept® 
Manufacturer CIBA Vision CIBA Vision 
Disinfectant 3% hydrogen peroxide 3% hydrogen peroxide 
Surfactant Pluronic 17R4 none 
Other Components 
Phosphonic acid, sodium 
chloride, phosphate buffer 
system 
Phosphonic acid, sodium 
chloride, phosphate buffer 
system 
Neutralization Method Platinum Disc Platinum Disc 
 
6.3.3 INCUBATION VIAL PREPARATION 
All 6 mL borosilicate glass incubation vials were pre-conditioned with non-
radioactive ATS with shaking at 37°C for at least four days. This pre-conditioning 
allows the vial surface to become coated with lipid and protein prior to contact lens 
incubation, thereby allowing the full concentration of lipid and protein in the 
radioactive ATS incubation solution to be available.  Following pre-conditioning, the 
vials were emptied, rinsed out with saline, and the fresh radioactive contact lens 
incubation solution was then be dispensed into the vials.  
 
6.3.4 EXPERIMENTAL DESIGN 
A flow chart explaining the seven day experimental design can be found in 
Figure 6-1. On the first morning, all contact lenses were removed from their blister 
pack solution and placed directly into 1.5 mL of the incubation ATS containing of 
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one of the two radiolabeled lipids: 14C-cholesterol or 14C-phosphatidylcholine. Each 
lens material was incubated in the radioactive ATS at 37oC with gentle shaking for 
the eight hours, which is intended to represent a normal time for a patient wearing a 
contact lens.  After the 8 hours of incubation, all lens materials were removed from 
the incubation solution, rinsed in three successive 250mL beakers of complex salt 
solution (CSS), and gently dabbed on lens paper to remove excess solution.  The 
rinsed lenses were then placed into the appropriately marked left/right domed lens 
holder (2 lenses per holder, 3 holders per solution; n=6) containing 10 mL of either 
ClearCare (CC) or AOSept (AO). The lens holder was then inserted into the 
disinfection solution and the lens case was tightened.  The lens cases were kept at 
room temperature for 16 hours (overnight). A set of control lenses were also 
processed alongside disinfected lenses. These controls (CNRL) represented the total 
deposition of lipid on lenses that were not disinfected daily. The control lenses were 
rinsed using the same protocol, but instead of being placed in disinfection solution, 
lenses were returned to their original incubation vials, which had been rinsed and 
emptied of the incubation ATS. The lenses, in their emptied vials, were then stored 
at 4°C overnight.  This was 1 cycle. 
The next morning, following the disinfection cycle, the lenses were removed 
from the disinfection solutions and rinsed as previously described and placed back 
into the original incubation vials containing fresh radioactive ATS to start the next 
cycle. The fresh radioactive ATS was directly added to the control vials and all of the 
lenses were incubated at 37oC for another 8 hrs.  The empty contact lens holders 
and lens cases were cleaned by rinsing them with hot running tap water followed by 
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rinsing them in reverse osmosis water and letting them air-dry prior to the next 
disinfection cycle.  No harsh chemicals or mechanical treatments were used to the 
clean lens holders and lens cases.  Alternating cycles of lens incubation in the ATS 
and disinfection were carried out throughout the study period (7 days).   
At the end of the 7-day cycle (disinfection period), lenses were removed and 
rinsed by dipping into three successive 250 mL beakers containing CSS and dabbed 
on lens paper to remove excess liquid. The 14C-cholesterol incubated lenses were 
placed into 20 mL glass scintillation vials with 2 mL of (2:1) chloroform: methanol 
(v/v) extraction solution and were incubated for three hours each at 37°C with 
shaking.  Each 14C-cholesterol incubated lens was extracted in this way two separate 
times and both extracts were pooled in the same vial. The 14C-phosphatidylcholine 
incubated lenses were placed into 20 mL glass scintillation vials with 2 mL of 
(60:50:1:4) chloroform: methanol : acetic acid : water (v/v/v/v) extraction solution 
and were incubated for three hours at 37°C with shaking.  Each 14C-
phosphatidylcholine incubated lens was extracted in this way on two separate 
occasions and both extracts were pooled together.  
The extract vials were then dried down completely using nitrogen evaporation 
and heat up to 37oC.  All contact lens extracts were re-suspended in 1 mL of 
chloroform, sonicated for one minute, and 10 mL of Ultima Gold F scintillation 
cocktail was added.  The vials were then submitted for beta counting using a 
Beckman-Coulter L6500 liquid scintillation counter.  In the experiment, the 
radioactive lipid was used as a probe and the ratio of radioactive lipid to non-
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radioactive lipid in the incubating ATS was kept constant.  Therefore, quantification 
of the total amount of cholesterol and phosphatidylcholine deposited was 
extrapolated and calculated using standard radioactive lipid calibration curves.  
 







6.3.5 STATISTICAL ANALYSIS 
Statistical analysis was performed with Statistica 9, using repeated measures 




The results for cholesterol deposition on each of the three contact lens 
materials and for disinfection solutions tested are found in Figure 6-2 and Table 6-5.  
Balafilcon A lenses deposited the most cholesterol, followed by senofilcon A and 
lastly etafilcon A, which had very little cholesterol deposition. For all three lens 
materials, the control lenses deposited the most cholesterol and all of the lens 
materials that were disinfected with ClearCare had the least amount of cholesterol 
deposited.  Etafilcon A lenses disinfected with ClearCare were found to have 40% 
less cholesterol deposited when compared with the controls. In contrast, balafilcon 
A and senofilcon A had 6% and 14% less cholesterol, respectively. Etafilcon A lenses 
disinfected with AOSept had 23% less deposited cholesterol when compared with 
the control. Balafilcon A had 3% less and senofilcon A had 10% less cholesterol 





FIGURE 6-2: CHOLESTEROL DEPOSITION 
 







TABLE 6-5: CHOLESTEROL DEPOSITION (NG/LENS) 
  Disinfection Solution 
  ClearCare AOSept Control 
Etafilcon A 
Avg C  (ng/lens ± SD) 27.99 ± 3.21 35.96 ± 2.82 46.76 ± 6.08 
Avg mass removed 
(ng/lens) 
18.77 10.80 - 
Avg % C removed 40% 23% - 
Balafilcon A 
Avg C  (ng/lens ± SD) 724.27 ± 28.28 743.13 ± 21.05 766.10 ± 30.76 
Avg mass removed  
(ng/lens) 
41.83 22.97 - 
Avg % C removed 6% 3% - 
Senofilcon A 
Avg C  (ng/lens ± SD) 630.19 ± 42.13 661.22 ± 20.91 730.97 ± 17.93 
Avg mass removed  
(ng/lens) 
100.78 69.75 - 
Avg % C removed 14% 10% - 
 
The results of the repeated measures ANOVA are seen in Table 6-6 and the 
results of the Tukey post-hoc comparison analyzing the individual variables can be 
seen in Table 6-7.  The repeated measures ANOVA results found statisticaly 
significant differences between the disinfection solutions used and between the lens 
materials tested, and the interaction between the two variables. As for the post-hoc 
results, balafilcon A and senofilcon A materials disinfected with ClearCare had 
statistically less cholesterol deposited when  compared with the control (p<0.05), 
however etafilcon a had no statistical differences (p=0.88).  Etafilcon A and 
balafilcon A lens materials had no statisical difference in cholesterol deposition 
(p>0.05) when disinfected with AOSept, however senofilcon A did have statsitically 
less cholesterol (p=0.002).  When the two hydrogen peroxide solutions were 
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compared for each lens material, no statistically significant differences were seen 
(p>0.45). 
 
TABLE 6-6: REPEATED MEASURES ANOVA FOR CHOLESTEROL DEPOSITION 
 
SS DF MSq F p 
Solution 21646 2 10823 15.25 0.0019 
Lens Material 4524876 2 2262438 3431.98 <0.0001 
Solution * Lens Material 9272 4 2318 6.31 0.0030 
Error 5878 16 367 
  
SS = sum of squares, DF = degrees of freedom, MSq = mean square, F = F statistic, 
 
TABLE 6-7: TUKEY POST-HOC ANALYSIS COMPARING THE VARIOUS DISINFECTION ON 
CHOLESTEROL DEPOSITION 
Solution  CC CC CC AO AO AO CNRL CNRL 
 Lens ETA BAL SEN ETA BAL SEN ETA BAL 
CC BAL 0.0002 
       
CC SEN 0.0002 0.0002 
      
AO ETA 0.9991 0.0002 0.0002 
     
AO BAL 0.0002 0.8284 0.0002 0.0002 
    
AO SEN 0.0002 0.0080 0.1995 0.0002 0.0006 
   
CNRL ETA 0.8813 0.0002 0.0002 0.9960 0.0002 0.0002 
  
CNRL BAL 0.0002 0.0493 0.0002 0.0002 0.5403 0.0002 0.0002 
 
CNRL SEN 0.0002 0.9896 0.0002 0.0002 0.9991 0.0015 0.0002 0.2348 
CC= ClearCare, AO = AOSept, CNRL = control uncleaned lenses,  






The results for phosphatidylcholine deposition on each of the three contact 
lens materials and the two disinfection solutions tested are found in Figure 6-3 and 
Table 6-8.  Balafilcon A and senofilcon A lenses deposited very similar quantities of 
phosphatidylcholine, and etafilcon A deposited very little phosphatidylcholine when 
compared with the two silicone hydrogel lens materials. For all three lens materials, 
the control lenses deposited the most phosphatidylcholine and all lens materials 
that were disinfected with ClearCare had the least amount of phosphatidylcholine 
deposited.  Etafilcon A lenses disinfected with ClearCare were found to have 13% 
less phosphatidylcholine deposited when compared with the controls, but balafilcon 
A and senofilcon A only had 9% and 6% less phosphatidylcholine, respectively. 
Etafilcon A lenses disinfected with AOSept had 11% less deposited 
phosphatidylcholine when compared with the control. Balafilcon A had 2% less and 
senofilcon A had 5% less phosphatidylcholine deposited on the lenses when 




FIGURE 6-3: PHOSPHATIDYLCHOLINE DEPOSITION 
 
* denotes statistical difference from corresponding lens control 
 
TABLE 6-8: PHOSPHATIDYLCHOLINE DEPOSITION (NG/LENS) 
  Disinfection Solution 
  
ClearCare AOSept Control 
Etafilcon A 
Avg PC (ng/lens ± SD) 519.67 ± 4.05 532.90 ± 3.79 599.89 ± 12.21 
Avg mass removed    
(ng/lens) 
80.22 66.99 - 
Avg % PC removed  13% 11% - 
Balafilcon A 
Avg PC (ng/lens ± SD) 1009.27 ± 64.77 1092.28 ± 8.17 1113.96 ± 29.21 
Avg mass removed  
(ng/lens) 
104.69 21.68 - 
Avg % PC removed 9% 2% - 
Senofilcon A 
Avg PC (ng/lens ± SD) 1025.68 ± 11.42 1038.69 ± 25.34 1091.16 ± 11.74 
Avg mass removed 
(ng/lens) 
65.48 52.47 - 




The results of the repeated measures ANOVA are seen in Table 6-9 and the 
results of the Tukey post-hoc comparison analyzing the individual variables can be 
seen in Table 6-10.  The repeated measures ANOVA results found statisticaly 
significant differences between the disinfection solutions used and between the lens 
materials tested, however the interaction between the two variables was not 
statisically significant (p=0.074). As for the post-hoc results, balafilcon A and 
etafilcon A disinfected with ClearCare had statistically less  phosphatidylcholine 
deposited when  compared with the control (p≤0.01), but senofilcon A did not show 
a significant difference in deposition (p=0.07).  Only the etafilcon A lens materials 
had statisically less phosphatidylcholine deposited (p=0.04) when disinfected with 
AOSept and compared to the control.  When the two hydrogen peroxide solutions 
were compared for each lens material, only balafilcon A lenses had statistical 
differences  in deposition (p<0.01). 
 
TABLE 6-9: REPEATED MEASURES ANOVA FOR PHOSPHATIDYLCHOLINE DEPOSITION 
  SS DF MSq F P 
Solution 0.05276 2 0.02638 62.81 <0.0001 
Lens Material 2.59643 2 1.29821 3369.63 <0.0001 
Solution * Lens Material  0.00934 4 0.00233 2.62 0.0740 
Error 0.01425 16 0.00089 
  




TABLE 6-10: TUKEY POST-HOC ANALYSIS COMPARING THE VARIOUS DISINFECTION SOLUTIONS 
ON PHOSPHATIDYLCHOLINE DEPOSITION 
Solution  CC CC CC AO AO AO CNRL CNRL 
 Lens ETA BAL SEN ETA BAL SEN ETA BAL 
CC BAL 0.0002 
       
CC SEN 0.0002 0.9942 
      
AO ETA 0.9966 0.0002 0.0002 
     
AO BAL 0.0002 0.0095 0.0458 0.0002 
    
AO SEN 0.0002 0.9360 1.0000 0.0002 0.0969 
   
CNRL ETA 0.0100 0.0002 0.0002 0.0427 0.0002 0.0002 
  
CNRL BAL 0.0002 0.0014 0.0062 0.0002 0.9742 0.0136 0.0002 
 
CNRL SEN 0.0002 0.0143 0.0679 0.0002 1.0000 0.1402 0.0002 0.9291 
CC= ClearCare, AO = AOSept, CNRL = control uncleaned lenses 
BAL = balafilcon A, ETA = etafilcon A, SEN = senofilcon A 
 
6.5 DISCUSSION 
This study was designed to examine the efficacy of lipid removal from contact 
lenses by two different hydrogen peroxide contact lens disinfection solutions, using 
our in vitro radiochemical lipid deposition model.  The ideal contact lens cleaning 
and disinfection solution must fulfill many criteria. It must:  rapidly disinfect a broad 
range of microorganisms, be safe for the ocular tissue, compatible with all lens 
materials, inexpensive and easy to use,  condition the lens surface and reduce 
deposition of tear film components, including the removal of lipid deposition.30    
Little work has been published on lipid removal from contact lenses.  In addition, 
new materials have been introduced into the market and the specific contact lens 
material characteristics may also play a role in altering lipid removal by cleaning 
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and disinfection solutions. For example, the currently available silicone hydrogel 
contact lens materials all have very different structures and polymers when 
compared to each other and the conventional hydrogel materials.  Some of the 
materials are trimethylsiloxy silane (TRIS) derivatives, some are newer silicone 
macromers, some have solid surface treatments, some have leaky surface 
treatments, some have internal wetting agents, and some have no wetting agents 
(Table 6-3).  With all of these variations, it is possible that a particular contact lens 
solution formulation may show enhanced efficacy when cleaning a particular lens 
material but not another. 
From this experiment it was seen that the two CibaVision hydrogen peroxide 
systems tested, AOSept and ClearCare, vary in their ability to remove lipid from 
contact lens materials and that the process was governed both by the specific lipid 
and contact lens material under investigation.  On average, silicone hydrogel lenses 
disinfected by ClearCare, had up to a 15% reduction in deposited cholesterol and 
phosphatidylcholine when compared to the control lenses.  This was equivalent to 
about 110 ng of lipid per lens removed when compared to the controls. The 
conventional hydrogel, etafilcon A, did have a higher percentage removal of 
cholesterol when disinfected with ClearCare (40%); however the average mass of 
lipid removed was only 18.77 ng, which is a lower amount than what was removed 
from silicone hydrogels disinfected with the same solution.  AOSept-disinfected 
silicone hydrogel lens materials showed a similar trend compared to ClearCare, 
except with a marginal loss in cleaning efficiency: silicone hydrogel cleaning 
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efficiency was on average <10% and on the conventional hydrogel was <23%.  All 
lens materials disinfected with AOSept removed a maximum of 70 ng of lipid. 
The trend showing a marginal increase in cleaning efficiency with ClearCare 
over AOSept, especially for cholesterol removal on senofilcon A lenses, is attributed 
to the addition of the surfactant, Pluronic 17R4.  Even though, the statistical analysis 
resulted in some significant differences in deposition between the two different 
disinfection solutions and between the disinfection solutions and the control, these 
differences may not be clinically significant for a contact lens wearer.  The statistical 
analysis does confirm however, that there was a high degree of repeatability in the 
in vitro model tested, as the six replicates of each variable completed had very small 
standard deviations. The model was also able detect small differences in contact 
lens lipid deposition when using different disinfection solutions.   
The next stage of this research will be to compare the efficiency of hydrogen 
peroxide versus multipurpose contact lens cleaning solutions to remove deposited 
lipid from various contact lens materials and to compare the data to published 
clinical data.  A few studies have recently examined the differences in lipid 
deposition when different contact lens cleaning solutions were utilized during a 
clinical ex vivo study.  Zhao et al.31 in 2009 published a clinical study examining 
cholesterol and protein deposition on various silicone hydrogel contact lens 
materials where the participants had utilized a number of different contact lens 
cleaning and disinfection solutions, including one hydrogen peroxide solution 
(ClearCare) and three multipurpose contact lens cleaning solutions. In this study 
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they found that the amount of cholesterol deposited was correlated to both the 
cleaning and disinfection solution utilized and the specific silicone hydrogel lens 
material that was worn.31 They also found that the hydrogen peroxide solution 
tested was not the most efficient at removing cholesterol from human worn contact 
lenses.31  In their study they found that balafilcon A lenses deposited 8.0±1.9 
µg/lens and senofilcon A lenses deposited on average 1.2±0.4 µg/lens of cholesterol 
when disinfected with ClearCare and worn for 30 days. 31   
Another study was recently published by Heynen et al.32 examining senofilcon 
A contact lens materials and their subsequent deposition of non-polar lipids 
following a clinical study where participants used either ClearCare or a 1-step 
multipurpose solution to clean their lenses.  This study found that the overall lipid 
deposition and total cholesteryl oleate deposition were significantly less on the 
senofilcon A lenses disinfected with the multipurpose solution.32  Average 
cholesterol deposition was similar between the two types of cleaning and 
disinfection solutions with deposition quantified to be 1.3 and 1.4 µg/lens. Once 
again, this study supports previous findings that lipid deposition is more efficiently 
removed from silicone hydrogel contact lens materials by a multipurpose solution. 
When the cholesterol deposition results found in this in vitro experiment are 
compared with these recent ex vivo publications, it is seen that some differences do 
exist.  However, at times it is difficult to make direct comparisons as the wear time 
of the ex vivo lenses are longer than the incubation time of this experiment.31-33    To 
date no studies have examined the effect of hydrogen peroxide disinfection solution 
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on phosphatidylcholine deposition.  One limitation and difference between the 
experimental design utilized here and average human contact lens wear, is that the 
lenses in this experiment were incubated for 8 hours in the ATS then removed and 
disinfected for 16 hours. In reality average human contact lens wear is closer to 16 
hours, with disinfection for 8 hours.  Therefore, in vitro deposition values similar to 
ex vivo reported masses may be possible by simply increasing the incubation time of 
the lenses and decreasing the disinfection time, to better mimic “normal” contact 
lens wearing cycles. 
In vitro models can be utilized to evaluate the cleaning efficacy of new and/or 
commercially available contact lens cleaning and disinfection solutions and to 
evaluate the deposition profiles of new and/or commercially available contact lens 
materials. The radiochemical in vitro deposition model developed by our laboratory 
has shown to be a sensitive, repeatable and versatile model that can be used for the 
screening of new products.  In addition to this, the model is easily altered to enable 
rapid investigations using a simplistic model or more physiologically relevant 
analysis using a multifaceted model that incorporates a complex artificial tear 
solution, and increased number of variables.  The concentrations of the ATS tear film 
components can be easily altered to mimic tear film concentrations which are 
typical in conditions such as meibomian gland dysfunction or Sjogren’s disease or to 
reach a desired mass of deposition.  These conditions can all be analyzed while 
comparing to a control lens that has not been disinfected, so that an absolute 
reference is obtained. Of course, in vitro models will never be able to mimic all of the 
variables and complexity present in human contact lens wear; however they can aid 
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in the development of new products and provide valuable information on contact 
lens interactions with the surrounding tear film.  
 
6.6 CONCLUSION 
Overall, the ClearCare hydrogen peroxide solution which contained a 
surfactant removed the most lipids from lenses when compared to AOSept or the 
control, for both lipids and all lens materials.  However, the differences found were 
quite small at times and whether these differences are clinically significant are yet 
to be determined.  
The in vitro model of lipid deposition utilized in this experiment was found to 
be repeatable and sensitive enough to detect small differences in lipid deposition on 
various lens materials and with the use of different disinfection solutions.   
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In this chapter, the effects of intermittent air exposure on in vitro lipid 
deposition of several contact lens materials using a radiochemical experiment are 
analyzed with the use of a “model blink cell” designed and built in our laboratory.  
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7 THE IMPACT OF INTERMITTENT AIR EXPOSURE ON THE 
DEPOSITION OF LIPIDS ON SILICONE HYDROGEL AND 
CONVENTIONAL HYDROGEL CONTACT LENS MATERIALS 
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Purpose: To evaluate the influence of air exposure during in vitro deposition of two 
model lipids on silicone hydrogel (SH) and conventional hydrogel (CH) contact lens 
materials, via a custom-designed model blink cell (MBC).  
Methods: Four SH (balafilcon A; lotrafilcon B; comfilcon A ; senofilcon A) and two 
CH (etafilcon A and omafilcon A) contact lens materials were mounted on six pistons 
and placed in a controlled atmosphere chamber at 35°C with a relative humidity of 
18%.  The pistons were connected to a motor that cycled the contact lenses in and 
out of a custom-designed artificial tear solution (ATS) that closely mimicked the 
human tear film composition.  Lenses were cycled for 10 hours; 2 seconds in the 
ATS then exposed to air for 5 seconds, which allowed the tear film to break over the 
surface of the contact lens. Control lenses were kept submerged for 10 hours. The 
incubation solution used was a complex ATS that contained six common tear film 
lipids, proteins, mucin, salts and a trace amount of one of the radioactive lipids; 14C-
cholesterol or 14C-phosphatidylcholine.  A longer term incubation was tested with 
lotrafilcon B and balafilcon A materials incubated in 14C-cholesterol ATS. For this 
study, air exposed lenses were cycled for 14 hours then submerged for 10 hours. 
This was completed for 6 days and the control lenses were simply submerged for all 
6 days. Following incubation, each lens was extracted twice in 2 mL of chloroform: 
methanol (2:1, v/v) for three hours, evaporated under nitrogen, re-suspended in 
chloroform and then Ultima Gold F scintillation cocktail.  Extracts were counted in a 
LS6500 Beckman Coulter beta counter and raw data were translated into absolute 
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amounts (ng/lens) via extrapolation from standard curves run for each of the test 
lipids.  
Results:  For the two model lipids tested, SH lens materials deposited statistically 
more lipid than the CH lens materials, with balafilcon A depositing the most lipid. 
Air exposure significantly increased the amount of cholesterol that deposited on 
omafilcon A, balafilcon A, comfilcon A, and senofilcon A (p≤0.03). No change in 
deposition was seen for lotrafilcon B and etafilcon A (p>0.05). The longer term 
incubation of lotrafilcon B and balafilcon A showed statistically significant increases 
in cholesterol deposition for both lens materials that were exposed to air (p<0.02). 
All lenses exposed to air resulted in increased amounts of phosphatidylcholine 
deposited. These levels were statistically significantly higher (p<0.04) for lotrafilcon 
B, senofilcon A, comfilcon A and omafilcon A, but not statistically significant 
(p>0.05) for balafilcon A or etafilcon A.   
Conclusion:  This model has demonstrated that lipid deposition kinetics can be 
impacted by air exposure and that lipid deposition profiles are contact lens 
dependent. In vitro models must begin to use more physiologically relevant 
incubation solutions and conditions that mimic contact lens wear within the natural 
tear film if in vitro data is to be extrapolated to the in vivo situation.  These 
methodologies will provide hitherto unavailable information on the way in which 
lipid interacts with silicone hydrogel materials and will be of interest to the contact 






In vitro models in contact lens research have been used previously to examine 
lipid deposition, protein deposition, protein denaturation and interactions with tear 
film components. 1-14 Many of the in vitro models utilized are simple model systems 
where an individual lipid or protein was examined in isolation, without the 
incorporation of the other prevalent tear film components.4, 5, 9, 10, 13, 14  These in vitro 
models are too simplistic and they ignore several key elements of human contact 
lens wear.  If in vitro models are really meant to mimic human conditions, the 
models utilized have to become more physiologically relevant so that it is more 
conducive to the human contact lens wear experience.  This, in turn, should provide 
better and more true-to-life data on contact lenses and tear film interactions.  
Some of these key elements that were not addressed in early in vitro models 
included the complexity of the tear film, the exposure to air in-between blinks and 
the sheering force of the lid.    Our laboratory, and others, have begun using a more 
complex tear film solution, which contains mixes of both lipids and proteins, in their 
in vitro models.2, 3, 15-20  However, very few if any researchers have looked at the 
effect of air exposure or the lid effects on lipid or protein deposition.   
The effect of lens drying in the inter-blink period is especially of interest in 
lipid deposition on silicone hydrogel contact lens materials, as these lenses are more 
hydrophobic and less wettable than conventional hydrogel materials.  These lens 
properties are attributed to the silicone components of the contact lenses.  Silicone 
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is known for its superior ability to carry oxygen, which is ideal for daily and 
especially extended wear contact lens materials, however silicone is known to be 
very hydrophobic in nature.  This hydrophobicity makes the lens material more 
lipophilic and less wettable, which can lead to contact lens associated discomfort, 
increased lipid deposition and decreased visual acuity for the wearer. 21 
When a contact lens material is naturally hydrophobic and unwettable, the 
anterior tear film that covers the lens surface may not remain stable and intact for a 
long period of time. Therefore, the tear film may break, collapse and recede across 
the surface of the lens prior to the next blink.  This breaking of the tear film 
encourages the lipid layer of the tear film to come into direct contact with the lens 
material itself, which could increase the degree of lipid deposition.  This process 
could be exacerbated by the fact that silicone hydrogels, much like their 
conventional hydrogel predecessors, have very freely rotating polymer structures.  
This means, when the polymer is exposed directly to air it will rotate to expose its 
more hydrophobic backbone and “hide” the hydrophilic moieties toward the matrix.  
This may form an inward attraction for lipid to deposit during the inter-blink 
period.   
When a blink occurs, the tear film will re-form over the anterior surface of the 
contact lens and the hydrophilic polymer moieties flip back to the surface to come in 
contact with the aqueous phase of the tear film.  Deposited lipid on the lens surface 
may then be encouraged to move further into the lens matrix to avoid the aqueous 
phase of the tear film and the hydrophilic moieties of the lens polymer. This is a very 
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dynamic process that may have a huge impact on the quantity of lipid, types of lipid, 
state of the lipid, and the mechanism of how the deposition onto and into contact 
lens materials occurs.   
In order to test this effect of air exposure on lipid deposition using an in vitro 
model, a novel device was built by our laboratory. This device, called a “model blink 
cell” (MBC), was designed to mimic the inter-blink drying time that occurs during 
contact lens wear.  This MBC is placed into an atmospherically controlled chamber 
and mounted contact lenses are cycled in and out of an artificial tear solution (ATS).  
When the lenses are out of the ATS the artificial tear film will “break” over the 
surface of the lens and allow for drying, to mimic human contact lens wear.  This 
was completed and tested against an in vitro model where the contact lenses 
remained submerged in the ATS for the entire incubation time, without cycling, 
similar to traditional in vitro vial incubations.   
In this experiment, two different model lipids, 14C-cholesterol and 14C-
phosphatidylcholine, were examined for their deposition onto conventional and 
silicone hydrogel contact lens materials using our specially designed model blink 





7.3.1 ARTIFICIAL TEAR SOLUTION (ATS) 
Chapter 3 of this thesis introduced the protocol to prepare an ATS solution 
specifically optimized for closed-system or in-vial incubations.  However, this study 
involved an experiment that required incubation of contact lenses in an open-to-air 
system; therefore an ATS was developed for open-system incubations which were 
able to remain stable in pH and osmolality throughout the incubation period when 
exposed to air.  This ATS is very similar in composition and preparation to the 
previously described system outlined in Table 3-1 and the changes from the original 
in-vial ATS components are italicized and remain limited to the complex salt 
solution.  
Preparing a radioactive open-system ATS involves the same main steps in 
protocol. The preparation of the complex salt solution was the first step in preparing 
this ATS.  The salt components were mixed into the required amount of MilliQ water 
in the concentrations and order that they appear in Table 7-1.   The second step was 
to construct the lipid stock, which was a concentrated mix of pure lipids dissolved 
into hexane and ethyl ether in their desired ratios.  The lipid stock can be prepared 
in advance and then stored at -20oC prior to use.  The third step in the ATS 
preparation was dissolving the lipid stock into complex salt solution, drive in 
nitrogen gas and sonicate for at least 30 minutes to complete the lipid tear solution.  
This process ensures that the lipid was well mixed into the saline solution and 
confirms that the hexane and ether were evaporated.  The fourth step was to 
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incorporate the radioactive lipid, which was used as an experimental tracer.  The 
radiolabeled cholesterol and phosphatidylcholine was added to the ATS at a 
concentration of 5.6% and 27% of the total individual lipid concentration 
respectively. Following an additional 15 minutes of sonication, the protein/mucin 
were then dissolved into the solution and sonicated for an additional 5 minutes.  
The radioactive lipid details can be found in Table 7-2. 
 
TABLE 7-1: ARTIFICIAL TEAR SOLUTION COMPONENTS FOR THE OPEN-INCUBATION SYSTEM 
Salt component mM Lipid Component 
Concentration 
(mg/mL) 
Sodium chloride 110.0 Cholesterol 0.0018 
Potassium chloride 16.0 Cholesteryl oleate 0.024 
Sodium citrate 1.5 Oleic acid 0.0018 
Glucose 0.2 Oleic acid methyl ester 0.012 
Urea 1.2 Phosphatidylcholine 0.0005 
Calcium chloride 0.5 Triolein 0.016 
Sodium carbonate 12.0   
Potassium hydrogen carbonate 3.0 Protein Component 
Concentration 
(mg/mL) 
Sodium phosphate monobasic 26.0 Bovine Albumin 0.20 
Hydrochloric acid (10 M) 2.33 Hen Egg Lysozyme 1.90 





TABLE 7-2: RADIOACTIVE LIPID CHARACTERISTICS 












Supplier Perkin-Elmer Perkin-Elmer 
 
7.3.2 CONTACT LENS MATERIALS 
Six contact lens materials were tested in triplicate: Acuvue® 2 [etafilcon A; 
Vistakon], Proclear® [omafilcon A; CooperVision], Acuvue® OASYS™ [senofilcon A; 
Vistakon], Air Optix™ [lotrafilcon B; Ciba Vision], Biofinity® [comfilcon A; 
CooperVision], PureVision™ [balafilcon A; Bausch & Lomb]. The material 




TABLE 7-3: CONVENTIONAL HYDROGEL CONTACT LENS MATERIAL CHARACTERISTICS 
Material Type Conventional Hydrogel 
USAN Etafilcon A Omafilcon A 
Proprietary name Acuvue®2 Proclear® 
Manufacturer Johnson & Johnson CooperVision 
Monomers HEMA, MA HEMA, PhC 
Surface Modification None None 
Oxygen Transmissibility (x10-9) 31.0 52.3 
Water Content 58% 62% 
FDA Class Group IV Group II 
USAN: United States adopted name; DMA (N,N-dimethylacrylamide);  
HEMA (poly-2-hydroxyethyl methacrylate); MA (methacrylic acid); PhC (phosphorylcholine) 
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TABLE 7-4: SILICONE HYDROGEL CONTACT LENS MATERIAL CHARACTERISTICS 
Material Type Silicone Hydrogel 
USAN Senofilcon A Lotrafilcon B Comfilcon A Balafilcon A 
Proprietary name Acuvue® OASYSTM Air OptixTM Biofinity® PureVisionTM 
Manufacturer Johnson & Johnson CIBA Vision CooperVision Bausch & Lomb 
Monomers 






M3U, FM0411M, HOB, 
IBM, NVP, TAIC, 
VMA 
NVP, TPVC, NVA, PBVC 
Surface 
Modification 





None Plasma oxidation 
Dk/t (x10-9) 147 138 160 110 
Water Content 38% 33% 48% 36% 
FDA Class Group I Group I Group I Group III 
Dk/t: oxygen transmissibility; USAN: United States adopted name; DMA (N,N-dimethylacrylamide); EGDMA (ethyleneglycol dimethacrylate); FM0411M (2-ethyl [2-[(2-
methylprop-2-enoyl)oxy]ethyl]carbamate); HEMA (poly-2-hydroxyethyl methacrylate); HOB ((2RS)-2-hydroxybutyl 2-methylprop-2-enoate); IBM (Isobornyl 
methacrylate); M3U (α-[[3-(2-[[2-(methacryloyloxy)ethyl] carbamoyloxy]ethoxy)propyl]dimethylsilyl]-ω-[3-(2-[[2-(methacryloyloxy)ethyl] 
carbamoyloxy]ethoxy)propyl]poly([oxy[(methyl) [3-[ω-methylpoly(oxyethylene)oxy]propyl]silylene] /[oxy[(methyl)(3,3,3-trifluoropropyl)]silylene]/oxy 
(dimethylsilylene)])); mPDMS (monofunctional polydimethylsiloxane); NVA (N-vinyl aminobutyric acid); NVP (N-vinyl pyrrolidone); PBVC (poly[dimethysiloxy] di 
[silylbutanol] bis[vinyl carbamate]); PVP (poly(vinylpyrrolidone)); TAIC (1,3,5-triprop-2-enyl-1,3,5-triazine-2,4,6(1H,3H,5H)-trione); TPVC (tris-(trimethylsiloxysilyl) 




7.3.3 MODEL BLINK CELL 
 
 The “model blink cell” (MBC) is a device specially designed and built in our 
laboratory to mimic the inter-blink period during contact lens wear (Figures 7-2 and 
7-3).  The blink cell itself is composed of a trough with contact lenses mounted on 
six form-fitting Teflon® pistons (Figure 7-1) connected to a motor that cycles the 
pistons in and out of the artificial tear solution contained in the trough. The cycling 
of the pistons is programmable so that a desired blink frequency can be chosen. The 
model blink cell itself is contained within a temperature and humidity controlled 
















FIGURE 7-2: A DRAWING OF THE MODEL BLINK CELL 
REMOVED FROM THE ATMOSPHERIC CHAMBER 
FIGURE 7-1: THE FORM-FITTING 
PISTON TO HOLD THE CONTACT 
LENSES. A CIRCULAR RING IS 
FITTED OVERTOP THE PISTON 
TO KEEP THE CONTACT LENS IN 






7.3.4 EXPERIMENTAL DESIGN 
All contact lens materials were soaked in saline with agitation for 24 hours to 
remove the blister pack solution components. Following pre-soaking, the lenses 
were blotted on lens paper before mounting onto the pistons in the MBC.   
Two identical model blink cell units were presoaked with ATS without 
radioactivity for at least 48 hours to reduce any non-specific binding to the MBC of 
lipid and proteins in subsequent incubations. When the contact lenses were ready 
for incubation, the ATS was replaced with fresh ATS containing a single radioactive 
lipid. Three replicates of two contact lens types were incubated in each unit. One 
unit cycled the lenses in and out of ATS (referred to as “air exposed”) and the lenses 
in the other unit remained submerged for the duration of the experiment 
(“submerged”). The blink rate was set such that the lenses were submerged for 2 
seconds and then were out of solution and exposed to the atmosphere for 5 seconds. 
FIGURE 7-3: LABELED PHOTOGRAPH OF THE MODEL BLINK CELL 
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The atmosphere in the chamber was set at 36°C ± 1°C and had a relative humidity of 
16% ± 1%. Both MBC units were filled with 18 mL of ATS solution, containing a 
single tracer of radioactive (cholesterol or phosphatidylcholine). To compensate for 
solution evaporation, both units were refilled as needed, maintaining appropriate 
osmolality and final volume. Uniformity of the ATS between the units was achieved 
by pooling ATS from both units during the refill. 
 
7.3.4.1 SHORT-TERM INCUBATION 
The first experimental test mimicked wear of a daily disposable contact lens 
with one 10 hour incubation period.  This short-term test was conducted with both 
radioactive lipids and all lens materials. Following the 10 hour incubation in either 
the submerged or air exposed model blink cell the lenses were removed and 
processed as described below. 
 
7.3.4.2 LONG-TERM INCUBATION 
The long-term incubation experiment was tested on balafilcon A and 
lotrafilcon B contact lens materials for six days to mimic extended wear conditions.  
Air exposed lenses in this experiment were cycled in and out of the solution for 14 
hours (to mimic wear time) and were then submerged for the 10 hours (to mimic 
the overnight wear). This cycle was repeated for each of the 6 days.  Submerged 
lenses were simply submerged for the entire 6 days.  Fresh radioactive ATS replaced 
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the used solution every other day. Following the long-term incubations, the lenses 
were removed and processed as will be described next. 
 
7.3.5 PROCESSING OF CONTACT LENSES 
At the end of the incubation, the lenses were removed, rinsed in saline and 
extracted twice with 2 mL of chloroform: methanol (2:1, v/v) for three hours at 37oC 
with constant shaking. The extracts were dried under nitrogen and re-suspended in 
1 mL of chloroform, and 10 mL of Ultima Gold F scintillation cocktail then counted 
using the LS6500 Beckman Coulter beta counter. In the experiment, the radioactive 
lipid was used as a probe and the ratio of radioactive lipid to non-radioactive lipid in 
the incubating ATS was kept constant.  Therefore, quantification of the total amount 
of cholesterol and phosphatidylcholine deposited was extrapolated and calculated 
using standard radioactive lipid calibration curves. 
 
7.3.6 STATISTICAL ANALYSIS 










Exposure to air significantly increased (p≤0.03) the amount of cholesterol 
deposited on most lenses (omafilcon A; balafilcon A; comfilcon A; senofilcon A), with 
lotrafilcon B and etafilcon A depositing lower (but statistically identical) amounts 
(Table 7-5 and Figure 7-4). The order of cholesterol deposits in submerged lenses 
was omafilcon A = etafilcon A = lotrafilcon B = senofilcon A = comfilcon A <balafilcon 
A.   Air exposure for cholesterol deposits occurred in the following order:  etafilcon 
A < lotrafilcon B < senofilcon A < omafilcon A < comfilcon A < balafilcon A.   As can 
be seen from Table 7-5, the air exposed lenses generally deposited 1.6-4.3x more 
cholesterol than the submerged lenses, except for etafilcon A and lotrafilcon B 
materials, which deposited equal or slightly less cholesterol.   
 
TABLE 7-5: CHOLESTEROL UPTAKE AFTER 10 HOURS ON VARIOUS LENS MATERIALS (NG/LENS ± 
SD) SUBMERGED OR AIR EXPOSED.  T-TESTS (N=3) WERE PERFORMED AND A P VALUE <0.05 WAS 
CONSIDERED SIGNIFICANTLY DIFFERENT. 
Lens Material 
Submerged (A) 
(ng/lens ± SD) 
Air-Exposed (B) 
(ng/lens ± SD) 
B ÷ A p 
Etafilcon A 9.5 ± 3.0 7.4 ± 1.7 0.78 0.349 
Omafilcon A 7.7 ± 7.2 22.2 ± 5.7 2.88 0.014 
Balafilcon A 40.3 ± 16.6 90.6 ± 20.6 2.25 0.030 
Comfilcon A 12.4 ± 2.2 53.4 ± 17.0 4.31 0.014 
Lotrafilcon B 11.1 ± 0.7 10.6 ± 0.9 0.95 0.487 




FIGURE 7-4: CHOLESTEROL UPTAKE AFTER 10 HOURS ON VARIOUS LENS MATERIALS 
 
 
The longer term incubation was tested for both balafilcon A and lotrafilcon B 
lenses.  These specific lenses were chosen as they are both approved for at least 6 
days of continuous wear and they represented the two extremes of silicone hydrogel 
lens deposition in the short-term 10 hour experiment, both in quantity of 
cholesterol deposited and in the effect of air exposure. After 6 days of incubation in 
the MBC both lens material exhibited a statistically significant increase in 
cholesterol deposition in the air exposed lenses (p<0.011) and both materials had 
deposited significantly more cholesterol when compared with the 10 hour 
experiment (Table 7-6 and Figure 7-5).  Once again, balafilcon A lenses deposited 







deposited 2.8x more cholesterol on balafilcon A and 1.8X more cholesterol on 
lotrafilcon B materials. 
 
TABLE 7-6: CHOLESTEROL UPTAKE AFTER 6 DAYS ON TWO CONTACT LENS MATERIALS (NG/LENS 
± SD) SUBMERGED OR AIR EXPOSED.  T-TESTS (N=3) WERE PERFORMED AND A P VALUE <0.05 
WAS CONSIDERED SIGNIFICANTLY DIFFERENT.  
Lens Material 
Submerged (A) 
(ng/lens ± SD) 
Air-Exposed (B) 
(ng/lens ± SD) 
B ÷ A p 
Balafilcon A 227.71 ± 69.68 646.87 ± 98.75 2.84 0.011 
Lotrafilcon B 102.78 ± 10.85 189.30 ± 23.93 1.84 0.005 
 










For all lenses, air exposure resulted in higher levels of phosphatidylcholine 
(PC) being deposited. These levels were statistically significantly higher (p<0.04) for 
the neutral charge FDA Group I (lotrafilcon B, senofilcon A, comfilcon A) and II 
lenses (omafilcon A) exposed to air.  However, no differences in deposition were 
found (p>0.05) for the ionic FDA Group III (balafilcon A) or IV (etafilcon A) lens 
materials (Table 7-7 and Figure 7-6).  
The masses deposited were all low, reflecting the low concentration of PC in 
the solution.  The relative increase of PC on air-exposed lenses is smaller than the 
effect seen with cholesterol, in the range of 17% more for senofilcon A and up to 
60% more for omafilcon A (Table 7-7).  The order of deposition for submerged 
lenses was etafilcon A < omafilcon A < comfilcon A < lotrafilcon B < senofilcon A < 
balafilcon A.  Exposing the lenses to air resulted in the following order of PC 





TABLE 7-7: PHOSPHATIDYLCHOLINE UPTAKE AFTER 10 HOURS ON VARIOUS LENS MATERIALS 
(NG/LENS ± SD) SUBMERGED OR AIR EXPOSED.  T-TESTS (N=3) WERE PERFORMED AND A P VALUE 
<0.05 WAS CONSIDERED SIGNIFICANTLY DIFFERENT. 
Lens Material 
Submerged (A) 
(ng/lens ± SD) 
Air-Exposed (B) 
(ng/lens ± SD) 
B ÷ A p 
Etafilcon A 1.3 ± 0.9 1.4 ± 0.4 1.08 0.831 
Omafilcon A 1.5 ± 0.4 2.4 ± 0.2 1.60 0.006 
Balafilcon A 5.3 ± 2.5 6.3 ± 1.1 1.19 0.579 
Comfilcon A 2.1 ± 0.1 3.0 ± 0.1 1.43 0.001 
Lotrafilcon B 3.1 ± 0.4 4.7 ± 0.4 1.52 0.008 
Senofilcon A 3.4 ± 0.2 3.9 ± 0.2 1.15 0.032 
 
FIGURE 7-6: PHOSPHATIDYLCHOLINE UPTAKE AFTER 10 HOURS ON VARIOUS LENS MATERIALS 









Examining lipid deposition on contact lenses in an in vitro model system helps 
researchers and developers to gain an understanding of the processes and 
interactions that occur in vivo.   Our laboratory has developed a blink-cell model to 
simulate the inter-blink tear film thinning and drying that occurs during the inter-
blink period of contact lens wear.  This model has demonstrated that a change in the 
kinetics of lipid deposition occurs when incubating contact lenses using this 
intermittent air-exposure method versus incubating lenses in a fully submerged 
aqueous environment.   
This experiment specifically found that the effect of intermittent air exposure 
on lipid deposition is both lipid and lens material dependent.  For example, etafilcon 
A lens materials did not differ from control values when this material was exposed 
to air during the blink cycle for either lipid examined. However, omafilcon A, 
senofilcon A and comfilcon A all deposited significantly more cholesterol and PC 
when incubated with intermittent air exposure.  Balafilcon A, showed no statistical 
differences in deposition with PC but did with cholesterol.  In contrast, lotrafilcon B 
had the opposite occurrence with the 10 hour incubation, but when lotrafilcon B 
was incubated to mimic 6 days of continuous wear, significantly higher cholesterol 
deposition was found.   
Cholesterol deposition increased for all lens materials when intermittently 
exposed to air, with the exception of etafilcon A.  Overall, PC deposition increased on 
all lens materials when exposed to air, however only four of the six materials had 
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statistically significant differences.  Once again, etafilcon A was one of the 
statistically unaffected lenses. Etafilcon A is well known as a material which deposits 
little amounts of lipid but deposits large amounts of lysozyme, due to its hydrophilic 
hydroxyl moieties.13 Therefore, it is not a surprise that its lipid deposition profile is 
not easily manipulated for either cholesterol or PC. The second lens which was 
found to have no statistical difference in PC deposition when exposed to air was 
balafilcon A, which may be due to larger standard deviations in the data. On average, 
exposure to air had a larger impact on cholesterol deposition when compared to PC 
deposition and lens materials deposited more cholesterol, on average, than PC.   
The deposition of both cholesterol and PC in this experiment is lower than 
other in vitro and ex vivo experiments conducted.4, 5, 16, 22, 23  There are several 
reasons for this: first, the experimental procedure tested for all lenses was the short 
term (10 hour) incubation, without replenishment of the solution, which is a shorter 
incubation time than most other in vitro experiments. The short time frame was 
used to mimic the wear time on a daily disposable lens and was utilized to 
determine the impact that air exposure has on lipid deposition.  If statistical 
differences in deposition could be found after only 10 hours of incubation then it 
can be deemed a significant effect and longer incubation times would be expected to 
find greater masses of deposition and similar if not greater deposition effects with 
air exposure. Secondly, phosphatidylcholine deposition was very low, which is likely 
due to its low concentration in the ATS. Lastly, the model blink cell will favour 
anterior surface deposition and discourage deposition on the posterior surface.  
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This is because the lens needs to be clipped in place with a specially designed ring 
manufactured to fit on the model blink cell pistons.  Due to its structure, this ring 
will reduce the flow of ATS beneath the lens and it will also reduce the anterior lens 
surface area exposed and available for deposition.  All of these factors together 
explain the lower deposition found in this in vitro model. Although the tear film 
exchange on the posterior side of human-worn soft lenses is reduced when 
compared to rigid lenses, there is still much more movement and tear film exchange 
than in the model blink cell due to lens movement during blinking.  
It is hypothesized that the exposure to air increases the lipid deposition on 
conventional and silicone hydrogel lens materials due to their polymer mobility and 
chain rotation, as mentioned previously.  This chain rotation or hysteresis can be 
analyzed while measuring wettability through advancing and receding contact angle 
measurements such as sessile drop, captive bubble or Wilhelmy plate techniques, 
just to name a few.24  In human contact lens wear, immediately following a blink, the 
lens is immersed in the tear film and lenses hydrophilic moieties face outward with 
the hydrophobic back bone situated within the matrix.24  As the period between 
blinks grows longer, the tear film begins to thin and then break over the surface of 
the contact lens bringing the lipid layer and then air into direct contact with the lens 
material.  When the lens is exposed to lipid and/or air the previous lens polymer 
arrangement becomes undesirable and the hydrophilic groups will rotate inward to 
expose the materials’ hydrophobic backbone to the air.24 This then encourages lipid 
to deposit and then the air exposure will drive the lipid into the lens matrix. Once 
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another blink occurs, the hydrophilic polymer moieties will again flip to the anterior 
surface.  This occurrence is especially true for lenses which have higher contact 
angles and for a contact lens wearer with dry eyes, more unstable tear films, and 
thus shorter tear break up times. This wetting/de-wetting cycle can occur after 
every blink and therefore thousands of times a day, thus allowing lipid to 
continuously accumulate on and in the lens material. 
In the 1990’s, Bontempo and Rapp’s in vitro studies found that FDA Group II 
lens materials were the lens materials that were prone to the highest masses of lipid 
deposition.1 They therefore published a theory for lipid deposition on conventional 
hydrogel contact lens materials called the “push/pull” theory.1 The theory outlined 
that the forces involved in lipid deposition onto conventional hydrogel lenses were 
the material, which pulled lipid in to the lens, and the water component, that pushed 
the lipid into the matrix of the lens.1 This theory can be modified for silicone 
hydrogel lens materials as the incorporation of silicone will provide a strong pull of 
lipid into the lens material and then the lipid is forced to “hide” within the matrix 
due to air exposure during the inter-blink period.  This creates a more powerful 
push/pull dynamic for lipid deposition on silicone hydrogel lens materials. The 
mechanism of lipid deposition introduced here, is much different than experienced 
with in-vial incubations. During in-vial incubations, the lens remains in an aqueous 
environment and the deposition is mainly driven by hydrophobic/hydrophilic 
interactions with the lens and the ATS.   
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To-date, the effect of intermittent air exposure on in vitro lipid deposition on 
contact lens materials has not been examined. Peters and Millar analyzed the 
stabilizing effects of phospholipids on tear break up time (TBUT) using a Tearscope 
and a very complex upright model blink eye system.25 Their blinking model eye held 
a contact lens and was able to spread ATS over the surface of the contact lens using 
a solenoid and an artificial eyelid.  However, this study only examined TBUT and 
lipid deposition was not examined.  In 2004, Copley and Radke presented a poster at 
the Association of Research in Vision Science and Ophthalmology (ARVO) 
conference which outlined an experiment that used a model blink to analyze the 
wettability of lens materials.26 Their model included a blink cell that held a single 
contact lens and the ATS used was pumped in and out of the cell, thus raising and 
lowering the liquid levels. In this experiment a layered ATS was used by spreading a 
single lipid layer on the anterior surface of the liquid.26  Once again, lipid deposition 
was not quantified or compared with in-vial incubations.26  
In vitro models for lipid deposition onto various contact lens materials have 
proven to be valuable for the examination of extraction efficiency (Chapter 4), the 
effect the tear film composition (Chapter 5),18 the effects of ATS concentration,20 the 
effect of ATS replenishment (in house data), the effect of incubation time19 and the 
efficiency of hydrogen peroxide solutions to remove lipid from contact lens 
materials (Chapter 6).   
The model blink cell unit introduced in this paper has effectively modeled the 
exposure to air experienced by contact lenses during the inter-blink period.  Further 
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work is needed to determine if the changes in deposition are a phenomenon specific 
to early stages of deposition or if the effects are cumulative over a longer period of 
time for all lens materials and lipids.  It also may be interesting to see if the lenses 
incubated with the model blink cell contain a higher mass of oxidized lipids than 
conventional in-vial incubations and to compare that to ex vivo lens data.  
Additionally, since the model blink cell elicits a different mode of deposition than in-
vial incubations, it may be prudent to examine the depth of lipid penetration into 
the lens matrix using both incubation models.  
The ATS used in this experiment was a homogenous mix of all incorporated 
components and did not incorporate the human biophysical tear film structure. It is 
well known, that the human tear film is composed of three main phases: the anterior 
lipid layer, the larger aqueous phase and the mucin glycocalyx phase that covers the 
epithelium.27-29 The model blink cell unit could support a layered ATS, with 
mechanical modifications, to make the device similar to a Langmuir trough.  It 
would be of great interest to see if the deposition pattern and masses deposited 
differed with a change in ATS structure. The experiment presented here, was a pilot 
study for this device and therefore further experimentation is needed. 
It is true that an in vitro model will never be able to fully mimic human contact 
lens wear, as there are just too many variables and individual differences in 
home/work environment, diet, disease and tear film composition.  However, the 
incorporation of a complex ATS and now air exposure has increased the validity of 




In conclusion, this in vitro blink cell model has demonstrated that lipid 
deposition kinetics can be impacted by air exposure and that lipid deposition 
profiles are contact lens and lipid dependent. In vitro models must begin to use 
more physiologically relevant incubation solutions and conditions that mimic 
contact lens wear within the natural tear film if in vitro data is to be extrapolated to 
the in vivo situation.  These methodologies will provide hitherto unavailable 
information on the way in which lipid interacts with silicone hydrogel materials and 
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8 OVERALL DISCUSSION AND CONCLUSIONS 
Since the release of silicone hydrogel contact lens materials on the market in 
1999, practitioners and researchers around the world have found that these 
materials are more prone to lipid deposits in the form of calculi and oily films, when 
compared to the traditional conventional hydrogel materials.1-4 It is well known that 
silicone hydrogels, with their incorporation of siloxane groups are more 
hydrophobic and less wettable and therefore more prone to lipid deposition. 5-7  
Many companies have therefore incorporated a wetting agent or surface coating to 
reduce the hydrophobic effect of their lenses.   
Historically, lipid deposition has not been the focus of extensive research as 
conventional hydrogel materials are hydrophilic and more susceptible to protein 
deposition, especially for group IV materials.3, 8-17 For this reason, there has been a 
relative dearth of information on lipid deposition, the factors that influence it, and 
its impact on lens wear.  Now that silicone hydrogels have been on the market for 
over ten years and are becoming a popular choice for lens wearers around the 
world, researchers are scrambling to assess all of the factors that influence lipid 
deposition and how to manage it.  
It is clear that a vast amount of research needs to be completed to even begin 
to comprehend the complex interactions that occur during human contact lens 
wear. Therefore, many researchers have begun to conduct both in vitro and ex vivo 
experiments to assess the many unanswered questions.  There are many advantages 
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and disadvantages of conducting both in vitro and ex vivo studies.  Some of the main 
advantages of in vitro research are that all of the variables in the system can be 
controlled, unique experimental techniques can be utilized that may not be suitable 
for clinical studies, and that in vitro models can be as complex or simplistic as 
required.  The main purpose of the research conducted in this thesis was to start 
from the beginning and to slowly, yet systematically build up a model for lipid 
deposition which incorporates and analyzes the many different interactions and 
variables. 
The optimization and assessment of a new artificial tear solution was 
described in Chapter 3. In this chapter, the formulation for an updated incubation 
solution was tested for its chemical stability, physical stability, and for the lens 
parameter stability following incubation.  Lipid deposition onto two different lens 
materials following incubation in two different artificial tear solution iterations was 
also examined.  From the plethora of small individual experiments conducted it was 
found that the optimized complex artificial tear solution remains stable in its pH, 
osmolality, homogeneity, and surface tension throughout a four week incubation. 
When various contact lenses are incubated within this solution, their base curve, 
centre thickness, and diameter remain stable with no clinically significant changes.  
When lipid deposition was examined using a radiochemical experiment, it was 
found that the addition of lactoferrin and immunoglobulin G to the ATS significantly 
increased deposition. Overall, the cholesterol and phosphatidylcholine deposition 
was lower than other in vitro and ex vivo lipid deposition publications; however 
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differences in protocol were noted.  Despite this, the hierarchy of deposition on the 
various lens materials was consistent with other studies.  
The efficiency of (2:1) chloforom:methanol as a lipid extraction method was 
assessed on both silicone hydrogel and conventional hydrogel lenses for both model 
lipids in Chapter 4.  Through the use of radiolabeled lipids, both of the model lipids 
could be assessed for their extraction from several contact lens materials by 
calculating the lipid remaining in the used incubation solutions. Overall, it was 
determined that three extractions of 3 hrs at 37°C in 2 mL of (2:1) chloroform: 
methanol delivered an extraction efficiency of >90% for all lens materials examined.  
This (2:1) chloroform: methanol protocol was found to be efficacious for 
phosphatidylcholine extraction for four out of the six lens materials, however 
lotrafilcon B and balafilcon A had extraction efficiencies ≤85%.  Therefore, three 
other extraction methods were examined to see if the lipid recovery and thus the 
extraction efficiency could be improved.  Ultimately, it was found that extractions of 
3 hrs at 37°C in 2 mL of (60:50:1:4) chloroform: methanol: acetic acid: water were 
able to increase phosphatidylcholine extraction efficiency to approximately 100%.  
This experiment revealed the need that all lens materials being utilized have to be 
tested with the corresponding extraction protocol, as different lens materials may 
bind lipids with different strengths. 
The effect of artificial tear solution composition on cholesterol and 
phosphatidylcholine deposition after 3 and 14 days of incubation was assessed in 
chapter 5.   Balafilcon A, senofilcon A and etafilcon A contact lens materials were 
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incubated in four different compositions and complexities of artificial incubation 
solutions using radiochemical experiments.  The four artificial tear solutions tested 
were: a single lipid tear solution (SLTS), a lipid tear solution (LTS) containing five 
common lipids, a protein tear solution (PrTS) and an artificial tear solution (ATS) 
containing the LTS and the PrTS, at physiological concentrations.  It was found that 
the incubation solution composition had a profound effect on the deposition profile 
of each radioactive lipid and the pattern of deposition was directly correlated to the 
contact lens properties, lipid properties, and interactions between the solution 
components.  The experiment supported the theory that single component and even 
moderately complex artificial tear solutions have a very different effect on lipid 
deposition when compared with a fuller tear solution containing a range of lipids, 
proteins, and mucin.  
The sensitivity and reliability of the radiochemical protocol and the ability for 
hydrogen peroxide solutions to remove lipid from contact lenses was examined in 
Chapter 6.  Lenses were incubated in the artificial tear solution daily for eight hours 
and then either stored or cleaned with one of two commercially available hydrogen 
peroxide cleaning solutions for the remaining sixteen hours.  This cycle was 
continued for one week and then the lenses were extracted and cholesterol and 
phosphatidylcholine was quantified.  Both ClearCare and AOSept hydrogen peroxide 
solutions both showed decreased deposition over the control, however the 
improvement was minimal and possibly not clinically relevant. 
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Chapter 7 probed the effect of intermittent air exposure on lipid deposition 
using a custom-built model blink cell. Due to the hydrophobicity and ease of 
polymer chain rotation for silicone hydrogel lenses, it was found that most lenses 
exposed to air experienced an increase in cholesterol and phosphatidylcholine 
deposition after a 10 hour cycling period when compared with lenses that were 
simply submerged for the incubation period.  This model blink cell device was 
designed to mimic the effect of tear film breaking in between blinks during human 
contact lens wear and this study found that lipid deposition increases as tear break 
up time decreases.    
Overall, this thesis has contributed greatly to our understanding of lipid 
deposition and the in vitro model built here can be utilized in various ways in the 
future to assess other aspects and variables of lipid and protein deposition.  For 
instance, the model developed here has already been used to assess the effect of 
lipid concentration in the incubation solution on lipid deposition, the kinetic uptake 
of lipids on a range of materials, and the effect of replenishing the incubation 
solution on deposition.18, 19  
Future research using the model blink cell alone has a vast range of abilities in 
the ophthalmic industry including: assessing the penetration profile of lipids during 
submersion and intermittent air exposure with fluorescently tagged lipids, tear film 
stability and tear break up time and the factors that effect it, the release of 
pharmaceuticals from contact lenses, the effect of air exposure and light on lipid 
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deposition, the ability of contact lens cleaning solutions to remove lipid from 
various lens materials, and the substantivity of surfactants on contact lens materials.   
In general, future research in lipid deposition should focus on how the 
deposited lipid changes in structure and how the contact lens surface and matrix 
change because of deposition.  Other questions to be examined include: Does UV 
light, exposure to aerosols and chemicals in disinfecting and multipurpose solutions 
create oxidized lipids and by-products which can signal an inflammatory response?  
Do oxidized lipids and their by-products affect comfort of a contact lens?  How much 
lipid should remain on a contact lens following cleaning and which lipids should be 
preferentially removed?  What effect do various pharmaceuticals have on meibum 
composition and contact lens wear? Does lipid preferentially deposit in the 
periphery or central portion of the lens? What effect does MGD treatment have on 
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contact the original author of the articles to obtain their permission for use of the 
figures? 
Thank you again 
Holly 
 
From: Essenpreis, Alice, Springer DE [mailto:Alice.Essenpreis@springer.com] 
Sent: October 17, 2011 9:51 AM 
To: hmelchin@sciborg.uwaterloo.ca 
Subject: WG: Use of a couple of figures 
--> 
Dear Ms. Lorentz, 
Thank you for your e-mails. 
We were attending the Frankfurt Book Fair last week, therefore, the delayed reply. 
With reference to your request to reprint in your thesis material on which Springer 
Science and Business Media control the copyright, permission is granted, free of 
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charge, for the use indicated in your enquiry. Licenses are for one-time use only 
with a maximum distribution equal to the number that you identified in the 
licensing process. 
 
This License includes use in an electronic form, provided it is password protected or 
on the university's intranet, destined to microfilming by UMI and University 
repository. For any other electronic use, please contact Springer at 
(permissions.heidelberg@springer.com) 
 
The material can only be used for the purpose of defending your thesis, and with a 
maximum of 100 extra copies in paper. 
 
Although Springer holds copyright to the material and is entitled to negotiate on 
rights, this license is only valid, provided permission is also obtained from the (co) 
author (address is given with the article) and provided it concerns original material 
which does not carry references to other sources (if material in question appears 
with credit to another source, authorization from that source is required as well). 
Permission free of charge on this occasion does not prejudice any rights we might 
have to charge for reproduction of our copyrighted material in the future. 
Springer Science + Business Media reserves all rights not specifically granted in the 
combination of (i) the license details provided by you and accepted in the course of 
this licensing transaction, (ii) these terms and conditions and (iii) CCC's Billing and 
Payment terms and conditions. 
 
Please include the following copyright citation referencing the publication in which 
the material was originally published. Where wording is within brackets, please 
include verbatim. 
"With kind permission from Springer Science+Business Media: <journal title, article 
title, volume, year of publication, page, name(s) of author(s), figure number(s), and 
any original (first) copyright notice displayed with material>." 
 
This license is personal to you and may not be sublicensed, assigned, or transferred 







Rights and Permissions 
_ 
Tiergartenstrasse 17 | 69121 Heidelberg GERMANY 







Von: Holly Lorentz [mailto:hmelchin@sciborg.uwaterloo.ca] 
Gesendet: Dienstag, 11. Oktober 2011 09:31 
An: Permissions Heidelberg, Springer DE 
Betreff: Use of a couple of figures 
Hello 
I am currently writing up my PhD thesis and would like to use a couple figures from 
a couple different journal articles in my thesis introduction. 
 
I tried going on the Copyright Clearance RightsLink – but it instructed me to contact 
Springer directly. 
 
I would like to use: 
1) Figure 5 (morphology of a single meibomian gland) from Knop N, Knop E. 
[Meibomian glands. Part I: anatomy, embryology and histology of the Meibomian 
glands] Meibom-Dru¨sen Teil I: Anatomie, Embryologie und Histologie der Meibom- 
Dru¨sen. Ophthalmologe.2009;106:872–883. 
2) Figure 4 (pathophysiology of obstructive MGD) from Knop E, Knop N. 
[Meibomian glands, Part IV: functional interactions in the pathogenesis of 
meibomian gland dysfunction (MGD).] Meibom-Dru¨sen, Teil IV: Funktionelle 
Interaktionen in der Pathogenese der Dysfunktion (MGD). Ophthalmologe. 
2009;106:980–987 
 
For both figures I wish to use the English versions as published in Knop E, Knop N, 
Millar T, Obata H, Sullivan DA. The international workshop on meibomian gland 
dysfunction: report of the subcommittee on anatomy, physiology, and 
pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci. 2011 
Mar;52(4):1938-78. 
 
Please let me know if I have permission to use these two figures, how you want me 




Holly Lorentz BSc, MSc 
PhD Candidate in Vision Science 
Centre for Contact Lens Research 
School of Optometry 
University of Waterloo 
200 University Avenue West 
Waterloo, Ontario, Canada N2L 3G1 
1-519-888-4567 




ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY 
From: Debbie Chin 
To: Holly Lorentz 
Subject: RE: Use of a couple figures in my PhD thesis 
Date: October 4, 2011 11:43:43 AM 
--> 
Dear Dr. Lorentz, 
 
The two figures from the Knop article (#1 and #3 in your email) were reprinted 
from a different journal. You will need to obtain permission from them to use the 






Permission is granted to reprint the following figure in your PhD thesis: 
Figure 1 from Green-Church KB, Butovich I, Willcox M, Borchman D, Paulsen F, 
Barabino S, Glasgow BJ. The International Workshop on Meibomian Gland 
Dysfunction: Report of the Subcommittee on Tear Film Lipids and Lipid-Protein 
Interactions in Health and Disease. Invest Ophthalmol Vis Sci. 
2011;52:1979-1993. 
 
A reprint of the material must include a full article citation and acknowledge ARVO 





Association for Research in Vision and Ophthalmology 
1801 Rockville Pike, Suite 400 
Rockville MD 20852 USA 
Direct: +1.240.221.2926 | Main: +1.240.221.2900 | Fax: +1.240.221.2370 
www.arvo.org 
2012 ARVO Annual Meeting 
May 6 – 10 | Fort Lauderdale, Florida 
www.arvo.org/am 
--- 
From: Holly Lorentz [mailto:hmelchin@sciborg.uwaterloo.ca] 
Sent: Monday, October 03, 2011 2:58 PM 
To: Debbie Chin 
Subject: RE: Use of a couple figures in my PhD thesis 
Hello Debbie 





The figures I wish to use as part of my PhD thesis are the following: 
Figure 3 (morphology of a single meibomian gland) from: Knop E, Knop N, Millar T, 
Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: 
report of the subcommittee on anatomy, physiology, and pathophysiology of the 
meibomian gland. Invest Ophthalmol Vis Sci. 2011 Mar;52(4):1938-78. 
 
Figure 1 (A proposed model of the precorneal tear film…) from: Green-Church KB, 
Butovich I, Willcox M, Borchman D, Paulsen F, Barabino S, et al. The international 
workshop on meibomian gland dysfunction: report of the subcommittee on tear film 
lipids and lipid-protein interactions in health and disease. Invest Ophthalmol Vis Sci. 
2011 Mar;52(4):1979-93. 
 
Figure 25 (pathways and proposed sequence of events …) Knop E, Knop N, Millar T, 
Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: 
report of the subcommittee on anatomy, physiology, and pathophysiology of the 
meibomian gland. Invest Ophthalmol Vis Sci. 2011 Mar;52(4):1938-78. 
 
Please let me know how you wish me to cite and acknowledge IOVS and ARVO for 







OPTOMETRY AND VISION SCIENCE 
From: Zadnik, Kurt 
To: Holly Lorentz 
Subject: RE: Permission for use of my own article 
Date: October 3, 2011 2:52:28 PM 
--> 
Hi Holly, 




Optometry and Vision Science 
Kurt A. Zadnik, Managing Editor 
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The Ohio State University, College of Optometry 
338 West 10th Avenue 
Columbus, OH 43210 




From: Holly Lorentz [mailto:hmelchin@sciborg.uwaterloo.ca] 
Sent: Monday, October 03, 2011 2:48 PM 
To: Zadnik, Kurt 
Subject: Permission for use of my own article 
Hi Kurt 
Thank you very much for this permission. I do want to make one amendment to my 
request: I would like to be able to use the entire section subtitled “lipid deposition 
on contact lens materials”, including Figures 2,3 and 4 from my paper: Lipid 
deposition on hydrogel contact lenses: how history can help us today. Optom Vis Sci 
2007;84:286-95. 
Of course I will use the citation you listed:  
“Reproduced with permission from: Lorentz H, Jones L. Lipid deposition on hydrogel 
contact lenses: how history can help us today. Optom Vis Sci 2007;84:286-95. ©The 
American Academy of Optometry 2007.” 
Please confirm that this is still approved – This description will better cover the 




From: Zadnik, Kurt [mailto:ovs@osu.edu] 
Sent: September-27-11 12:53 PM 
To: Holly Lorentz 
Subject: RE: Permission for use of my own article 
--> 
Hi Holly, 
Permission is granted to use the excerpt and figures, as described, from your 
original paper. Please use the following, so that the proper credit is given to OVS 
and the AAO: 
“Reproduced with permission from: Lorentz H, Jones L. Lipid deposition on hydrogel 
contact lenses: how history can help us today. Optom Vis Sci 2007;84:286-95. ©The 
American Academy of Optometry 2007.” 
Best of luck with your thesis, 
Kurt 
************************************************** 
Optometry and Vision Science 
Kurt A. Zadnik, Managing Editor 
The Ohio State University, College of Optometry 
338 West 10th Avenue 
286 
 
Columbus, OH 43210 




From: Holly Lorentz [mailto:hmelchin@sciborg.uwaterloo.ca] 
Sent: Monday, September 26, 2011 1:00 PM 
To: Zadnik, Kurt 
Subject: Permission for use of my own article 
Hello 
My name is Holly Lorentz and I have a article published in OVS (Lorentz H, Jones L. 
Lipid deposition on hydrogel contact lenses: how history can help us today. Optom 
Vis Sci. 2007 Apr;84(4):286-95.) and I would like to use a significant portion of this 
article in my PhD thesis. I am unable to use the entire article (due to new data and 
research completed since the original review paper’s publication), but I would like 
to use the portion titled “lipid deposition on contact lens materials” specifically 
pertaining to past research completed on lipid deposition on conventional hydrogel 
lens materials, including Figures 2,3 and 4. 
Please let me know if this is possible and how I can obtain official permission for 
this request. I do not know if this request fits under normal rights and permission 




Holly Lorentz BSc, MSc 
PhD Candidate in Vision Science 
Centre for Contact Lens Research 
School of Optometry 
University of Waterloo 
200 University Avenue West 
Waterloo, Ontario, Canada N2L 3G1 
1-519-888-4567 
extension # 37009 (lab) or #36210 (office) 
hmelchin@scimail.uwaterloo.ca 
 
